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SUMMARY
The development of techniques of anaesthesia, and the 
pharmacology of currently used injectable anaesthetic agents, have 
been reviewed to illustrate recent progress in medical and 
veterinary anaesthesia, and to identify areas where improvements 
in drugs and techniques could be sought.
In routine veterinary anaesthesia arterial blood pressure 
is rarely monitored, and the adequacy of ventilation is generally 
assessed by observation of the rate and depth of respiration. In 
this study, simple techniques, suitable for the measurement of 
arterial blood pressure and carbon dioxide tension in anaesthetised 
dogs, have been validated. Values of alveolar carbon dioxide 
tension, obtained with an infra-red analyser sampling end-tidal 
expired gas, were shown to correlate well with measurements made 
with a Severinghaus carbon dioxide electrode on samples of 
arterial blood; while the accuracy of indirect measurements of 
arterial pressure, made with a Newcastle infant sphygmomanometer, 
was shown to be dependent on the size of the occluding cuff.
The above techniques were used in a comparative study 
of the clinical efficacy, in dogs, of three neuroleptic and 
analgesic drug combinations. The incidence of excitatory side 
effects with all three mixtures was such that none could be 
considered as a reliable alternative to conventional general 
anaesthesia for major surgery. For use in minor procedures 
the combination of etorphine and methotrimeprazine produced
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the most consistent analgesia, but also the greatest degree of 
respiratory depression. The respiratory depressant effect of 
fentanyl alone was shown to be greater than that produced by 
the combination of droperidol and fentanyl.
In medical anaesthesia, a renewed interest in techniques 
of total intravenous anaesthesia has been one of the 
consequences of recent concern about the possible deleterious 
effects of operating theatre pollution with waste anaesthetic 
gases and vapours. The profile of an ideal, short acting and 
non-cumulative drug has been outlined as the review of the 
properties of currently used injectable anaesthetic agents 
indicated that none could be considered to be entirely 
satisfactory when used to maintain anaesthesia by intravenous 
infusion.
Preliminary examination of the anaesthetic properties 
of a series of 2,6-dialkyIphenols in mice and rabbits indicated 
that 2,6-diisopropylphenol (disoprofol) appeared to have a 
desirable pharmacological profile. Methods were developed 
to examine in detail the anaesthetic potency of this compound, 
its speed of onset, cumulative effect, cardiovascular and 
respiratory effects, and its interactions with ancillary 
drugs used in anaesthesia. Results obtained with disoprofol 
were compared with those of standard agents and the importance 
of using equianaesthetic doses and constant injection times 
was demonstrated. These results indicate that disoprofol 
is a rapidly acting agent with an anaesthetic potency 
similar to that of methohexitone. The duration of
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anaesthesia produced by a single dose was short and, in marked 
contrast to thiopentone, minimal cumulation was seen when the drug 
was given by repeated injection to mice. The cardiovascular 
and respiratory effects produced by disoprofol in pigs were 
generally similar to those produced by thiopentone and 'Althesin'. 
A secondary pressor response followed the initial hypotensive 
effect of thiopentone and 'Althesin' but was not seen after the 
administration of disoprofol.
In human patients the anaesthetic, propanidid, has been 
reported to potentiate the neuromuscular blocking effects of 
suxamethonium. An animal model, in which this interaction can 
be demonstrated was developed and using this model it has been 
shown that a similar potentiation of the effect of 
suxamethonium does not occur with disoprofol, thiopentone, 
methohexitone or 'Althesin'.
Water solubility is accepted as a highly desirable 
property in an intravenous anaesthetic agent. Unfortunately 
disoprofol is a highly lipophilic compound which does not , 
dissolve readily in water. This drug is currently solubilized 
with the aid of Cremophor EL, a surfactant which is present 
in the commercial preparation of propanidid and the mixture of 
anaesthetic steroids containing alphaxalone and alphadolone 
acetate.
In man a number of anaphylactoid reactions to Cremophor- 
containing anaesthetic agents have been reported and uncertainty 
still exists as to the role of the surfactant in these reactions.
IV
An animal model has been developed, using the miniature pig, 
in which it has been possible to demonstrate a characteristic 
anaphylactoid response to Cremophor SL and Cremophor-containing 
anaesthetics, when a second injection has been given seven 
days after an initial dose. A similar response was not produced 
when propanidid was given in a non-Creraophor formulation, but 
the results obtained with alphaxalone and alphadolone suggest 
that the steroids and the surfactant may both contribute to the 
reactions to this agent seen in man. These findings indicate 
that Cremophor EL is unlikely to be a satisfactory agent for the 
formulation of disoprofol, but the results obtained in the pig 
appear to be sufficiently consistent to allow the model to 
be used for the evaluation of alternative surfactants for 
lipophilic intravenous anaesthetics.
INTRODUCTION
The development of new drugs for use in human anaesthesia has 
provided veterinary anaesthetists with the opportunity of examining 
the efficacy of these new agents in clinical veterinary anaesthesia. 
The opposite situation may also occur where the effects of new 
chemical compounds are first examined in experimental animals, to 
define the pharmacological profile of these compounds, before 
they are subjected, after the satisfactory completion of safety 
evaluation studies, to clinical trial in man.
In the selection of potential new anaesthetic agents a knowledge 
of the deficiencies of currently used agents and techniques is 
required. By comparing the pharmacological effects of new agents with 
those of established agents, the likely advantages of a new agent 
can be predicted from results obtained in a range of experimental 
animals.
The first part of this investigation describes the development 
of simple methods for the estimation of arterial blood pressure and 
carbon dioxide tension in anaesthetized dogs and a study of the 
clinical pharmacology and efficacy of some injectable anaesthetic 
agents which have been recently introduced into clinical veterinary 
anaesthetic practice. The second part is concerned with aspects 
of the detailed evaluation in experimental animals of a chemical 
compound, 2,6-diisopropylphenol, an agent which had not previously 
been used as an anaesthetic in man.
Over the years the basic aims of anaesthesia, i.e. to provide 
suitable conditions for surgery and to protect the patient from the 
effects of surgery, have remained unchanged. The concept of general
anaesthesia has however changed to a certain extent, largely 
due to evolution of new techniques and the development of new 
drugs, such that the components required for a satisfactory 
anaesthetic technique may now be provided by a number of 
alternative methods.
1. HISTORICAL DEVELOPMENTS IN ANAESTHESIA
1.1 Developments in medical anaesthesia
The merit of the discovery of general anaesthesia belongs 
to William Morton who, on October 16th, 1846, demonstrated the 
practicability of ether anaesthesia at Massachusetts General 
Hospital in Boston. In discussing the events which preceded 
this discovery Armstrong Davison (1965) has pointed out that, 
by the end of the eighteenth century, there had grown up a 
sufficient body of knowledge to have rendered anaesthesia 
practicable, had it been possible to draw the relevant 
facts together.
Paracelsus (von Hohenheim), who died in 1541, 
described the synthesis of ether in his 'Opera Medico-Chemica 
sive Paradoxa' which was first printed in 1605. This author 
even described experiments with ether: ".... it has an
agreeable taste, so that even chickens take it gladly and 
thereafter fall asleep for a long time, awakening unharmed.
In view of the effect of this vitriol, I think it especially 
noteworthy that its use may be recommended for painful 
illnesses, and that it will mitigate the disagreeable 
complications of them." However, not until the circulation 
of the blood had been demonstrated by William Harvey in 1628 
could there by any rational attempt at the administration of 
drugs by inhalation or by intravenous injection.
In the eighteenth century scientific advances continued with 
an increasing tempo and an important part of the scientific research 
of this period was directed towards work with gases. Hydrogen was 
isolated by Cavendish in 1766 and Joseph Priestly, closely followed 
by Scheele, produced oxygen in 1771 and nitric and nitrous oxide 
in 1772. Humphry Davy experimented with nitrous oxide and in his 
Researches Chemical and Philosophical, chiefly concerning Nitrous
Oxide..... and its Respiration the following statement appears:
"As nitrous oxide in its extensive operation appears capable of 
destroying physical pain, it may probably be used with advantage 
during surgical operations in which no great Qffusion of blood 
takes place".
The exhilarating effects of both ether and nitrous oxide 
became well known and were demonstrated at fairs in the United 
States of America by itinerant chemists. Horace Wells, a 
Connecticut dentist attended a demonstration of the intoxicating 
effects of nitrous oxide in 1844. He arranged to have one of 
his own teeth extracted under the influence of this gas and 
later satisfied himself that nitrous oxide was an effective 
anaesthetic by using it in a dozen cases. Wells attempted 
to demonstrate his technique to students and physicians at 
the Massachusetts General Hospital, but the patient was only 
partly anaesthetized and the audience were unimpressed.
William Morton witnessed the failure by Wells to produce 
anaesthesia with nitrous oxide and sought a more powerful agent. 
After consulting an eminent chemist, Charles Jackson, on the 
properties of ether, Morton initiated studies with this agent 
which culminated in his successful demonstration of anaesthesia 
in Boston in 1846. News of the discovery of anaesthesia 
spread quickly and in a short time ether was being widely used.
In 1847 it was introduced into obstetric practice by 
Sir James Y. Simpson, Professor of Midwifery at Edinburgh.
Sinçjson also experimented with chloroform, which had been 
discovered in 1831, and introduced this agent in his practice 
in 1847.
Nitrous oxide was later re-introduced and ether and 
chloroform, administered alone, or in combination with this 
gas remained for a time the most widely used anaesthetic agents.
In 1933 Waters and his colleagues at Madison, Wisconsin introduced 
cyclopropane into clinical practice. Dennis Jackson of 
Cincinnati University re-described in 1934 the anaesthetic 
properties of trichloroethylene, which had first been used 
as an anaesthetic agent in animals by Lehmann in 1911 while 
working at Wurzburg University (Wylie and Churchill-Davidson,
1966). The pharmacological properties of halothane, a 
fluorinated hydrocarbon, were first described by Raventos 
(1956) and this agent, being non-flammable and stable in 
the presence of soda lime, rapidly achieved considerable 
popularity as an inhalation anaesthetic. Another fluorinated 
hydrocarbon, methoxyflurane, was first studied by Van Poznak
and Artusio (1960) and more recently the methyl ethyl ether, 
enflurane, has been introduced into clinical practice (Virtue, 
Lund, Phelps, Vogel, Beckwitt and Heron, 1966). Isoflurane, 
an isomer of enflurane, has been examined in animals (Byles, 
Dobkin, Ferguson and Levy, 1971) and in limited human studies 
(Dobkin, Byles, Ghanooni and Valbuena, 1971; Stephens, 
Cromwell, Halsey, Eger, Shakespeare and Bahlman, 1971) but has 
not yet been widely used in patients.
By 1853 the stage had been set for the development of 
intravenous medication by Alexander Wood of Edinburgh when 
he combined the hollow hypodermic needle developed by 
Francis Rynd, a Dublin surgeon, with a glass syringe with 
a tapered nozzle developed in the same year by Charles 
Gabriel Pravaz of Lyons (Dundee and Wyant, 1974). Intravenous 
anaesthesia was first undertaken in 1872 by Ore of Bordeaux 
with chloral hydrate, but the first successful use of this 
route depended on the development of the bariturate group, 
first synthesized by Fischer and von Mering in 1903. In 
1932, Weese and Scharpff introduced hexobarbitone and this 
was quickly followed by thiopentone, introduced by Lundy at 
the Mayo Clinic in 1934 (Armstrong Davison, 1965). Despite 
some competition from other barbiturates, thiopentone has 
remained essentially unchallenged among the intravenous 
anaesthetics. Of the many other barbiturates examined, 
methohexitone, which was first given to human patients 
by Stoelting (1957), has been the only barbiturate to compete
with thiopentone and only in recent years have any practical 
alternatives to the barbiturates appeared. Propanidid 
was the first eugenol derivative to be used on a wide scale 
in anaesthesia. An early clinical comparison of propanidid 
with methohexitone and thiopentone in man soon established 
its main properties (Dundee and Clarke, 1964). A mixture 
of two steroids, alphaxalone and alphadolone acetate, 
was first given to human patients by Campbell, Forrester, 
Miller, Hutton, Kennedy, Lawrie, Lorimer and McCall (1971).
An imidazole derivative, etomidate, is the latest intravenous 
induction agent to be introduced into clinical practice 
(Doenicke, 1974).
The first neuromuscular blocking drug to be used in 
anaesthesia was a relatively crude extract of curare 
(Griffith and Johnson, 1942), Gray and Halton (1946) 
described a series of over 1,000 patients to whom a pure 
crystalline alkaloid, d-tubocurarine chloride, had been 
administered. A significant milestone in the development 
of anaesthesia was the introduction by Rees and Gray (1950) 
of the concept which views anaesthesia as a triad, the 
components of which, narcosis, relaxation and analgesia, 
ideally are provided by specific drugs with selective 
actions. The technique, whereby thiopentone was used to 
induce sleep, muscular relaxation was produced with a 
neuromuscular blocking drug, and the response of the 
patient to noxious stimuli was reduced by the use of 
nitrous oxide and occasionally a more potent specific
analgesic drug, was described in more detail by Gray and Rees 
(1952) .
Techniques aimed at the production of sedation or light 
sleep with intense analgesia were first devised in France 
between 1952 and 1954. A 'lytic cocktail' combining a 
potent analgesic and two tranquilizers was used and the 
resulting state was termed 'artificial hibernation'.
De Castro and Mundeleer (1959) introduced the tezrm 
'neuroleptanalgesia' for a similar technique which combined 
the neuroleptic properties of certain butyrophenones with 
the profound analgesia produced by potent short acting 
analgesics. Recent developments in the use of both 
neuroleptics and analgesics have followed the trend set 
by Brown, Horton and Macrae (1963) and have been directed 
toward their inclusion with nitrous oxide and a muscle 
relaxant as part of a balanced anaesthetic technique.
Ketaraine, a phenylcyclohexylamine derivative, was 
first given to human patients by Corssen and Domino 
(1966). These authors described the effect as 
"dissociative anaesthesia" as the drug produced a state 
characterized by catalepsy, amnesia and marked analgesia, 
with only superficial sleep. Anaesthesia with ketamine 
is accompanied by a high frequency of undesirable side 
effects, and emergence excitement and unpleasant dreaming 
have caused this drug to retain only a limited place in 
human anaesthetic practice (Dundee, Knpx, Black, Moore, 
Pandit, Bovill, Clarke, Love, Elliot and Coppel, 1970).
The most recent development in the use of injectable 
anaesthetic agents has been the investigation of techniques for 
the maintenance of anaesthesia by the infusion of intravenous 
anaesthetic agents (Du Cailar, 1972; Savage, Ramsey, Curran, 
Cotter, Walling and Simpson, 1975; Mocavero, Gregoretti and 
Bosatra, 1976; Park and Wilson, 1978). One stimulus to 
developments in this direction has been the increasing concern 
in recent years that pollution of the operating room atmosphere 
with anaesthetic gases and vapours may have harmful effects on 
operating room personnel.
1.2 Developments in veterinary anaesthesia
General anaesthesia was first induced in animals by the 
inhalation of ether. Almost immediately after the publication 
of Morton's work on the administration of ether to human beings 
this agent was adopted as an anaesthetic for animals in the 
Royal Veterinary College, London. The introduction of 
chloroform as an anaesthetic in man was followed by its 
application in the horse throughout the United Kingdom 
(Hall, 1971).
Chloral hydrate was one of the earliesf'basal narcotic" 
agents to be introduced into veterinary practice and this agent 
is still widely used in equine practice. Pentobarbitone was 
used as a general anaesthetic in veterinary surgery in America 
and Kreutzer (1931) and Haigler (1931) were amongst the first to
record its use. In this country the use of pentobarbitone was
described by Wright (1934). The drug was initially
administered orally or by intraperitoneal injection and
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entirely consistent results could not be obtained. Auchterlonie 
(1934) administered hexobarbitone to animals by intravenous 
injection and the later use of this route for the administration 
of pentobarbitone was one of the factors which made possible a 
considerable increase in general surgical work. The use of 
thiopentone for animal anaesthesia was first recorded in 
America by Sweebe (1936) and it has since been extensively 
employed throughout the world.
A technique of balanced anaesthesia for the dog and cat, 
using a combination of inhalation and injectable anaesthetic 
agents, was described by Hall and Weaver (1954) and Campbell and 
Lawson (1958) examined in detail the signs by which the level of 
anaesthesia in animals could be judged. Halothane was 
introduced into veterinary anaesthesia by Hall (1957) and 
Fisher and Jennings (1961) described its respiratory effects 
in cattle, horses, sheep and dogs.
In more recent years the development of new agents for 
use in human anaesthesia has continued to be followed by an 
examination of their utility in veterinary practice.
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2. METHODS USED IN CLINICAL PHARMACOLOGICAL STUDIES OF INJECTABLE 
ANAESTHETICS IN DOGS
2.1 Indirect blood pressure measurement
Detailed investigations of the haemodynamic effects of new 
anaesthetic agents have in the past been restricted to studies in 
experimental animals. In early studies with phencyclidine 
(Chen, Ensor, Russell and Bohner, 1959), fentanyl and droperidol 
(Yelnosky and Gardocki, 1964) and with ketamine (McCarthy, Chen, 
Kaump and Ensor, 1965) blood pressure in a cannulated carotid 
or femoral artery was measured in anaesthetised dogs with a 
mercury manometer. The latter authors also examined the 
haemodynamic effects of ketamine in conscious dogs and measured 
arterial blood pressure in a previously isolated, skin covered, 
carotid loop with a strain gauge transducer. In an experimental 
study of the cardiovascular effects of etomidate, propanidid and 
thiopentone Patschke, Bruckner, Gethmann, Tarnow and Weymar 
(1975) used a pressure transducer to measure blood pressure 
in a cannulated femoral artery in dogs initially anaesthetised 
with piritramide. Blane, Boura, Fitzgerald and Lister (1967) 
also used a pressure transducer and cannulated an artery in 
pentobarbitone anaesthetised dogs in an experimental study 
of the actions of etorphine hydrochloride.
Although direct measurement of blood pressure, 
involving some degree of surgical intervention, can readily 
be employed in experimental situations, the use of this 
technique on a routine basis cannot be justified in 
investigations performed on clinical cases. Methods of
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indirect blood pressure measurement are frequently employed in 
clinical studies in man but it is noteworthy that the early 
clinical studies with neuroleptanalgesia mixtures in dogs 
(Yelnosky and Field, 1964? Soma and Shields, 1964?
Marsboora et al, 1964? Franklin and Reid, 1965? Crooks,
Whiteley, Jenkins and Blane, 1970) provide no detailed 
information on the effects of the various drugs investigated 
on arterial blood pressure. The most probable explanation 
for this omission is the fact that techniques of indirect 
blood pressure measurement have not become established as 
part of the routine monitoring procedure during clinical 
veterinary anaesthesia. Numerous methods for indirect
Î
measurement of blood pressure in dogs have been described 
but technical difficulties and the inaccuracy inherent 
in many of the methods employed have prevented their more 
widespread use. The development of a simple and satisfactory 
technique for the indirect measurement of blood pressure 
was one of the objectives of this study.
2.2 Measurement of end-tidal carbon dioxide concentration
As a number of drugs used in anaesthetic practice are 
known to reduce metabolic rate and oxygen consumption (Jennett, 
1968) measurement of alveolar ventilation alone may provide an 
inaccurate assessment of the degree of any respiratory depression 
present. With drugs which reduce oxygen consumption and carbon 
dioxide production, a reduced level of alveolar ventilation may 
be adequate to maintain a normal arterial carbon dioxide tension.
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In this situation the direct measurement or estimation of arterial 
carbon dioxide tension provides a more accurate assessment of 
the adequacy of ventilation.
Although only a small and statistically insignificant 
reduction in basal metabolic rate was produced by the 
administration of a neuroleptanalgesia mixture containing 
fentanyl and droperidol in a study in human patients (Forbes, 
Ovassapian, Smith and Wollman, 1967) a 45 to 50 per cent 
reduction in oxygen consumption has been reported with 
neuroleptanalgesia techniques in dogs (Gemperle, 1965). While 
fentanyl has been shown to have little effect on heart rate 
in man (Prys-Roberts and Kelman, 1967) a marked reduction 
in heart rate to less than 50 per cent of control values has 
been noted in dogs (Marsboom et al., 1964). A marked 
reduction in myocardial oxygen consumption would be 
expected to accompany this degree of bradycardia in the 
dog and this factor may partly explain the conflicting 
results in the two species.
The method most frequently used for the measurement 
of arterial carbon dioxide tension (PaCO^) involves 
electrometric measurement using a carbon dioxide electrode 
of the type developed by Severinghaus and Bradley (1958) .
The collection of arterial blood samples requires either 
repeated needle puncture of an artery or the placement of 
a catheter in an artery. The latter method is frequently 
employed in experimental studies and arterial blood samples
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were collected in a study of the respiratory effects of 
neuroleptanalgesia mixtures in dogs reported by Short, 
Greenwald and Bendick (1970). It is rarely possible to 
collect numerous arterial samples during investigations 
performed on clinical cases and a method for the indirect 
measurement of PaCO^ is required in this situation.
It is usually assumed that the average PCO^ in 
alveolar gas equals that in arterial blood as the alveolar- 
capillary membrane offers no significant obstruction to the 
diffusion of carbon dioxide. Many investigators have found 
PaCO^ to be nearly equal to that found in expired gas at the 
end of expiration (Suskind and Rahn, 1954; Severinghaus, 
Stupfel and Bradley, 1957; Evans, Hogg and Rosen, 1977; 
Littlejohn, 1969). Severinghaus and Stupfel (1957) noted 
an average arterial-alveolar difference of 3ramHg in
normal dogs without anaesthesia or artificial respiration.
In anaesthetised dogs these authors found that the arterial- 
alveolar PCOg difference followed closely any changes in 
alveolar dead space.
As the measurement of PaCO^ in dogs has in the past 
been restricted to experimental studies, one objective of 
the present study was to assess the accuracy of end-tidal 
PCO^ measurement in dogs as a method for the estimation of 
arterial during clinical anaesthesia when using a
variety of anaesthetic techniques.
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3. PHARMACOLOGICAL PROPERTIES OF CURRENTLY USED INJECTABLE 
ANAESTHETIC AGENTS
In any assessment of the utility of new anaesthetic 
compounds it is necessary to have a knowledge of the properties 
of, and the conditions provided by, established agents. A 
brief review will be provided of the pharmacological 
properties of the most widely used injectable anaesthetic 
agents and some of the drugs which have been more recently 
introduced into anaesthetic practice, and are relevant to 
the studies described in this investigation. The chemical 
structures of the compounds discussed are shown in Fig. 1.
3.1 Thiopentone sodium: sodium 5-ethyl-(1-methylbutyl)-2-
thiobarbiturate
Thiopentone was the first thiobarbiturate to be used 
as an anaesthetic and is still the one in most widespread 
clinical use. It is a rapidly acting agent and the time taken 
to produce loss of consciousness is essentially the vein-to- 
brain circulation time. Thiopentone has a dissociation 
constant (pKa) of 7.4 (Bush, 1961) so that about 50% of the 
drug in blood is present in the non-ionised form. The non­
ionised fraction has a high lipid solubility which allows it 
to pass rapidly into the brain (Price, Dundee and Conner,
































Fig. 1 Chemical structures of currently used injectable
anaesthetics
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It has been observed that when a large 
dose of thiopentone is used for the induction of
anaesthesia, recovery of consciousness occurs at a greater plasma 
drug concentration than after a small dose (Dundee, Price and 
Dripps, 1956). This 'acute tolerance' is probably the explanation 
for the clinical observation that recovery from the rapid injection 
of a given dose of thiopentone occurs more quickly than would be 
the case if the same dose were to be given more slowly.
The immediate uptake of thiopentone by the brain is 
accompanied by a similar rapid uptake in other well perfused 
non-nervous, tissues such as the liver and kidneys and the 
plasma concentration falls quickly. The amount of drug reaching 
the brain is thus decreased and as the brain content falls 
anaesthesia lightens. With the exception of muscle and fat, 
the maximum tissue concentration of thiopentone is reached within 
one minute of a single intravenous injection. Equilibrium with 
muscle tissue is not attained until 15 minutes after injection, 
and despite its high affinity for fat, because of the poor blood 
supply, uptake of the drug in adipose tissues is slow and maximum 
deposition only occurs after about 2h hours (Price, Knovat, Safer, Conner 
and Price, 1960). By this time the content of thiopentone in fat greatly exceeds 
that of other tissues and body fat content may be a factor in 
determining the duration of action of large doses of thiopentone.
When thiopentone is given by intermittent injection or 
infusion, the concentration in some tissues approaches equilibrium 
with the thiopentone in blood. Thus the body gradually loses its 
ability to remove thiopentone from the brain and recovery 
following the administration of large doses becomes more
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dependent on metabolic degradation of the drug. This is a slow
process as only 10-15 per cent of the drug in the body is metabolised per hour
in man, and five per cent per hour in the dog (Brodie, Mark, Papper, Lief,
Bernstein and Rovenstine, 1950). Thus recovery from thiopentone occurs
when a large amount of drug remains unchanged in the body and
a cumulative effect is observed after repeated doses. In a
recent study of the pharmacokinetics of thiopentone in human
patients (Christensen, Andreasen and Jansen, 1980) terminal
serum half-lives were found to range from 4.5 - 22 hours in ,women
and 4 - 8  hours in men following a single induction dose.
Thiopentone produces a progressive depression of the central 
nervous system and respiratory depression is marked, as the sensitivity 
of the respiratory centre to carbon dioxide is depressed in 
proportion to the depth of narcosis (Patrick and Faulconer, 1952).
A variable degree of hypotension is the usual sequel to 
the injection of thiopentone. Price, Dundee and Conner (1957) found 
a linear relationship between blood thiopentone concentration and 
the degree of arterial hypotension in man.
Thiopentone, like all barbiturates, has little, if any, 
analgesic action and reflex responses to stimuli are not 
abolished until an appreciably greater depth of anaesthesia 
is reached than is required with such agents as ether. With 
the barbiturates the clinical depth of anaesthesia is related to 
the intensity of the surgical stimulus as well as the degree of 
cerebral depression. In human patients Clutton-Brock (1960) 
and Dundee (1960) demonstrated an increased sensitivity to 
pain following the administration of subnarcotic doses of thiopentone.
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An apparent increase in the sensitivity of the laryngeal reflexes 
also occurs under light thiopentone narcosis. This is probably due 
more to a failure of the barbiturate to depress the laryngeal 
reflexes rather than to any stimulant action.
Aqueous solutions of thiopentone are strongly alkaline 
(pH 10.5) and therefore irritant to tissues. If enough of the 
solution is placed extravenously it may cause necrosis of the 
subcutaneous tissue. Intra-arterial injection of thiopentone 
produces arterial spasm and thrombosis of the artery or its 
distal terminations may occur (Kinmonth and Shepherd, 1959).
The popularity of thiopentone is a consequence of the 
effectiveness of the drug in rapidly producing anaesthesia, 
the onset of which is usually smooth and unaccompanied by any 
movement or other excitatory side effects. One contraindication 
to the use of the drug in man is the condition of porphyria, 
where, in the latent stage of the disease, any barbiturate 
administration may cause an acute exacerbation with porphyrinuria, 
paralysis and frequently death.
Thiopentone is widely used in all of the domestic animal species 
and few absolute contraindications to its use exist. Although 
porphyria has been described in cats (Tobias, 1964) it is 
probably a very rare condition. The duration of effect is 
generally predictable in dogs but in a breed such as the 
greyhound, which has very little body fat, an impaired ability 
to reduce the concentration of thiopentone may cause narcosis 
to be prolonged (Stevenson, 1958; Bogan, 1970).
19
Significant disadvantages of thiopentone are its cumulative 
effect on repeated administration which limits its use to the 
induction of anaesthesia, its lack of analgesic properties, and 
its irritant effects following perivascular or intra-arterial 
injection.
3.2 Pentobarbitone sodium; sodium 5-ethyl-5-(1-methylbutyl)-barbiturate
Pentobarbitone is less lipid soluble than thiopentone and 
takes longer to cross the blood-brain barrier (Brodie, Kurz and 
Schanker, 1960). Hermann and Wood (1952) found that in rats the 
duration of narcosis was unaffected by the amount of body fat 
present and that the removal of pentobarbitone from plasma depended 
primarily on the rate of metabolic breakdown of the compound. In 
the dog the plasma concentration of pentobarbitone is reduced at 
a rate of 10-15 per cent per hour whereas in man the equivalent figure is 
about 4 per cent per hour (Brodie, Burns, Mark, Lief, Bernstein and Papper, 
1953). The duration of anaesthesia in both man and animals is significantly 
greater than that produced by an equivalent dose of thiopentone.
Pentobarbitone is non-irritant if injected perivascularly 
but in other respects, including its effects on respiration and 
circulation, it has pharmacological properties similar to those 
of thiopentone.
In man, pentobarbitone is seldom used as an anaesthetic 
agent but it may be employed as a pre-operative sedative. In 
veterinary practice pentobarbitone continues to have some 
limited use as a sole anaesthetic agent in situations where 
facilities are not available to allow inhalation techniques 
to be used.
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Difficulty in accurately controlling the depth of anaesthesia 
and a prolonged recovery period are the major disadvantages of 
pentobarbitone anaesthesia.
3.3 Methohexitone sodium: sodium a - -5-allyl-l-methyl-5-
-^2dlH®!Ë^]Xkz^Z£££IËâîBZii^ ^£ËiiH£Ê^2.
The properties of methohexitone in roan have been described 
by Taylor and Stoelting (1960). It shares many of the properties 
of thiopentone but is about three times as potent and has a 
shorter duration of action. Respiratory depression is present 
at effective anaesthetic doses and may be greater than with 
equivalent doses of thiopentone. Laryngospasm and coughing 
are no more frequent than after other barbiturates but the 
incidence of hiccough is greater. Muscle movement and tremor 
are often reported as a complication of its use and their 
frequency and severity appear to be related to the premedication 
used. Moore and Dundee (1961) noted that the incidence of 
excitatory phenomena was reduced by premedication which had an 
analgesic component and was increased by premedication which 
increased sensitivity to somatic pain.
The administration of methohexitone produces pain at the 
site of injection in a high proportion of patients but the 
incidence of vascular damage is low and no untoward sequelae 
have followed its extravenous or intra-arterial injection.
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The lower fat solubility of methohexitone, in comparison 
with thiopentone seems to be associated with less extensive 
localization of the drug in fat (Brand, Mark, Snell, Vrindten and 
Dayton, 1963) and Clarke and Dundee(1966) have confirmed that it 
is less cumulative than thiopentone when both drugs are given by 
intermittent injection. Full recovery after raethohextione 
anaesthesia also occurs more rapidly than with thiopentone 
(Barry, Lawson and Davidson, 1967). This is supported by the 
finding of a relatively short elimination half-life of 70-125 
minutes for methohexitone (Breimer, 1976), which indicates that 
the rate of hepatic metabolism is considerably greater than 
that of thiopentone.
Methohextione has been used in both large and small 
domestic animals and in general the anaesthetic properties of 
this agent are similar to those described in man. Unfortunately, 
in animals the recovery period is often complicated by muscle 
tremors or even frank convulsions (Fowler and Stevenson, 1961). 
These undesirable features are not seen if the animal is 
allowed to recover quite undisturbed, or if pethidine or a 
phenothiazine ataractic drug is used for premedication.
In comparison with thiopentone, the shorter duration 
of anaesthesia and the more consistent rapid awakening provided 
by methohexitone are significant advantages. Pain on injection 
and a high frequency of excitatory phenomena are the main 
disadvantages associated with the use of this compound.
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3.4 Propanidid: propyl 4-diethyl~carbamoylmethoxy-3-
methoxyphenyl acetate
Propanidid, a eugenol derivative, was the first non­
barbiturate to be used widely as an intravenous anaesthetic 
agent. Though propanidid is an oil, a five per cent solution 
miscible with water can be achieved by dissolving it in a 
20 per cent solution of the non-ionic surface active agent 
Cremophor EL. More recently Micellophor, a 16 per cent 
solution of the hydrophobic fraction of Cremophor EL has 
been used as the solvent.
The pharmacological properties of propanidid in 
animals have been described by Wirth and Hoffmeister (1965). 
Anaesthesia is induced in the vein-to-brain circulation time 
and potency is similar to that of thiopentone. The duration 
of anaesthesia is very short and animals return to normal 
rapidly. Blood pressure falls during the first few minutes, 
mainly as a result of peripheral vasodilatation, but usually 
returns to normal within 3 to 10 minutes. The early stages 
of anaesthesia are accompanied by hyperventilation which is 
followed in the higher doses by a period of apnoea. There 
is no evidence of analgesia or anti-analgesia, though 
propanidid has a definite local anaesthetic action when 
injected into tissues.
In the dog propanidid produces an anaphylactoid 
response with the release of histamine and other vaso-active
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substances. Lorenz, Meyer, Doenicke, Schmal, Reimann, Hutzel 
and Werle (1971b)have demonstrated that the surface active 
agent, Cremophor EL, is responsible for this reaction.
Propanidid has not been used on a wide scale in 
veterinary anaesthesia because of the above response in the 
dog and because of its brevity of action in other species 
which makes anaesthesia very difficult to control.
Early studies with propanidid in man (Dundee and 
Clarke, 1964; Howells, Odell, Hawkins and Steane, 1964) 
indicated that the induction dose of 4.1 mg kg  ^was 
similar to that required with thiopentone. These 
workers also demonstrated that the duration of anaesthesia 
with propanidid was shorter than with thiopentone, with a 
more rapid return to clear headedness, and that no cumulation 
of effect occurred with repeated doses. Propanidid induced 
fewer excitatory phenomena than methohexitone but caused 
more postoperative emetic sequelae than methohexitone 
and thiopentone, when used with nitrous oxide:oxygen in 
patients undergoing gynaecological operations.
Respiratory effects in man were similar to those 
predicted from animal studies. There is general agreement 
than in man a 4 mg kg“  ^dose of propanidid produces a minor 
degree of hypotension similar to that seen with the same 
dose of thiopentone. Above a dose of 8 mg kg“  ^of 
propanidid the frequency and severity of hypotensive 
episodes increase beyond clinically acceptable levels
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(Clarke, 1974), There is some electrocardiographic 
evidence (Johnstone and Barron, 1968) that an initial 
quinidine like cardiac depression may contribute to the 
hypotensive effect.
In a comparative study with thiopentone, 
methohexitone and Althesin (alphaxalone:aiphadolone acetate), 
propanidid was found to produce a higher incidence of phlebitis 
and thrombophlebitis than the other three agents (Carson, 
Alexander, Hewitt and Dundee, 1972).
The extremely short duration of action of propanidid 
in man is the result of rapid hydrolysis of the active agent 
by plasma cholinesterase (Doenicke, Krumey, Kugler and 
Klerapa, 1968).'
Two features of propanidid anaesthesia will be 
discussed in more detail in later sections. The first is 
the interaction between propanidid and suxamethonium.
Clarke, Dundee and Daw (1964) confirmed an earlier 
observation that a period of apnoea and respiratory 
depression produced by suxamethonium was greater following 
induction of anaesthesia with propanidid than was the 
case when thiopentone was the anaesthetic agent. The 
second is the occasional occurrence of hypersensitivity 
reactions, characterized by marked hypotension and 
cutaneous vasodilatation, following induction of anaesthesia 
with propanidid (Larard, 1970; Bradburn, 1970).
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3.5 Alphaxalone and aiphadolone acetate ('Althesin' )'"Saffan"
Although Selye (1941) demonstrated that certain steroids 
possess anaesthetic properties in animals it was not until 
hydroxydione was introduced by Laubach, P'an and Rudel (1955) 
that a steroid was used on a wide scale as an intravenous 
induction agent in man (Murphy, Guadagni and De Bon, 1955). 
Hydroxydione produced anaesthesia which was followed by 
smooth recovery but it had several disadvantages. The dose 
was large, induction of anaesthesia was slow and it produced 
a high incidence of thrombophlebitis in the injected vein 
(Robertson and Wynn Williams, 1961). The pharmacological 
properties in animals of the steroid combination Althesin 
were first reported by Child, Currie, Davis, Dodds, Pearce 
and Twissell (1971) and with this mixture the disadvantages 
of hydroxydione appear to have been avoided.
Althesin contains 9 mg ml  ^ 3a-hydroxy-5a-pregnane-ll, 
20-dione (alphaxalone) and 3 mg ml 21-acetoxy-3a-hydroxy-5a- 
pregnane-11,20”dione (aiphadolone acetate) in an aqueous 
formulation containing 20 per cent of the surface-active 
agent Cremophor EL. In animals Child et al (1971) 
found that Althesin produced immediate induction of anaesthesia 
of short duration with rapid and uncomplicated recovery. It 
had a high therapeutic index (LD^^/ED^^) and was free from 
vascular irritation effects even when administered intra- 
arterially. In mice, repeated doses of Althesin were 
almost non-cumulative in marked contrast to thiopentone.
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In a detailed comparative study of the cardiovascular
and respiratory effects of intravenous anaesthetics in cats
(Child, Davis, Dodds and Twissell, 1972) Althesin was found
to produce less respiratory depression than other agents.
The cardiovascular effects of Althesin were characterized by
an initial short lasting tachycardia and fall in aortic blood
pressure succeeded by a secondary depressor response.
*
Althesin in a dose of 9,6 mg kg  ^exerted a hypotensive effect 
similar to that produced by a comparable dose of thiopentone 
(24 mg kg“^),
Evans, Aspinal and Hendy (1972) described the first 
clinical use of Althesin in cats by the intravenous or 
intramuscular routes. They concluded that a dose of 
9 mg kg"l induced anaesthesia of 10 to 12 minutes, sufficient 
for castration or dental procedures. The required level of 
anaesthesia could be maintained for longer periods with small 
supplementary intravenous doses as required. Satisfactory 
results following intramuscular injection were only obtained 
when a technique was adopted which ensured that the drug was 
not deposited into the fascial tissues surrounding muscles.
Although the effects of Althesin in horses, sheep 
and pigs have been investigated (Hall, 1972), the clinical 
use of the drug in veterinary practice has been largely 
restricted to its us e in cats, Althesin cannot be safely 
used in dogs because of the ability of the solubilizing 
agent, Cremophor EL, to produce marked histamine release 
and hypotension in this species.
*total steroid dose
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The use of Althesin in human patients was first described 
by Campbell et al (1971) and dose-response effects were 
subsequently investigated by Clarke, Montgomery, Dundee and 
Bovill (1971). The drug proved to be an effective and rapidly 
acting induction agent. The most suitable dose in adults was 
found to be 0,6 to o,72 mg kg  ^and with this dose minimal 
effects on respiration were seen. Hypotensive effects at 
induction were similar to those seen with equivalent doses 
of thiopentone. Recovery was rapid and there was a low 
incidence of postoperative nausea and vomiting.
Slight muscle movement or tremor is seen in about 20 
per cent of patients (Clarke, Dundee and Carson, 1972) 
but this occurs less frequently and is less marked than 
after an equivalent dose of methohexitone.
The lack of cumulative effect with Althesin 
suggests that the steroids are rapidly inactivated or 
eliminated from the body. Studies in the rat (Card, McCulloch 
and Pratt, 1972; Child, Gibson, Harnby and Hart, 1972) 
have shown that the plasma half life of ^^C-alphaxalone is 
six to eight minutes with the liver being the main site 
of metabolism. Approximately 80 per cent of the administered 
radioactivity was excreted in the bile during the first 3 hours 
after administration and subsequently appeared in the faeces.
A later study with '^^ C alphaxalone indicates that, in man, 
the major route of excretion is via the urine (Strunin,
Strunin, Knights and Ward, 1977), These studies with 
radiolabelled drug did not distinguish between alphaxalone
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and the metabolites formed. Recent work using a gas-liquid 
chromatographic method for the analysis of alphaxalone defined 
a plasma elimination half life of alphaxalone of 34 minutes 
(Simpson, 1978),
For a number of years Althesin was a popular induction 
agent in man, particularly for out patient procedures where 
rapid recovery from its effects was a distinct advantage.
More recently its popularity has declined as a significant 
number of hypersensitivity reactions have been associated 




Etomidate, the most recently introduced intravenous 
anaesthetic, has been more widely used in man in Europe 
than in the United Kingdom, Its animal pharmacology has 
been described by Janssen, Niemegeers, Schellekens and 
Lenaerts (1971) and Janssen, Niemegeers and Marsboom (1975),
The drug is water soluble and was originally used as the sulphate 
salt. In rats etomidate is about 6 times more potent than 
methohexitone and 20 times more potent than thiopentone and 
propanidid. The therapeutic index of etomidate is also 
greater than that of the other three agents investigated 
and is similar to that of Althesin (Child et al, 1971).
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Induction of anaesthesia with etomidate is rapid, duration of
hypnosis is dose dependent, and recovery from its effects occurs
very rapidly. In dogs anaesthesia was induced with a dose 
-1of 0,75 mg kg etomidate and in this species myoclonic 
contractions and tremors were occasionally observed.
In a comparative study of the cardiovascular effects 
of intravenous anaesthetics Patschke et al (1975) found that 
in dogs, anaesthetised with piritramide and nitrous oxide, 
etomidate produced less alteration of cardiovascular 
haemodynamics than equivalent doses of thiopentone and 
propanidid. Dogs given propanidid were pretreated with an 
antihistamine drug to prevent the effects of histamine 
release produced by the solubilizing agent, Cremophor EL,
An early study with etomidate in man (Doenicke, 1974) 
confirmed that the drug produced very minor circulatory 
effects and little effect on respiration. A dose of 
0,3 mg kg  ^was recommended for induction of anaesthesia 
and the duration of action of this dose corresponded to that 
following methohexitone 1,5 mg kg~^. Uncontrolled and 
uncoordinated spontaneous movements were noted in 30 per 
cent of the patients in this study and pain on injection 
was also encountered.
30
Minimal cardiovascular and respiratory effects, and 
similar side effects, were also reported by Morgan, Lumley 
and Whitwam (1975). Attempts to modify the effects of 
etomidate by changes in formulation and opiate premedication 
(Holdcroft, Morgan, Whitwam and Lumley, 1976; Hendry, Miller 
and Lees, 1977; and Zacharias, Dundee, Clarke and Hegarty, 
1979) have not been entirely successful in eliminating the 
undesirable side effects of pain on injection and myoclonic 
movements.
Etomidate has been given by repeated injection to 
maintain sleep in human patients and little evidence of 
cumulation has been seen (Kay, 1976). Van Hamme, Ghoneim 
and Ambre (1978) found a plasma elimination half life of
4.6 2.6 hours in patients given a single dose of 
0,3 mg kg~^ etomidate.
Etomidate has not yet been used to any significant 
extent in veterinary practice,
3.7 Dissociative anaesthetics
The characteristic property of dissociative anaesthetics 
which differentiates them from conventional anaesthetics is 
their ability to produce a state of catalepsy (Chen, 1965),
The first study in man with ketamine was described by 
Corssen and Domino (1966), In suggesting that the state 
induced by ketamine should be called 'dissociative 
anaesthesia' these authors believed that sensory input 
might reach cortical receiving areas but failed to be 
perceived in some of the association areas because
31
these were depressed by the drug,
Ketamine as the hydrochloride salt, is water soluble 
and was found to be well tolerated by tissues following 
intravenous or intramuscular administration. Surgical 
anaesthesia was established about 30 seconds after 
completion of the intravenous injection of doses of 
1.0 to 2.0 mg kg  ^ and five to eight minutes after the 
intramuscular injection of doses of 4 to 11 mg kg ^, 
Administration of ketamine resulted in an increase in 
arterial pressure in the majority of adult patients, A 
brief period of respiratory depression followed induction 
of anaesthesia but respiratory exchange rapidly returned 
to normal. Protective pharyngeal and laryngeal reflexes 
were present during the course of anaesthesia and skeletal 
muscle tone was usually increased, Ketamine produced good 
analgesia of the extremities and skeleton but was less 
effective in blocking responses to visceral pain. Vivid 
dreaming, with or without psychomotor activity, was 
experienced by a number of adult patients but did not 
occur in infants and children.
Although ketamine has been described as a rapidly 
acting general anaesthetic, the rate of onset is slower 
than after methohexitone (Bovill, Coppel, Dundee and 
Moore, 1971). Plasma decay curves show a biphasic or 
triphasic decline with an initial fast phase up to about 
45 minutes and a more slowly declining phase up to 12 hours,
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The plasma elimination half life was found to be 2,5 hours in one 
study in human patients (Wieber, Gugler, Hengstmann and Dengler, 
1975) and 3 hours in another (Clements and Nimmo, 1981).
Ketamine has now been widely studied in man and in 
general the initial clinical impressions have been 
confirmed. Knox, Bovill, Clarke and Dundee (1970) found 
that the chief complications at induction were hypertension 
and hypertonus, the incidence of which was only broadly 
related to dosage. Recovery of consciousness was rapid 
but marred by a high incidence of delirium at all dose 
levels. Hallucinations at this stage were so unpleasant 
that patient acceptance was much lower than with the 
barbiturates. Subsequent reports have been mainly concerned 
with attempts to minimise the undesirable side effects of 
ketamine with a variety of premedicant drugs. Pentobarbitone 
and droperidol were found to have little effect in improving 
the quality of the recovery period (Sadove, Hatano, Redlin, 
Thomason, Arastounejad and Roman, 1971).
Ketamine has retained more popularity in the United 
States of America than in the United Kingdom and this may 
be a reflection of differences in philosophy and standards 
of acceptability in the two countries. The desirable 
properties of the drug, in particular its efficacy by 
both the intravenous and intramuscular routes, its good 
analgesia, and the maintenance of laryngeal and 
pharyngeal reflexes, are such that it is likely to retain
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a limited place in anaesthetic practice. In children, where 
emergence problems are rarely encountered, it has been found 
to be particularly valuable for repeated burn dressings 
(Corssen and Oget, 1971) and cardiac catheterization studies 
(Coppel and Dundee, 1972). The drug may also find a place 
as an analgesic when given in subanaesthetic doses. In a 
recent experimental study, Grant, Nimmo and Clements 
(1981) found that pain tresholds were elevated 15 and 30 
minutes after the intramuscular injection of 0,5 mg kg“  ^
ketamine. With this dose all subjects remained conscious 
and orientated.
In veterinary practice ketamine has been used in sheep 
(Taylor, Hopkins, Young and McFadyen, 1972), in pigs 
(Thurmon, Nelson and Christie, 1972), in cattle (Fuentez 
and Tellez, 1974), in horses, in combination with xylazine 
(Brouwer, Hall and Kuchel, 1980) and in cats. The use 
of the drug as an intramuscular anaesthetic for cats 
was first reported in America by Commons (1970) and 
Beck, Coppock and Ott (1971). The latter authors 
summarized the results of six separate clinical trials 
involving 442 cats, and found that doses under 22 mg kg~^ 
ketamine produced basic chemical restraint, whereas 
doses of 22 to 44 mg kg provided cataleptoid anaesthesia.
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3.8 Neuroleptanalgesic drug combinations
The term 'neuroleptanalgesia* describes a neurophysiological 
state produced by the combination of a neuroleptic drug with an 
analgesic drug. This type of combination involving the use of a 
phenothiazine tranquilizer with an opiate analgesic has been a 
common component of balanced anaesthesia techniques for a number 
of years. The term has, however, come into more prominent use 
in recent years due to the development of more potent tranquilizers 
and analgesics and by using certain combinations it has been 
claimed that the neuroleptic component can potentiate the 
effect of the analgesic agent used (Yelnoski and Gardocki,
1964).
The new neuroleptic drugs are butyrophenone derivatives 
and have structures and actions similar to the phenothiazine 
class of tranquilizers. The most commonly used drugs of this 
type are droperidol and fluanisone (Fig. 2). The pharmacology 
of droperidol has been investigated in experimental animals 
by Janssen, Niemegeers, Schellekens, Verbruggen and Van Nueten 
(1963), Yelnosky, Katz and Dietrich (1964) and by Green
(1972). Low doses of the drug reduce spontaneous motor 
activity in dogs while larger doses produce ataxia and 
sleep from which animals may be readily aroused by 
handling. Side effects associated with higher doses are 
muscle tremors and twitching. The butyrophenone neuroleptics 
have a greater cataleptigenic effect than chlorpromazine.
A degree of alpha adrenergic blockade similar to that seen 
with chlorpromazine is produced. This contributes to the
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Fig. 2 Chemical structures of neuroleptic drugs used 
in neuroleptanalgesia techniques
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slight and transient hypotension produced by the drug, a 
reduction in total peripheral resistance, and an increase in 
peripheral blood flow. Slight respiratory stimulation may be 
seen and minimal myocardial depression is produced. Droperidol 
is also a very potent centrally acting anti-emetic.
The new analgesic drugs fentanyl and phenoperidine are 
similar in structure to pethidine (Fig. 3) but are much more 
potent. The pharmacological effects of fentanyl, in dogs, were 
investigated by Gardocki and Yelnosky (1964) who found that in 
addition to analgesia the drug produced sedation, bradycardia, 
hypotension and respiratory depression. The tone of the gastro­
intestinal tract was increased and sphincters relaxed. The 
drug has some emetic activity in man but this has not been 
seen in dogs. Fentanyl is 500 times more potent than 
pethidine as an analgesic and has a relatively short duration 
of action. Phenoperidine is about 50 times more active than 
pethidine and has a longer duration of action than fentanyl 
(Nilsson, 1963).
The potent analgesic, etorphine (Fig. 3), an oripavine 
derivative has been used in veterinary anaesthesia. When given 
intravenously it is about 150 and 2000 times more potent than 
morphine in the mouse and rat respectively. In laboratory 
animals etorphine produces a greater degree of catatonia and 
respiratory depression than equi-analgesic doses of morphine 




















When neuroleptanalgesia was first introduced into clinical 
practice in man (de Castro and Mundeleer, 1959) it was offered 
as an alternative to general anaesthesia and patients, although 
conscious, underwent even major surgery under the influence of 
droperidol and an analgesic alone. Although apparently well 
tolerated by patients this form of 'pure' neuroleptanalgesia 
has not gained wide acceptance in the United Kingdom. The 
technique has however proved satisfactory for the provision of 
general sedation for investigative techniques such as 
bronchography (Stevenson, Pandit, Dundee, McDowell and Morrison, 
1972) and pneumoencephalography (Brown, 1969) and has 
been advocated as an effective method of anaesthesia for 
repeated burn dressings (Smith and Hollis, 1966).
A fixed ratio of 50:1 droperidol:fentanyl was used 
in an early study in man (Holderness, Chase and Dripps, 1963). 
These authors used additional sedative drugs for preanaesthetic 
medication and nitrous oxide was used as a maintenance supplement. 
Profound analgesia, minimal hypotension and a smooth post­
operative course were described as appealing features of the 
technique. Because of the difference in the duration of 
action of the neuroleptic and analgesic components of 
neuroleptanalgesia, the two drugs are now rarely given together 
in a fixed ratio combination. The individual agents are 
generally given separately as required and are frequently 
used with neuromuscular blocking agents and nitrous oxide
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as part of a balanced anaesthesia technique (Brown, Horton and 
MacRae, 1953).
In veterinary practice three neuroleptanalgesic mixtures 
have been advocated for use in the dog. The first of these, 
which was made available to the author for clinical trial 
studies, contained droperidol and fentanyl. This mixture 
has not been marketed for veterinary use in the United Kingdom 
but two other combinations, one containing fluanisone and 
fentanyl and another containing methotrimeprazine and 
etorphine have subsequently become available for clinical 
use in the dog. The neuroleptic, methotrimeprazine (Fig. 2) 
which is present in the latter formulation is a tranquilizer 
of the phenothiazine class which is also claimed to have 
significant anticholinergic properties (Blane, Boura and 
Dobbs, 1968),
The first clinical reports of the use of the 
combination of droperidol and fentanyl, in dogs, appeared 
in America. Yelnosky and Field (1964) used a mixture 
containing 20mg droperidol and 0,4rag fentanyl per ml 
and examined the clinical utility of this combination 
when given in a range of doses by the intramuscular 
route. These authors found that the most effective 
dose was 0.1 ml kg~^. With this dose dogs became 
ataxic in two to three minutes, recumbent in five minutes 
and were unresponsive to painful and auditory stimuli in 
eight to lb minutes. Laparotomies were attempted in
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6 dogs at each dose investigated and a dose of 0.1 ml kg was 
claimed to provide adequate operating conditions for 25 minutes 
while a dose of 0.05 ml kg  ^was found to be inadequate in one 
dog. With this lower dose it was also reported that three other 
animals showed some discomfort during suturing.
A fixed intramuscular dose of 0.1 ml kg  ^of the same 
50:1 ratio of droperidol and fentanyl was also used by Soma and 
Shields (1964). These authors reported their experience with tlie 
mixture in a series of 100 dogs, in some of which neurolept­
analgesia was supplemented with local infiltration anaesthesia 
or small amounts of thiobarbiturates. Sedation and ataxia were 
noted after 3 to 4 minutes and recumbency and maximum analgesia were 
obtained within lO to 15 minutes. Bradycardia occurred in dogs 
not premedicated with atropine and some dogs defaecated. A slow 
rhythmic oscillation of the eyeballs was observed in 10 dogs, a 
vigorous eyelid reflex persisted and pupillary constriction 
occurred at the time of peak effect. These authors found that 
attempts to intubate animals could provoke swallowing whereas 
Yelnosky and Field (1964) claimed that intubation could be 
readily performed. A number of dogs responded to auditory 
stimuli with movements and in 5 dogs spontaneous movement 
of the head and limbs, unrelated to auditory or painful 
stimulation, was reported. Variable effects on respiration 
were noted with tachypnoea being seen in some animals and a 
reduced respiratory rate in others. No measurements of 
the effectiveness of respiration were made. Analgesia 
was found to be adequate for surgical interventions lasting
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30 to 40 minutes and dogs were generally capable of maintaining 
sternal recumbency after 60 to 90 minutes. The effect of the 
analgesic component could be readily reversed with nalorphine 
but dogs remained sedated under the influence of droperidol. 
Although unconsciousness was not produced the technique was 
found to provide adequate conditions for diagnostic 
procedures and minor surgical interventions.
The advantages of the technique were found to be ease 
of administration with a wide margin of safety, a quiet post 
operative state, and the ability to antagonise the narcotic 
component of the mixture. The disadvantages which were 
encountered were, the variable response obtained in some 
breeds, particularly Australian Terriers and, in some cases, 
the occurrence of spontaneous movements and the need for 
supplementary local anaesthesia.
A brief report by Franklin and Reid (1965) described
further studies with the same mixture of droperidol and
“1fentanyl again given at a dose of 0.1 ml kg . Little 
information is provided in this report on the operative 
procedures attempted and in a number of cases additional 
anaesthetic agents were used.
The clinical use of fluanisone and fentanyl in 
dogs was first described by Marsboom et al (1964).
Two techniques were described: in the first fluanisone
5 mg kg was given subcutaneously or intramuscularly
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20 to 30 minutes before an intravenous injection of
- i
0.1 mg kg fentanyl. In the second technique both drugs 
were given in a single intramuscular injection. A variety 
of techniques including laparotomies were performed and 
the authors claimed that both methods could be accepted 
as fully adequate replacements for orthodox general 
anaesthesia despite the inclusion of the comment:
"As loss of consciousness did not parallel analgesia, 
the animals were tied to the operating table to avoid 
possible sudden reactions of the animal to noises". In 
15 per cent of the animals which received fentanyl 
intramuscularly, a supplementary injection of analgesic 
was necessary to obtain surgical anaesthesia and additional 
doses of fentanyl were sometimes given during the operative 
procedure. Although it was noted that defaecation occurred 
in most anaesthetized dogs few other side effects were 
described. Animals generally recovered within two hours 
but in some sleep lasted for up to 10 hours postoperatively.
Early studies in dogs with the neuroleptanalgesic 
combination containing etorphine and methotrimeprazine were 
described by Alford and Wozniak (1970) and Crooks et al 
(1970). The former authors conducted a dose finding
study in experimental Beagles and found that a
-1 -1 combination of 7.5iag kg etorphine and 6 mg kg
methotrimeprazine provided successful neuroleptanalgesia;
41
and minor surgical procedures were performed without eliciting
any painful response. With a combination containing
-1 “1 5 ng kg etorphine and 2 mg kg methotrimeprazine, 9 out
of 10 dogs became cyanotic which suggested that the lower
dose of methotrimeprazine failed to antagonise the
respiratory depressant effect of etorphine. Transient
bradycardia and hypothermia were also noted.
Crooks et al (1970) used a fixed ratio combination of
etorphine and methotrimeprazine. The drugs were given
intramuscularly and doses ranged from 3.75 ng kg ^
-1 -1 etorphine:1 rag kg methotrimeprazine to 15 ug kg
-1etorphine:4 mg kg methotrimeprazine. In a minority of 
cases halothane was used to supplement neuroleptanalgesia.
The technique was deemed to be satisfactory in the majority 
of cases and was mainly used for diagnostic and minor 
surgical procedures. The drug combination was given to 
131 dogs and slight cyanosis was reported in 9 animals. 
Defaecation or excessive salivation did not normally 
occur and emesis was never observed. In most cases the 
narcotic antagonist diprenorphine was given at the end 
of the procedure and animals were able to walk after 
0.5 to 36 minutes. Recovery took 2 to 4 hours in two 
dogs not given the antagonist.
42
Whilst some authors have stated that the technique can 
provide suitable conditions for major surgery (Yelnosky and 
Field, 1954; Marsboom et al, 1964) others have found that the 
state obtained was suitable only for diagnostic and minor 
surgical procedures (Soma and Shields, 1964; Crooks et al, 1970), 
Differences have also been described in relation to the incidence 
of side effects and the degree of respiratory depression produced 
by the various combinations- Because of these discrepancies it 
seemed important to examine the effects produced by three 
different neuroleptanalgesic mixtures using a standardized 
protocol in the same population of dogs.
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4. DESIRABLE PROPERTIES SOUGHT IN NEW INTRAVENOUS ANAESTHETIC AGENTS 
No existing compound possesses all of the features which 
would be desirable in an ideal intravenous anaesthetic agent 
(Davis, 1975). The properties of an ideal compound can be listed 
as follows;
Stable in aqueous solution 
Rapid induction 
Wide safety margin
No cumulation of effect on repeated administration 
Compatibility with other agents used in anaesthesia 
Minimal respiratory or cardiovascular depression 
Some degree of analgesia 
Freedom from undesirable side effects;
laryngospasm or bronchospasm 
pain on injection 
excitatory effects 
dreams or hallucinations 
local tissue or vascular damage 
anaphylactoid responses.
The requirement for many of the features listed is self 
evident but some additional comments can be added.
A major problem in the development of new intravenous 
anaesthetics has been the difficulty in obtaining water soluble 
compounds which are sufficiently lipid soluble to pass rapidly 
into the brain. Combination of the first two seemingly incompatible 
properties has been achieved in the past by adopting two different 
expedients. With the rapidly acting barbiturates, aqueous solutions 
are achieved by using sodium salts at a high pH, whereas with
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propanidid and the steroid mixture of alphaxalone and alphadolone , 
the surface-active agent Cremophor EL has been used to form water 
miscible solutions. A relatively high incidence of anaphylactoid 
reactions has been encountered with these Cremophor containing 
anaesthetics (Clarke et al, 1975) and it is possible that the 
solubulizing agent may be responsible for at least some of the 
sensitivity reactions reported. This topic will be discussed 
in more detail in a later section.
The absence of any cumulative effect is a particular 
requirement in agents which may be used to maintain anaesthesia 
when given by intermittent injection or infusion. A rekindling 
of interest in techniques of total intravenous anaesthesia has 
been one of the consequences of recent concern shown by 
anaesthetists about possible risks from inhalation of trace 
amounts of anaesthetic gases released into the theatre 
atmosphere. A number of studies have provided results which 
suggest that anaesthetic practice may be associated with an 
increased susceptibility to spontaneous abortion in female
theatre personnel (Askrog and Harvald, 1970; Cohen, Bellville and Brown, 1971;
Knill-Jones, Rodrigues, Moir and Spence, 1972). There is no direct
evidence for the involvement of anaesthetic gases and vapours
in the production of this effect, but as this possibility
cannot be excluded a number of methods have been devised to
reduce the amount of waste anaesthetic gases in the operating
room environment. (Vaughan, Mapleson and Mushin, 1973; Parbrook and Monk,
1975; Davenport, Halsey, Wardley-Smith and Wright, 1976).
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A retrospective study by Bruce, Eide, Linde and Eckenhoff 
(1968) showed a higher incidence of death from cancer of lymphoid 
tissue among anaesthetists compared with the general population 
but a later prospective study failed to substantiate this 
finding (Bruce, Bach and Arbit, 1974). Although early animal 
studies suggested there was some association between exposure 
to anaesthetic agents and foetal abnormalities in chick embryos 
(Smith, Gaub and Moya, 1965) and in rats (Fink, Shepard and 
Glandau, 1967), more recent studies, with concentrations of 
anaesthetics at least 500 times higher than are likely to be 
found in the atmosphere of an operating theatre, failed to 
demonstrate any evidence of teratogenicity or any significant
increase in foetotoxicity (Lansdown, Pope, Halsey and Bateman,
1976).
Considerable attention has also been paid to the effects 
of trace concentrations of anaesthetics on the psychomotor 
performance of operating theatre personnel. Detrimental 
effects were demonstrated by Bruce, Bach and Arbit (1974) 
but the balance of experimental evidence indicates that 
concentrations of halothane much higher than 10 ppm are 
required before any impairment in performance can be
detected (Smith and Shirley, 1978).
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While debate continues on the possible detrimental 
effects of inhalation agents, an alternative solution to the 
removal of expired gases and vapours is the development of 
techniques where anaesthesia is maintained by the administration 
of intravenous drugs.
A technique of intravenous anaesthesia using a 
continuous infusion of alphaxalone and alphadolone (Althesin) has 
been described by Savage et al (1975). Although satisfactory 
operating conditions were obtained in a majority of 
patients, the principle complication of the technique was 
one of movement. In some cases movement occurred in 
response to painful stimuli despite the use of analgesic 
supplements. In other instances movement was apparently 
random and unrelated to surgical stimuli. The mean 
awakening time was 18 minutes after the end of surgery.
As this is significantly longer than the recovery time 
which can be achieved with techniques utilizing inhalation 
agents, it would appear that Althesin is not an ideal 
agent for the maintenance of anaesthesia by intravenous 
infusion.
Only with an intravenous agent which is rapidly 
metabolised and does not accumulate in body tissues 
could one expect to achieve the fine control of 
anaesthetic depth and the rapid recovery of protective 
reflexes which can currently be obtained with inhalational 
techniques.
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5. METHODS USED IN THE PHARMACOLOGICAL EVALUATION OF NEW 
INJECTABLE ANAESTHETICS IN LABORATORY ANIMALS
The search for improved intravenous anaesthetic 
agents involves the chemical preparation of new compounds 
and their pharmacological evaluation in animals. The 
discovery of anaesthetic activity in a series of 
alkylphenols presented an opportunity for the development 
of pharmacological models for the selection of the best 
compound from the series for detailed biological evaluation, 
Considerations of potency, speed of onset, duration and 
quality of anaesthesia in mice and rabbits indicated that 
2,6-diisopropylphenol (disoprofol) had a desirable 
pharmacological profile. The factors considered in the 
selection of suitable methods and in the development of 
new methods, for this phase of the study, are discussed 
in the next section of the introduction. When disoprofol 
had been chosen for further investigation, subsequent 
experiments involved a comparison of its anaesthetic 
properties with those of currently used agents, and an 
evaluation of the role of the surfactant, Cremophor EL, 
in anaphylactoid reactions to anaesthetics formulated 
in this material.
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5.1 Assessment of anaesthetic potency
Administration of anaesthetics by the intravenous route 
in mice provides information on the speed of induction, potency, 
duration of action and lethality. In the present context potency 
can be defined as the amount of drug required to produce a given 
depth of sleep. Before the properties of any new agent can be 
compared with those of established agents the relative potencies 
of agents used in comparative studies must be determined. 
Erroneous values can lead to fallacious impressions concerning 
the relative duration of action of drugs, such as occurred in 
human studies with thiopentone and buthalitone. Although 
early clinical impressions had suggested that buthalitone 
produced a shorter duration of sleep than thiopentone, a 
similar conclusion was not reached when doses were used 
which produced an equivalent electroencephalographic depth 
of anaesthesia {O'Mullane, 1957).
In studies of the relative potency of anaesthetic 
agents in mice the depth of anaesthesia can be readily 
standardized. The median hypnotic dose (HD^^) can be 
established as that dose which produces hypnosis in 
50 per cent of animals. Hypnosis in mice has been 
defined by Carrington and Raventos (1945) as that 
condition in which it is not possible to elicit 'body 
righting reflexes'. The same authors defined anaesthesia 
as the state during which it is possible to make a 
cutaneous incision without evoking a response, and a
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similar end point has been used by Gibson, Doran, Wood and Swanson 
(1959) in a study with raethohexitone. The median anaesthetic dose 
(AD50) determined in this way is well in excess of the HD^^.
Child et al,(1971) in their examination of the potency of a
range of anaesthetic agents in mice defined the AD^^ as the
dose required to produce loss of the 'righting reflex' in 
50 per cent of mice and this dose can therefore be compared 
with the HDgQ dose as defined by Carrington and Raventos 
(1946).
Atkinson, Davis, Pratt, Sharpe and Tanich (1965), when 
testing a series of anaesthetic steroids, chose the dose 
producing loss of righting reflex for 25 minutes in mice as 
their criterion for activity. This '25 minutes sleeptime' 
dose was selected as many of the compounds tested produced 
a slow induction of anaesthesia and with group mean sleep 
times below 15 minutes some of the mice did not sleep.
Although this problem would be unlikely to be encountered
with rapidly acting agents the requirement for an agent to
produce sleep times of 15 to 25 minutes would mean that
the potency of agents with a very brief duration of action
would tend to be underestimated as a greater multiple of
the HD^Q would be needed to provide an extended period of
sleep. Nevertheless, it has been found that the accuracy of the HD^^
is improved when a short but finite minimum period
of sleep is specified. In this investigation the HD^^ is
thus defined as that dose which produces loss of
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righting reflexes for a minimum period of 30 seconds in 50 per cent 
of mice.
In previous studies of the relative potency of anaesthetic 
agents in mice little attention has been paid to the importance of 
standardizing the rate of injection to ensure that eguipotent 
doses are given over the same injection period. As a greater 
depth of anaesthesia is likely to be produced when a given dose 
of a compound is injected more rapidly,the potency of a highly 
active drug is likely to be overestimated if drugs are injected 
at a given volume per unit time. Conversely the relative potency 
of a less potent agent, such as propanidid, is likely to be 
underestimated, as a greater injection time would be required 
to inject the larger dose of this drug. The influence
of this effect can however be minimised by the use of more 
concentrated solutions of less active compounds. Carrington and 
Raventos (1946), in estimating the relative potency in mice of 
thialbarbitone, thiopentone and hexobarbitone, injected the 
drugs in 0.1 per cent and 1.0 per cent solutions at a constant 
rate of 0,1 ml per 10 seconds. As the drugs examined in this 
study were of similar potency it is unlikely that any 
significant discrepancy was introduced by the administration 
technique used. In the comparative study described by 
Child et al (1971), Althesin was injected into mice at a rate 
equivalent to 0.1 ml undiluted solution (1.2 mg) per kg per 
second. Although results obtained with a range of other 
anaesthetic agents are provided, the drug concentrations and 
injection rates used are not reported.
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In studies designed to define the pharmacological 
properties of phencyclidine (Chen et al, 1959)and ketamine
(McCarthy et al, 1965) in animals, no attempt was made to define the median 
anaesthetic dose, and this value is not relevant in connection with neuro­
leptanalgesic drug mixtures. Although Laubach, P'an and Rudel (1955) and P'an, 
Gardocki, Hutcheon, Rudel, Kodet and Laubach (1955) used the AD^^ 
in describing the anaesthetic properties of hydroxydione, these 
authors did not provide information on the rate of injection used.
One method which can be adopted to ensure that eguipotent 
doses of drugs are injected at an equivalent rate involves 
the use of a standard injection time for all of the doses given.
This method was used by Janssen, Niemegeers and Marsboom (1975) 
in their investigation of the anaesthetic properties of etomidate.
These authors used a standard injection time of 2 seconds and 
obtained valid comparative results with thiopentone, 
methohexitone and propanidid. A similar method was adopted in the 
present investigation and in the main comparative study all doses 
were given over an injection period of 10 seconds. In some 
preliminary experiments all doses were given over one to two 
seconds.
5.2 Assessment of speed of onset of anaesthesia
In clinical practice a rapid onset of anaesthesia is 
desirable to allow the dose administered to be titrated 
against the response of the patient. Differences in onset 
time between drugs can be accounted for by differences in lipid 
solubility of the undissociated drug molecule (Brodie, Kurz and
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Shankar, 1960). These authors demonstrated that the greater lipid 
solubility of thiopentone, in comparison with that of pentobarbitone, 
was responsible for the more rapid passage of the former drug across 
the blood-brain barrier. With any particular drug, the speed of 
onset of anaesthesia is likely to be affected by the dose given, 
the rate of injection, and the arm-brain circulation time.
The effect of different injection techniques on the onset of 
thiopentone narcosis, in man, has been investigated by a number of 
authors. Egbert and Mitchell (1961) noted the importance of the 
rate of injection; a decrease in the rate of injection being 
associated with a delay in the onset of hypnosis. Onset of 
anaesthesia was also found by these authors to be slower when the 
drug was given into a vein on the dorsum of the hand rather than 
into an antecubital vein, but the difference in onset time obtained 
with the same dose of thiopentone given as a 2.5 or 3.5 per cent 
solution, into the same vein, was not statistically significant.
In an early comparative study with methohexitone and thiopentone 
Wyant and Chang (1959) noted that onset of anaesthesia with 
methohexitone was slower than with thiopentone. In a later 
study (Wyant and Barr, 1960), in which both drugs were injected 
at the same rate, the difference in onset times was not confirmed 
and it was concluded that the discrepancy had resulted from the 
fact that, in the earlier study, methohexitone had been injected 
more slowly than thiopentone. The slower mean onset time obtained by Thomas 
(1967) with thiopentone (27.5 s) as compared with 10 to 11 seconds obtained 
by Clarke, Dundee, Barron and McArdle (1968) can also be attributed 
to the use of a slower rate of injection by the former author.
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Arm-brain circulation time is likely to be increased in patients 
with a reduced cardiac output and can also be influenced by changes 
in ambient temperature. Dundee (1955) noted a faster onset time with 
thiopentone when the ambient temperature was 29 to 32^C in comparison 
with that obtained at a temperature of 22 to 23°C. In a study of the 
speed of onset and potency of Althesin in man, Carson, Dundee and 
Clark (1975) injected the drug during a period of reactive 
hyperaemia following temporary ischaemia of the forearm to reduce, 
and hopefully to standardize, the effect of the arm-brain circulation 
time on the speed of onset of anaesthesia.
In studies in laboratory animals one investigator (Butler,
1941) has paid considerable attention to the factors likely to influence 
anaesthesia onset time. In a comparative study with phénobarbital 
and glucochloralose speed of onset was determined using equivalent 
multiples of the AD^^ of each compound. Although different rates 
of injection were used for the two drugs examined, all doses of 
each drug were given over a constant injection period. In other 
studies in animals little thought has been given to the factors 
affecting the rate of onset of anaesthesia (Child et al, 1971;
Janssen, Niemegeers and Marsboom, 1975) despite the facfthat, 
in the evaluation of the anaesthetic properties of a range of 
steroid compounds, Atkinson et al (1965) noted a significant 
delay in the onset of anaesthesia with a number of the agents 
examined. In this latter study the delay in the onset of 
anaesthesia can be attributed to the time required for the 
hydrolysis of ester pro-drugs to an active and more lipid soluble 
form.
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In the evaluation of new anaesthetic compounds with unknown 
lipid solubility it is essential that a standardized technique 
is used for the evaluation of the speed of onset of anaesthesia.
For this reason the relative importance of the effects of a number 
of factors which could influence speed of induction of anaesthesia 
in mice have been evaluated in the present investigation. The 
factors considered include drug dosage, rate of injection, drug 
concentration and ambient temperature.
5.3 Evaluation of cumulative effects
Although recovery after a single dose of thiopentone occurs 
rapidly and is dependent predominantly on redistribution of the 
drug into body compartments other than the brain (Price et al,
1960), the administration of repeated doses of thiopentone is likely 
to lead to prolonged anaesthesia. This occurs because of the 
accumulation of thiopentone in tissues, particularly fat, and the 
relatively slow rate of metabolism of thiopentone (Brodie et al, 
1950). Agents which are metabolised rapidly are less likely to 
accumulate to a significant extent in body tissues and are more 
likely to allow a rapid recovery following their administration 
for maintenance of anaesthesia, by repeated injection or infusion. 
Pharmacokinetic studies have confirmed that an agent such as 
methohexitone,which may be used in this manner, has a much shorter 
elimination half life than thiopentone (Breimer, 1976).
In the development of new anaesthetic agents it is not 
generally possible at an early stage, when a large number of 
compounds may have to be examined, to obtain information on the 
pharmacokinetic profile of each compound. For this reason some
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other method has to be used for the selection of compounds which are 
likely to be metabolised rapidly and unlikely to accumulate to a 
significant extent in body tissues.
Wyngaarden, Woods, Ridley and Seevers (1949) used the duration of action of 
repeated doses in dogs as a means of comparing the cumulative action 
of thiopentone with that of thiamylal. Doses of both drugs were 
adjusted to produce approximately the same duration of anaesthesia 
with the first injection and drug administrations were repeated 
at hourly intervals. Injections were stopped when one or more 
dogs in any group showed a duration of anaesthesia exceeding sixty 
minutes. The results obtained with this method indicated that 
thiamylal exhibited a lower rate of accumulation than thiopentone 
as evidenced by a smaller percentage increase in sleeping time with 
repeated doses, relative to the initial anaesthesia time.
A similar method has been used by Swanson and Chen (1953) 
to study a number of methylated thiobarbiturates and Dundee (1955) 
investigated the cumulative effects of four barbiturates in rats 
and dogs by noting the duration of narcosis with two doses of 
the same drug given at varying intervals to the same batch of 
animals in the case of rats, or to the same animal in the case of 
dogs. An appreciable increase in the duration of the second 
period of narcosis was noted with thiopentone, thioethanol, 
and thialbarbitone, if the interval between injections was less 
than 18 to 24 hours. With thiamylal a cumulative effect was not 
observed when the interval between injections was greater than 
12 hours. Wyngaarden et al (1949) concluded that the 
lesser cumulative effect seen with thiamylal following 
the administration of eguipotent doses of thiopentone and
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thiamylal was due to the greater potency of thiamylal as it was 
assumed that both drugs were metabolised at an equal rate. In the 
study reported by Dundee (1955), when equal doses of the two 
drugs were given, thiamylal still caused less potentiation of a 
subsequent dose, thus suggesting that thiamylal was metabolised 
more rapidly than thiopentone.
Although the techniques described above have demonstrated 
a difference in the cumulative actions of thiopentone and thiamylal, 
the methods used would be unlikely to be sufficiently sensitive 
to detect relatively minor differences in the rate of accumulation 
of more rapidly metabolised drugs. It can be envisaged that when a 
significant interval is allowed between injections the tissue 
concentration of a drug, which accumulates to only a minor 
extent, could decline to an insignificant level. Accumulation 
could more readily be demonstrated with a shorter interval between 
repeated injections. The technique used by Child et al (1971) 
to compare the cumulative effects of Althesin with those of 
thiopentone and methohexitone conforms with this approach. In 
this method successive equal doses of the anaesthetic agents 
were administered to mice 30 seconds after the animals regained 
their righting reflex following a proceeding injection. A 
cumulative effect was readily demonstrated with thiopentone 
where sleeping time increased from 5.7 to 178 minutes after 
only four doses, whereas successive doses of the other two 
agents produced minimal increases in sleeping time. This 
method, which appeared to be particularly sensitive, was 
selected as one of the methods to be used for the evaluation 
of the cumulative action of disoprofol.
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Some indication of the cumulative action of injectable 
anaesthetic agents can also be obtained from the slope of the 
dose/duration of effect curve obtained in animals. A compound 
such as thiopentone, which is metabolised slowly, has been shown 
to provide a much steeper curve than rapidly metabolised 
compounds such as etomidate and propanidid (Janssen, Niemegers 
and Marsboom, 1975). A possible limitation of this method, 
for use in a comparative study, is that differences in therapeutic 
ratio between compounds could, in some cases, prevent the 
examination of the effects of equivalent dose ranges.
Another satisfactory method, described by Dodds and 
Twissell (1973) utilised a comparison of recovery times after 
the maintenance of anaesthesia in cats for a period of three 
hours with supplementary doses of thiopentone or Althesin.
With this method these authors demonstrated that Althesin 
accumulated to a much lesser extent than thiopentone as 
recovery occurred at a mean time of 100 minutes after the 
last dose of Althesin whereas 28 hours elapsed before the 
recovery of righting reflexes in cats given thiopentone.
A modification of this latter method has also been used in 
the present investigation and recovery times were noted 
after maintenance of anaesthesia in rats with a constant 
continuous infusion of disoprofol for periods of one and 
two hours.
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5,4 Evaluation of cardiovascular and respiratory effects
The testing of intravenous anaesthetic drugs in chloralose or 
pentobarbitone anaesthetized animals is unsatisfactory as the 
injection of a second drug which depresses the central nervous 
system may induce severe respiratory and circulatory depression 
in doses much smaller than those required to induce anaesthesia 
in the conscious animal. Lerman and Paton (1960) noted that the 
depressant actions of hydroxydione on respiration and blood pressure 
were increased five to ten fold in chloralose anaesthetized cats 
in comparison with unanaesthetized or decerebrate animals and 
Chen et al (1959) commented on the great sensitivity of the 
respiratory centre of the cat to the combined depressant action of 
phenobarbitone and phencyclidine- McCarthy et al (1965) described 
similar effects with ketaraine in dogs anaesthetized with 
pentobarbitone or chloralose and a similar potentiation of the 
depressant actions of Althesin in cats anaesthetized with chloralose, 
pentobarbitone or inhalational anaesthetics has been observed 
by Child et al (1972a).
An alternative method which can be expected to give more 
reliable information involves the surgical implantation of polyvinyl 
or polyethylene catheters in a jugular vein and a carotid artery at 
some time prior to the investigation. When animals have recovered 
from the surgical preparation the effects of anaesthetic agents 
on blood pressure and respiration can then be examined in 
untreated and unrestrained subjects. The few studies in which 
the effects of intravenous anaesthetic drugs have been monitored 
in conscious intact animals include studies of 5-ethyl-6-phenyl-m- 
thiazine-2,4-dione and thiopentone (Cotton and Bay, 1956),
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a-chloralose and pentobarbitone (Van Citters, Franklin and Rushmer,
1964); pentobarbitone (Olmsted and Page, 1966) and thiamylal and 
pentobarbitone (Goldberg^ Linde, Gaal, Momma, Takahashi and Sarna, 1968)
The above studies were performed in dogs but surgically 
prepared unanaesthetized cats were used in a comparative study 
of the cardiovascular and respiratory effects of a range of 
intravenous anaesthetic drugs, described by Child et al (1972a).
The cat was chosen by these authors as the Creraophor containing 
agents Althesin and propanidid were included in their study.
Although some haemodynamic studies with propanidid have been 
undertaken in the dog (Conway, Ellis and King, 1968; Sankawa,
1965) this species would seem an inappropriate choice for the 
evaluation of any Cremophor containing formulation as this 
solubilizing agent is a potent liberator of histamine in the dog 
(Wirth and Hoffmeister, 1965). A significant degree of hypotension 
is much less likely to occur in the cat following the injection of 
Cremophor EL, but a small increase in plasma histamine concentration 
has been demonstrated in this species following the administration 
of this material (Lorenz et al, 1971b)and clinical signs 
indicative of histamine release have been noted in a number of
cats following the administration of Althesin in veterinary 
practice (Dodman, 1980).
As the pig has been shown to be insensitive to the histamine 
releasing properties of Cremophor EL (Lorenz et al, 1971b)this 
species was chosen for the present investigation. The pig has 
been rarely used in the past for the investigation of the 
respiratory and cardiovascular effects of intravenous anaesthetics
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but a recent study (Becker and Beglinger, 1980) investigated the 
effects of the intramuscular administration of the neuroleptanalgesic 
combination containing etorphine and acepromazine in surgically 
prepared, unanaesthetized pigs.
In animals with an implanted carotid artery catheter, 
respiratory effects of drugs can be readily examined by 
measurement of the partial pressures of oxygen and carbon dioxide 
in samples of arterial blood drawn anaerobically from the arterial 
catheter, and arterial blood pressure can be measured directly with 
a calibrated strain gauge transducer. The placement of a jugular 
venous catheter also allows test drugs to be given to the unrestrained 
animal.
5.5 Evaluation of interactions between injectable anaesthetics 
and ancillary drugs used in anaesthesia
As injectable anaesthetic drugs are frequently used in 
combination with ataractic, anticholinergic and analgesic drugs, 
inhalation anaesthetic agents, and neuromuscular blocking drugs, 
it is important that any significant interactions between these 
drugs are discovered at an early stage in the evaluation of 
new agents.
In the pharmacological investigation of propanidid, Wirth and 
Hoffmeister (1965) used mice to examine possible interactions 
between this agent and chlorpromazine, reserpine and iproniazid.
In a study with Althesin, Child et al (1971) examined the 
effects of a range of pre- and postoperative medicaments on 
the course and duration of anaesthesia in cats. In the present 
investigation, a selection was made of agents likely to be used for
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pre-anaesthetic medication and drugs were given subcutaneously 
to mice 30 minutes before induction of anaesthesia with an 
intravenous injection of disoprofol. By using mice it has been 
possible to use larger numbers of animals and to perform 
statistical analyses on the results.
Conventional anaesthetic techniques in cats, similar to 
those described by Child et al (1971) have been used in the 
present study to examine possible interactions between disoprofol 
and a range of inhalation anaesthetic agents and the neuromuscular 
blocking drugs suxamethonium, pancuronium and gallaraine. As 
tubocurarine is known to produce histamine release in the cat 
(Hall, 1971) the combination of this agent with disoprofol was 
examined in the pig.
It is generally accepted that in clinical practice anaesthetic 
requirements are reduced in patients who have received ataractic 
or sedative premedication (Dundee, Nicholl and Moore, 1963). An 
experimental study in animals has demonstrated that premedication 
with benzodiazepine drugs, particularly diazepam, potentiates 
the hypnotic effect of steroid anaesthetic agents (Gyermek, 1974) 
and it was expected that some potentiation of the anaesthetic 
effect of disoprofol would be encountered when the drug was 
given in combination with large doses of sedative drugs.
An unexpected interaction between the neuromuscular blocking 
agent suxamethonium and the intravenous anaesthetic propanidid 
was discovered in the early clinical evaluation of propanidid in 
human patients (Clarke, Dundee and Daw, 1964; Howells et al,
1964). These authors found that the duration of apnoea and
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respiratory depression produced by suxamethonium was increased 
when this drug was administered following induction of anaesthesia 
with propanidid, whereas no similar potentiation was found with 
methohexitone or thiopentone.
In human patients, potentiation of suxamethonium apnoea has 
also been observed following the co-administration of
suxamethonium with quinidine (Grogono, 1963), procaine (Salgado, 1961; Foldes, 
McNall, Davis, Ellis and Wnuck, 1953) and eyedrops containing ecothiopate 
iodide, an agent with potent anticholinesterase activity (Gesztes,
1966; Pantuk, 1966). Hydrolysis by pseudocholinesterase is a 
major step in the metabolism of procaine (Kalow, 1951), 
suxamethonium (Lehmann and Silk, 1953) and propanidid 
(Doenicke et al, 1968). Substrate competition for this enzyme 
has been proposed as the mechanism responsible for the 
interaction between procaine and suxamethonium (Foldes et al,
1953) and a similar mechanism may, at least in part, explain the 
interaction between suxamethonium and propanidid. This theory 
gains support from the clinical observation that propanidid 
neither potentiates nor prolongs the neuromuscular block 
induced by décaméthonium, another depolarizing relaxant, but 
one which is not dependent on hydrolysis by pseudocholinesterase 
for its elimination (Torda, Burkhart and Toh, 1972).
Interference with the activity of serum pseudocholinesterase 
cannot be the only mechanism responsible for the prolongation of 
suxamethonium apnoea as the neuromuscular effect of suxamethonium 
can still be potentiated by propanidid in an vitro nerve- 
rauscle preparation after the abolition of cholinesterase activity
63
(Ellis, 1968). This author concluded that propanidid was
probably producing this effect by causing a partial depolarization 
of the muscle cell membrane, which would potentiate the 
depolarization produced by suxamethonium in the vicinity of 
the end plate.
Attempts to demonstrate an interaction between propanidid 
and suxamethonium in vivo animal models have produced 
conflicting results. Howells et al (1964) found that propanidid 
did not potentiate the action of suxamethonium in a cat nerve- 
muscle preparation whereas this preparation has been used 
successfully by Cuthbert (1966) to demonstrate an interaction 
between both quinidine and procainamide and suxamethonium.
Using the same preparation. Miller, Way and Katzung (1967) 
demonstrated an interaction between quinidine and both the 
non-depolarizing and depolarizing muscle relaxants in producing 
neuromuscular blockade. In one study, conducted in Italy 
(Musinu, Tagliaraonte and G©ssa, 1968) muscle relaxant drugs 
were given to rabbits after they had recovered from the 
anaesthetic effects of propanidid. A greater degree of muscle 
paralysis was produced in those animals given suxamethonium than 
in those which received tubocurarine. The administration of 
neuromuscular blocking drugs to conscious animals would not be 
condoned in this country and an attempt has therefore been made, 
in the present study, to define an animaJ model in which it may 
be possible to demonstrate an interaction between suxamethonium 
and propanidid in anaesthetized animals. To demonstrate the 
clinical relevance of the model it would also be necessary to
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demonstrate that a similar potentiation of the effect of 
suxamethonium could not be produced by intravenous anaesthetics 
other than propanidid.
As significant serum pseudocholinesterase activity has 
been demonstrated in the mouse (Foldes, 1966) this species was 
chosen for this section of the work. This choice also allowed 
the use of previously determined equipotent doses of the 
intravenous anaesthetic agents.
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6. THE ROLE OF CREMOPHOR EL IN ANAPHYLACTOID REACTIONS PRODUCED 
BY CREMOPHOR CONTAINING ANAESTHETICS IN MAN
Being a highly lipophilic compound, disoprofol, 
is virtually insoluble in water and is currently solubilized with 
the aid of a polyoxyethylated ricinoleic acid surfactant, 
Cremophor EL. This agent is also present in the commercial 
preparations of propanidid and Althesin.
In man an increasing number of apparent hypersensitivity 
reactions to intravenous anaesthetics have been reported 
recently, and the recorded frequency of reactions to Cremophor 
formulations of propanidid, Althesin (Clarke et al, 1975) and 
diazepam (Huttel, Schou Olesen and Stoffersen, 1980) suggest 
that this solubilizing agent may be responsible for at 
least some of the reported reactions to these compounds.
A prospective study of the frequency and causes of 
adverse responses to intravenous anaesthetic agents has 
been completed recently (Beamish and Brown, 1981). The 
results show that adverse reactions involving Althesin 
(13 in 7904) occurred more frequently than 
reactions to thiopentone (2 in 45546). Other
66
estimates of the frequency of reactions to Althesin range from one 
in 430 (Scott, 1979) to one in 19000 (Clarke et al, 1975).
The clinical manifestations of reactions include cutaneous 
hyperaemia, bronchospasm and hypotension. These signs resemble 
those produced by an immediate, immune mediated, hypersensitivity 
response (Watkins, 1979). However, as reactions have been 
reported following the first administration of an anaesthetic 
drug, it has been suggested, that unless evidence for definite 
antibody involvement exists, hypersensitivity-type reactions 
are best described as anaphylactoid (Watkins and Clarke, 1978). 
Four different pathological mechanisms, which could lead to an 
adverse clinical response, have been described by Watkins 
(1979) as follows:
i) Type 1 hypersensitivity response. These require previous 
exposure and involve IgE antibodies. There is direct histamine 
release from mast cells without involvement of complement.
ii) Immune reactions. The class of immunoglobulins involved 
may be in doubt, but histamine release occurs following 
activation of complement by the classical pathway.
iii) Alternate pathway activation of complement C3. These 
involve direct activation of C3 and this group appears to 
contain both patients apparently sensitized by previous exposure 
to the substance and first time responders.
iv) Pharmacological or chemical release of histamine. The 
injected substance causes histamine release from the mast cell 
without antibody or complement involvement.
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Reactions to Althesin generally involve excessive activation 
of complement C3, leading to histamine release and are not 
reagin-antibody mediated, whereas reactions to barbiturates 
generally represent immediate, immune-mediated, hypersensitivity 
reactions (Watkins, 1979). The involvement of IgD in some 
instances has also been suggested, particularly in cases where 
close proximity of exposures to Althesin appears to be a factor 
predisposing to adverse response (Watkins, Allan and Milford-Ward, 
1978).
Thus, although histamine is involved in the majority of 
reactions, direct pharmacological release of this amine is 
probably a minor factor in reactions occurring in human 
patients. It has been shown that the injection of thiopentone, 
propanidid and Althesin can produce histamine release in man 
(Lorenz, Doenicke, Meyer, Reimann, Kusche, Barth, Geesing,
Hutzel and Weissenbacher, 1972; Doenicke, Lorenz, Beigl,
Bezecny, Uhlig, Kalmar, Praetorius and Mann, 1972) but the 
amount released is normally insufficient to be of any 
clinical significance. The same authors were unable to 
demonstrate histamine release in man following the administration 
of Cremophor EL; and volunteers who had shown an increase in 
circulating histamine concentration following propanidid did 
not show a similar response when given Cremophor alone.
These results suggest that Cremophor is unlikely to produce 
direct histamine release in man. However, they do not 
exclude the possibility that Cremophor could contribute
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to an adverse response by one of the alternative mechanisms 
mentioned above.
In animals there are considerable species differences 
in susceptibility to the histamine releasing properties of 
Cremophor EL. In a study reported by Lorenz et al (1971b) 
the administration of Cremophor produced a 630 per cent 
increase in whole blood histamine concentration in dogs, 
a 90 per cent increase in cats, and no significant change 
in pigs. Lorenz, Reimann, Schmal, Dormann, Schwarz and 
Neugebauer, (1977) have used dogs to examine the histamine 
releasing capacity of several preparations of Cremophor EL, 
other non-ionic detergents and several components of 
Cremophor. Using this model these authors were able to 
demonstrate that oxyethylated oleic acid was the most 
important histamine releasing constituent in Cremophor.
The use of histamine release in the dog as a model 
for the evaluation of alternative surfactants has two 
serious limitations. Firstly the dog is particularly 
sensitive to the histamine releasing properties of 
Cremophor whereas this mechanism is only one of a 
number encountered in anaphylactoid reactions in man. 
Secondly the response in the dog requires no previous 
sensitization to the compound, as appears to be necessary 
in a proportion of adverse reactions in patients. An 
attempt has therefore been made to develop an animal 
model using pigs, a species which resembles man in being
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insensitive to the direct histamine releasing effects of
Cremophor, It was hoped that by examining the effects of
repeated injections of a range of Cremophor-containing 
and Cremophor-free anaesthetics, some indication could
be obtained of the importance of the surfactant in the
pathogenesis of anaphylactoid reactions in man.
Chapter 1
AN EVALUATION OF A TECHNIQUE FOR THE INDIRECT MEASUREMENT OF 




The basic principle of indirect measurement ■ of blood pressure 
involves the occlusion of an artery by an inflatable cuff and the 
detection of returning blood flow below or distal to the site of 
occlusion as the occluding pressure is reduced. Available methods 
differ only in the manner in which returning blood flow is detected. 
The auscultatory technique is the method most widely used in man to 
detect returning arterial pulsations distal to an occluding cuff.
The conical shape of dog's limbs makes the proper application of an 
occluding cuff difficult but special cuffs have been devised 
which can be fixed around the thigh of dogs (Rule, 1944). Good 
correlation has also been shown between the auscultatory method 
and direct measurements with a capacitance manometer (Romagnoli, 1953) 
Disadvantages of the auscultatory technique are that access to the 
anaesthetised animal is required for auscultation, and in small 
animals the sounds may be difficult to detect.
The oscillometric technique has been used in animals by 
Romagnoli (1953) but this technique has the disadvantage that the 
systolic end-point is not clearly defined when a single cuff is 
used. Oscillations are detected at cuff pressures above systolic 
pressure, due to arterial pulsations impinging on the upper edge 
of the cuff.
Other methods of detecting peripheral pulses involve either 
palpation or the use of a condenser microphone transducer (Prioli 
and Winbury, 1960). Pulse monitors of this latter type have 
been tested in dogs by Campbell, Lawson and Sanford (1964)
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who found the tail to be the best site for the occluding cuff and 
pulse monitor. Movement artefacts are readily picked up by this 
type of transducer and the systolic end-point is often difficult 
to detect. A similar technique using a tubular metal tail cuff 
has been described by Klemm and Hembrough (1966). These authors 
measured both systolic and diastolic pressure but most authors 
have found diastolic pressure difficult to measure by indirect 
methods using pulse monitors.
Photo-electric cell transducers may also be used as pulse 
monitors as arterial pulsations cause changes in the amount of 
light reflected onto the cell. This method is difficult to apply 
in animals with pigmented skins and is also very liable to display 
movement artefacts.
Pulse monitors based on the ultra-sonic doppler technique have been 
used by Valtonen and Eriksson (1970) and Garner, Hahn, Hartley, Hutcheson 
and Coffman (1975). The former authors used an occluding cuff obtained from a 
piece of cycle tube placed on the upper forelimbs while the latter 
workers measured pressure in a hind limb with an occluding 
cuff placed round the tibial area.
Apart from oscillometry, changes in the volume of a limb 
segment can be detected with a xylol pulse indicator as 
originally described by Neligan and Rogers (1959). With this 
instrument volume changes under a cuff placed distally to the 
occluding cuff are detected by the movement of a 'bead' of xylol 
in a glass capillary tube. The use of this instrument for the 
indirect measurement of blood pressure in dogs has been 
described by Wilson and Clarke (1964). As this system obviates
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the need for an electronic transducer and appeared to be less 
sensitive to movement artefacts, it was selected for a detailed 
examination of its efficacy in different sizes of dogs.
The width of the occluding cuff has been shown to 
affect the accuracy of indirect measurements in studies in human adults 
(Karvonen,1962) and infants (Robinow, Hamilton, Woodbury and Volpitlo,1939 ; 
Schaffer, 1955). In infants a cuff which is too narrow for a 
given individual tends to overestimate the systolic pressure 
whereas an excessively wide cuff will tend to underestimate 
the true value. In adults, increasing the cuff width beyond 
13cm has little influence on either the systolic or diastolic 
reading while narrower cuffs provide high values (Karvonen, 1962).
The latter author has also shown that cuffs of insufficient 
length to completely encircle the limb used for the measurement 
will overestimate the true pressures. Differences in the 
efficiency of the transmission of cuff pressure to an artery 
are thought to be related to differences in limb circumference, 
the compressibility of tissues and the contour of the arterial 
pulse (Robinow et al, 19 39; Holland and Humerfelt, 1964) .
In only one study in dogs (Valtonen and Erikson, 1970) 
has serious consideration been given to the influence of cuff width 
on the accuracy of indirect measurements of pressure. Direct and 
indirect values were compared in 10 dogs and bodyweight and 
foreleg circumference were also noted. As only one dog weighed 
more than 20kg and as differences between direct and indirect 
measurements up to 60 mmHg were found in some instances these 
authors were unable to give any definite guidance on
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the correct size of cuff for different dogs. They did confirm 
however that narrow cuffs gave high values in large dogs and wide 
cuffs gave erratic, often too low, values in small dogs.
In the present study the accuracy of indirect measurements 
obtained using a xylol pulse monitor and three different widths 
of occluding cuff has been investigated and an attempt made to 
relate the correct size of cuff for a given dog to foreleg 




Preliminary experiments were done in adult dogs kept for 
experimental purposes. When the criteria for the systolic end point 
and a suitable size of occluding cuff had been chosen, subsequent 
studies were done in dogs admitted for routine surgical 
interventions in the Department of Veterinary Surgery of the 
University.
2.2 Apparatus
Indirect blood pressure was measured with a 'Newcastle' 
sphygmomanometer (C.F. Thackray Ltd., Leeds). The use of this 
instrument in human infants has been described by Ashworth,
Neligan and Rogers (1959). A schematic representation of the 
instrument is shown in Figure 4 .
The apparatus incorporates an occluding cuff connected to 
a mercury manometer, and a second, pulse sensing, cuff attached 
to a pulse indicator. The pulse indicator consists of a 
straight glass capillary tube whose lumen contains an interrupted 
column of xylol. Beyond this column is a cushion of 
compressible air against which the xylol can be moved by 
pressure changes within the connecting cuff. This cuff and 
the pulse indicator can be isolated from the occluding cuff 
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In fla tin g  bulb
Fig. 4 Schematic representation of ’Newcastle' sphygomomanometer
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The inflatable cuffs supplied with the instrument were made 
of polyvinyl chloride with a self adhesive 'tail' of the same 
material. Both cuffs were the same size and had an inflatable 
portion which measured 15 x 2,5 cm. This size was satisfactory 
for the pulse sensing cuff but early experiments indicated that 
complete arterial occlusion could not be produced in large dogs 
with a similar size of occluding cuff. A number of alternative 
cuffs were therefore obtained from the manufacturer of the instrument 
for use in the present investigation.
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3. METHODS
3.1 TECHNIQUE OF INDIRECT BLOOD PRESSURE MEASUREMENT
In dogs the pulse sensing cuff was placed on the metacarpal 
region and the occluding cuff over the brachial artery^ above the 
elbow, as described by Wilson and Clarke (1964). Cuffs were 
applied to the upper forelimb of anaesthetised dogs lying in the 
lateral position. In this situation artefacts caused by heart 
beats and respiratory movements being transmitted to the distal 
cuff were minimised. In all animals the trachea was intubated 
to avoid the occurrence of respiratory obstruction which would 
have accentuated the variations in arterial pressure which 
occur with different phases of respiration.
To record systolic pressure the whole system was first 
inflated to a pressure of about 60mmHg. The pulse indicator 
was then isolated from the rest of the system by clamping 
the rubber tubing at P (Figure ^ ). If the pulse indicator 
system was free from leaks it remained at a constant pressure 
until the clamp was released. When the pressure in the rest 
of the system, including the occluding cuff, was allowed to 
fall to zero by opening the control valve (Figure 4 ) 
movement of the xylol 'beads' in the capillary tube, 
representing the pulsation of the arteries of the foreleg, 
could be detected. The occluding cuff was then inflated until 
the xylol column ceased to move. Thereafter the pressure was 
allowed to fall slowly until the characteristic movements 
reappeared. Due to respiratory variations in systolic 
pressure, short runs of beats were noted before regular
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arterial pulsations were detected at the systolic pressure end 
point. The diastolic end point occurred when the excursion of 
the xylol column in the capillary tube regained its maximum 
range. As this point was difficult to judge by eye no attempt 
was made to record diastolic pressure routinely.
When measurements were made over a prolonged period the 
distal cuff was deflated at intervals to prevent venous 
congestion and swelling of the foot.
3.2 EXPERIMENTS TO EXAMINE THE FACTORS INFLUENCING THE ACCURACY 
OF INDIRECT MEASUREMENTS
To validate the indirect technique, results obtained with the 
'Newcastle' sphygmomanometer were compared with direct 
measurements of blood pressure taken from a femoral artery with 
a strain gauge transducer (Ether B.P. 15, Devices Sales Ltd., 
Welwyn Garden City, Herts). Percutaneous puncture of the 
artery was performed using a 19 or 21 B.W.G. needle connected 
to a short length of polythene tubing ('Butterfly INT' cannula, 
Abbott, Queenborough, Kent) and a 60 cm length of saline filled 
nylon manometer tubing (200/495/060, Portex Ltd., Hythe, Kent) 
was used to transmit pressure to the transducer. The transducer 
was calibrated with a mercury manometer and was placed at the 
same level as the upper forelimb to eliminate the effect of 
hydrostatic pressure on blood pressure readings. The direct 
pressure was displayed on a pen recorder (Polygraph, AEI, 
Scientific Apparatus Ltd., Urmston, Manchester) and, at the 
times when cuff pressure was read from the mercury manometer, 
an event marker on the recorder was activated. This allowed
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simultaneous comparisons of the results obtained with the two 
techniques to be made. To avoid any bias when reading the 
direct pressure, the indirect pressures were not marked on the 
pressure record but were noted sequentially in a separate list.
3.2.1 Definition of systolic pressure end-point
When taking an indirect measurement of systolic pressure the 
manometer pressure may be read at the point when occasional 
pulses, due to respiratory variations in systolic pressure, are 
first noted. Alternatively it may be recorded at the point when 
regular arterial pulsations are first detected. In one 
experiment in a dog weighing 19kg, direct and indirect readings 
were taken at both end points to determine the most accurate 
technique for subsequent studies. Anaesthesia was induced with 
26 mg kg  ^thiopentone ('Intraval', May and Baker, Dagenham, 
Essex) following premedication with lOmg droperidol 
('Droleptan', Janssen Pharmaceutical, Marlow, Bucks), and was 
maintained by the inhalation of halothane (*Fluothane', ICI, 
Macclesfield, Cheshire). An occluding cuff measuring 25 x
3.75 cm was used and in total 27 comparisons of direct and 
indirect systolic pressure were made as blood pressure was 
altered by adjusting the inspired concentration of halothane.
3.2.2 Guff length
In some preliminary experiments three sizes of occluding 
cuff were used. These were of varying lengths and widths and
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measured: 15 x 2.5 cm
20 X  3.75 cm 
25 X  5-0 cm
It was found that in a large dog weighing 25 kg with a forelimb 
circumference of 18 cm, the smallest cuff gave readings which were 
up to 50 mmHg higher than values obtained by direct measurement. 
This size of cuff did, however, give indirect values which agreed 
to within 10 mmHg with direct values in two dogs weighing 13 kg 
with forelimb circumferences of 12 and 13 cm respectively. To 
study the influence of cuff length, independent of cuff width, 
on the accuracy of indirect measurements a set of cuffs was 
obtained which measured:
15 X 2.5 cm 
20 X 2.5 cm 
25 X 2,5 cm
A dog weighing 12.5 kg with a foreleg circumference of 15 cm
—  1
was anaesthetised with 25 mg kg pentobarbitone ('Nembutal’,
Abbott Laboratories, Queenborough, Kent). At intervals during 
the experiment arterial pressure was increased by the 
intravenous injection of 10 mg bolus doses of methylamphetamine 
(•Methedrine', Wellcome Medical, Crewe, Cheshire) and decreased 
by the administration of halothane- Using three different 
lengths of occluding cuff, 23 comparisons of direct and indirect 
systolic pressure were made over a directly measured systolic 
pressure range of 82 - 180 mmHg.
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3.2.3 Cuff width
To study the influence of cuff width on the accuracy of 
indirect measurements of systolic pressure, occluding cuffs with 
the following dimensions were obtained:
25 X 2.5 cm 
25 X 3.75 cm 
25 X 5.0 cm
Using these cuffs, 57 comparisons of direct and indirect 
pressure were made in a dog weighing 32 kg with a foreleg 
circumference of 20 cm. As in the previous experiment, 
anaesthesia was induced with 25 rag kg  ^pentobarbitone and arterial 
pressure was altered at intervals by the administration of 
methylamphetamine or the inhalation of halothane. In this 
experiment the directly measured systolic pressure varied 
between 120 and 210 mmHg.
3.2.4 Body weight and forelimb circumference
The results obtained in preliminary experiments indicated 
that the occluding cuff width was more important than cuff 
length in affecting the accuracy of indirect measurements of 
systolic pressure in an individual animal. To define the 
correct width of cuff for a given size of animal the study 
was continued in dogs of different sizes.
Simultaneous measurements of direct and indirect systolic 
pressure were made during clinical anaesthesia in 51 dogs.
The anaesthetic technique used involved induction with 
thiopentone and maintenance with an inspired concentration
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of 1-2% halothane in oxygen. In 15 dogs acepromazine 
(’Acetylpromazine*, Boots Ltd., Nottingham) was given 
intramuscularly 30-45 min before induction of anaesthesia. 
Wider cuffs were used for large dogs and narrower cuffs 
for small dogs and, on a number of occasions, more than one 
size of cuff was used for the same animal. All animals were 
weighed and the circumference of the forelimb just above the 
elbow was measured by passing a nylon thread round the limb.
3,3 EVALUATION OF RESULTS
In experiments designed to define the systolic pressure 
end-point and the correct size of cuff for an individual 
animal the mean values of a number of estimates of indirect 
and direct pressure were calculated together with the mean 
of the difference between individual values. The correlation 
coefficient between a number of indirect and direct readings 
and equations of linear regression were also calculated.
In the study which attempted to define the correct 
width of cuff for a given animal the correlation of the 
difference between indirect and direct values with body 
weight and foreleg circumference was also calculated to 
quantify the influence of these variables on the 
accuracy of the indirect measurement. When the 'best' 
size of cuff for a given animal had been established a 
scatter diagram was drawn to display the results obtained
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in animals in which an appropriate size of cuff had been 
used.
The significance of the correlations established was
determined using the formula: t = / :P‘ (n-2)
l_r2
where r = correlation coefficient 
n = number of comparisons
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4. RESULTS
4.1 EXPERIMENTS TO EXAMINE THE FACTORS INFLUENCING THE ACCURACY 
OF INDIRECT MEASUREMENTS
4.1.1 Definition of systolic pressure end-point
Values of indirect pressure obtained in a single animal and 
read from the mercury manometer at the point when occasional 
pulses, due to respiratory variations in systolic pressure (IdR) 
were first detected in the pulse detector, and when continuous 
pulses (IdC) were first seen, are given in Table 1 .
Simultaneous direct measurements (D) of systolic pressure made 
at each indirect pressure end point are also shown.
The accuracy of the indirect pressure readings appeared to 
be little influenced by the indirect systolic end-point used.
A comparison of mean values of a number of indirect and direct 
pressure readings could be misleading as similar mean values 
would be obtained if high indirect values were balanced by 
other low values. In averaging the differences between the 
indirect and direct readings in Table 1 the arithmetic sign
has been ignored and it can be seen that the mean difference 
between the two readings was marginally less when the end 
point defined by continuous pulses was used- The equations 
of linear regression and correlation coefficients (r) obtained 
with the two end points were as follows :
D = 0.95 IdR +1.22; r - 0.91 Both correlations
D = 1.02 IdC +2.17; r = 0.92 significant at 0.1% level
Table 1 Comparison of direct and indirect, measurements of systolic
pressure when two different indirect pressure end-points
were used. All values in ininHg.
IdR D Difference IdC D Difference
(a) (b) IdR - D (c) IdC - D
132 130 + 2 128 130 2
120 120 0 110 114 - 4
126 120 + 6 115 120 - 5
118 116 + 2 120 120 O
116 112 + 4 110 113 - 3
110 108 + 2 114 112 + 2
114 100 + 14 104 108 - 4
100 95 + 5 110 100 + 10
lOO 100 O 96 96 0
110 110 0 96 95 + 1
115 114 + 1 108 108 0
120 120 O 114 114 O
124 117 + 7 115 116 - 1
120 118 + 2
Mean 115., 7 112.5 3.3 111.4 111.7 2.4
± SD ± 9.,3 ±  9.8 + 4.0 + 8,8 + 9 .7 + 2.7
(a) IdR = indirect pressure read when first occasional pulse due
to respiratory variation in systolic pressure was noted
(b) D = direct pressure
(c) IdC = indirect pressure read when continuous pulses first noted
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Using both end points a high degree of correlation was 
found between indirect and direct measurements. As no 
significant difference in the accuracy of the indirect 
reading was obtained by using one or other end-point an 
arbitrary choice was made. In all further experiments 
indirect pressure was noted when more than about four 
recognizable pulses in a row were seen.
4.1.2 Guff length
Values of indirect systolic pressure obtained with 
occluding cuffs of three different lengths, and 
simultaneously measured direct values in a single animal, 
are given in Table 2 . The correlation coefficients between 
indirect and direct values, and the equations of linear 
regression obtained with the three cuffs, were as follows:
D = 0.98 Id(15) - 4.62; r = 0.94
All correlations
D = 0.86 Id(20) + 7.55; r = 0,97
significant at 0 ,1% level
D ■= 1.12 Id(25) - 21.4; r = 0.95
A good correlation between indirect and direct values of 
systolic pressure was found with all three cuffs. The indirect 
technique tended to overestimate the direct pressure in most 
instances but the error was not increased significantly 
when the smaller cuffs were used. As the standard deviation 
of the difference between indirect and direct values was 
smallest when the 25 cm cuff was used, this length of cuff 
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The mean values of indirect pressure, obtained in one dog, with 
occluding cuffs of three different widths and mean values of 
simultaneously measured direct pressure are given in Table 3 .
The calculated equations of linear regression and the correlation 
coefficients between the direct and indirect values of systolic 
pressure are also shown. The individual values of direct and 
indirect pressure obtained from this animal are given in 
Appendix 1 .
In contrast to the results obtained with occluding cuffs 
of different lengths it was found that changes in cuff width 
produced marked and more consistent changes in the accuracy 
of the indirect measurements. The mean values for simultaneously 
measured direct and indirect pressures indicated that the 
smallest cuff size tended to overestimate the true systolic 
pressure while the two wider cuffs tended to underestimate 
the direct reading. The greatest error was produced by the 
5 cm cuff which underestimated the true reading by a mean 
value of 29 mmHg, When the calculated regression lines 
obtained from simultaneously measured direct and indirect 
pressures were plotted (Figure 5) this trend could be 
seen more readily and in addition it was noted that at 
values of direct pressure below 140 mmHg the 2.5 cm cuff 
also tended to underestimate the true pressure. The regression 
line obtained with the 3.75 cm cuff was closest to the 45° 
line of equal values and this cuff also provided the highest 
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Pig. 5 Calculated regression lines obtained from simultaneous 
measurements of indirect (Id) and direct (D) systolic 
pressure
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This experiment indicated that, for the dog used in this 
study, the 3.75 cm cuff gave the most accurate values of indirect 
pressure while the wider cuff gave readings which were much 
lower than the direct pressure and the narrower cuffs generally 
provided values in excess of the true pressure.
4.1.4 Body weight and forelimb circumference
Details of the number of comparisons of direct and 
indirect pressure made, and the correlation between the two 
measurements with different sizes of cuffs are given in 
Table 4. in 23 animals both the 2.5 and 3.75 cm cuffs were 
used and in a few animals the accuracy of all three cuffs 
was assessed. Simultaneously measured values of indirect and 
direct pressure obtained from all 51 dogs are given in Appendix 2 













Equation of linear 
regression
2.75 27 6.5 - 29 0.87* D = 0.94 Id + 5.39
3.75 46 8 - 47 0.91* D = 0.88 Id + 20.49
5.0 12 23 - 39 0.96* D = 1.08 Id + 0.95
*Significant at 0.1% level
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All the cuffs gave values for indirect pressure which correlated 
well with directly measured pressures. In the 23 animals where both 
the 2.5 and 3.75 cm cuffs were used the wider cuff generally gave a 
lower reading.
In Table 5 the correlation of the difference between indirect 
and direct measurements (Id - D) with body weight is shown.
Results obtained in individual animals are given in Appendix 3. 
Table 5 Correlation between (Id ~ D, mmHg) and body weight (kg) 
obtained with occluding cuffs of three different widths
Occluding cuff No. of Correlation Equation of linear
width (cm) comparisons coefficient regression
2.5 27 0.63* Id-D = 1.56 Wt - 21.72
3.75 46 0.58* Id-D = 0.94 Wt - 26.01
5.0 12 0.31 Id-D = 0.86 Wt - 38.44
*Significant at 0.1% level
The accuracy of the results obtained with the 2.5 and 3.75 cm 
cuffs was significantly affected by body weight whereas a similar 
degree of correlation was not obtained with the 5 cm cuff.
The accuracy of the indirect readings obtained with the two 
smaller cuffs was also affected by changes in foreleg 
circumference (Table 6 ) but the degree of correlation obtained 
was no greater than that found with body weight.
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Table 6 Correlation between (Id-D, mmHg) and foreleg circumference 
(F.C., cm) obtained with occluding cuffs of three different 
widths
Occluding cuff No. of Correlation Equation of linear
comparisons coefficient regression
2.5 27 0.58* Id-D = 4.17 FC - 67.28
3.75 46 0.54** Id-D = 2.82 FC - 59.56
5.0 12 0.21 Id-D = 1.06 FC - 36
*Signifleant at 1% level
**Significant at 0.1% level
To determine the correct width of cuff for a given size of 
animal the regression lines of the difference between indirect 
and direct measurements (Id-D, mmHg) and body weight, obtained 
with the 2.5 and 3.75 cm cuffs were drawn (Figure 6 ). It can 
be seen that the 2.5 cm cuff would be expected to provide the 
most accurate results (Id-D = O) in animals weighing 14 kg.
The results obtained with this size of cuff are liable to be 
greater than the true value in dogs heavier than 14 kg and less than 
the direct value in lighter dogs. Similar effects were found with 
the 3.75 cm cuff with the most accurate results being found in 










Fig. 6 Regression lines of the difference between indirect and 
direct measurements of systolic pressure (Id-D, mmHg) and body 
weight. At 19kg the positive error (AB) obtained with the 
smaller cuff is equal to the negative error (BC) incurred 
with the wider cuff
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When dealing with a range of sizes of animals the 'best' weight 
at which to change the size of the occluding cuff is that weight 
where the positive error incurred by using the smaller cuff is equal 
to the negative error obtained when the larger cuff is used. In 
Figure 6 it can be seen that this crossover point is reached at 
a weight of 19 kg. It would appear therefore that the 3.75 cm cuff
should be used for dogs heavier than 19 kg whereas the 2.5 cm cuff
can be expected to give more accurate results in lighter dogs.
An examination of the results obtained in individual animals 
showed that indirect measurements had been made with a 2.5 cm 
cuff in 19 dogs under 19 kg and with a 3.75 cm cuff in 26 dogs 
over this weight. A scatter diagram of the results obtained 
from these 45 dogs is shown in Figure 7 . The calculated 
regression line obtained with these values (D =0.96 ID + 5.81) 
lay very close to the 45° line of equal values and the
correlation coefficient between the two values was 0.91.
In only three dogs, where the 2.5 cm cuff was used, did the 
indirect pressure differ from the direct pressure by more than 
15 mmHg. Two of these dogs were terrier breeds in which accurate 
placement of the occluding cuff was found to be more difficult. 
Excessively high indirect readings were obtained in some very 
large dogs where bulging of the 3.75 cm cuff occurred. In a few 
of these cases the 5 cm cuff produced more accurate results but 
in general this size of cuff tended to underestimate the 
directly measured pressure.
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210 -
1 9 0 -
1 7 0 -
I—




1 3 0 -
110- 45° line of equal values 
Calculated regression line  




mm Hg Ind irect
Fig. 7 Scatter diagram to illustrate the relationship between direct 
and indirect measurements in 45 dogs. A cuff 2.5cm wide was 




The assessment of the state of the circulatory system of the 
anaesthetised dog is usually restricted to the measurement of 
pulse rate, estimation of pulse volume and observation of the 
colour and capillary refill time in the oral mucous membranes. 
The measurement of arterial pressure can provide useful 
additional information and where accurate measurement is 
required direct techniques are usually employed. For routine 
use, indirect methods, which do not require cannulation or 
needle puncture of an artery are preferable.
A technique suitable for use in the anaesthetised dog 
should be shown to provide indirect values which correlate 
well with simultaneous direct measurements of arterial 
pressure. The apparatus used should be as simple as 
possible and the technique should be applicable to dogs 
of varying size and conformation. The pulse sensing device 
should be sensitive enough to detect small peripheral 
pulses but should not be so sensitive that movement artefacts 
obscure arterial pulsations {Campbell, Lawson and Sanford,
1964). Once apparatus has been set up no access to the 
anaesthetised animal should be necessary as this may be 
difficult in animals covered with surgical drapes.
The present study has shown that the 'Newcastle' infant 
sphygmomanometer with a xylol pulse indicator fulfills the
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above requirements well. Indirect measurements of systolic pressure 
correlated closely with direct values in 51 dogs with a weight 
range of 6.5 - 47 kg. In an individual animal the accuracy of 
indirect measurements was found to be affected more by the width 
of the occluding cuff than by its length. In animals of varying 
size the accuracy of the indirect method was affected by body 
weight and a correlation with foreleg circumference was also 
established. From the calculation of linear regression 
equations derived from the difference between direct and indirect 
values and body weight it appears that a reasonably accurate 
estimate of systolic pressure can be made by using a cuff 
2.5cm wide in dogs weighing less than 19kg and a 3.75cm wide 
cuff in heavier animals.
Wilson and Clarke (1964) have reported the only previous 
study in which a xylol pulse monitor was used to measure 
indirect blood pressure in dogs. These authors found a 
good degree of correlation between indirect and direct 
readings in a single 12kg dog. The width of the occluding 
cuff used was 3cm and was similar to that recommended in the 
present work for a dog of this size.
In the original report of the use of the 'Newcastle' 
sphygmomanometer, in human infants, Ashworth, Neligan and 
Rogers (1959) compared the accuracy of measurements made 
with the xylol pulse indicator with indirect values
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obtained by auscultation or palpation of the peripheral pulse. 
Measurements made with the xylol indicator showed the smallest 
range of variation but indirect readings were not compared with 
directly measured pressures in these infants.
The results of the present study can be compared with those 
of Valtonen and Eriksson (19 70) who used an occluding cuff 
placed on the upper forelimb, and detected peripheral 
pulsations with a condenser microphone. The influence of 
cuff width on the accuracy of their indirect measurements was 
examined by comparing the results obtained with seven cuffs, 
varying in width from 3 - 5.6cm, with direct measurements 
from a femoral artery in 10 dogs weighing between 6 and 26kg.
It was found that narrow cuffs gave values greater than direct 
readings in large dogs while wide cuffs gave erratic values 
in small dogs. With the small number of animals examined 
it was not possible to give any definite guidance on the 
selection of the correct size of cuff for different dogs.
The inflatable portion of the occluding cuff used by 
these authors was made from a cycle tube and cuffs of 
different widths were prepared by covering this tube with 
non-distensible cloth. With this design of cuff it is 
possible that cuff pressure may not have been transmitted 
equally to the edges of the larger cuffs.
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In other investigations in dogs, where indirect and direct 
values have been compared, a single size of occluding cuff 
has generally been used and little attention has been paid to 
the effects of cuff width on the accuracy of the indirect 
reading (Rule, 1944; O'Connor, 1955; Prioli and Winbury, 
I960; Klemm and Heraborough, 1966; Baum and Rowles, 1969; 
Garner et al., 1975). Cuffs were applied to the thigh 
in the studies reported by Rule (1944) and Romagnoli 
(1953). Klemm and Hemborough (1966) used a tubular metal 
tail cuff and tail cuffs 2 and 3cm wide were used by 
Baum and Rowles (1969) and Prioli and Winbury (1960) 
respectively. The latter authors also shaved the tail prior 
to the application of the cuff. Garner et al., (1975) used
a 5cm wide cuff applied to the tibia of four dogs with a 
weight range of 20-27kg and O'Connor (1965) applied cuffs 
1-2.5cm wide to the femoral artery enclosed in a skin loop, 
when investigating a technique for use in physiological 
studies in dogs. In clinical practice one is likely to 
encounter some dogs with an insufficient length of tail to 
retain an occluding cuff and the conical shape of the 
thigh makes accurate placement of a cuff at this site 
difficult. When a tibial cuff is used it is possible 
that the arterial vessels may be displaced between the 
two bony structures at this site and may thus be protected 
from the pressure exerted by the occluding cuff. As a 
variety of different sizes of cuff were used by the above
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authors and no information on the circumference of the 
compressed area has been provided it is not possible to make 
a direct comparison of the results obtained with those of 
the present study.
To provide accurate indirect results in adult man it 
has been recommended that the inflatable portion of the 
occluding cuff should be 20% wider than the diameter of 
the limb on which it is placed (Kirkendall, Burton, Epstein 
and Freis, 1967). Ragan and Bordley (1941) compared 
readings taken in man with 13 and 20cm wide cuffs and 
found that values obtained with the wider cuff were 
significantly lower than directly measured pressures.
Some correlation between the accuracy of the indirect 
reading and the circumference of the arm was found by 
these workers but Holland and Humerfelt (1964) were 
unable to demonstrate a similar correlation in a 
study in which cuff pressure was found to underestimate 
direct systolic pressure by a mean value of 24.6ramHg. As 
arm diameter is difficult to measure accurately Gedde s 
and Whistler (1978) related the recommendation of 
Kirkendall et al. (1967) to arm circumference and 
suggested that an occluding cuff width equal to 40% 
of the arm circumference should be used. In a study 
which compared indirect values obtained with cuffs 9cm 
and 18cm wide with reference values obtained with a 12cm 
cuff these workers found that when the cuff width;arm 
circumference ratio was 0.34 blood pressure was
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overestimated by about 5%. When the ratio was increased to 0.50 
pressures were underestimated to a similar extent.
It can be calculated from the regression equations obtained 
in the present work that the 2.5cm and 3.75cm cuffs used would 
be most suitable in dogs with foreleg circumferences of 15cm 
and 21cm respectively. These figures provide cuff width:foreleg 
circumference ratios of 0.17 and 0.18. These ratios are 
much lower than those found to give satisfactory results in 
man and indicate that for a given limb circumference relatively 
narrower cuffs provide satisfactory indirect results in dogs.
A more relevant comparsion may be made between results 
obtained in dogs and in human infants. Robinow, Hamilton, 
Woodbury and Volpitto (1939) concluded that a cuff width 
of 2.5cm was suitable for newborn infants whereas a 5cm 
cuff was required to give accurate results in older infants.
In another study, in newborn infants, Schaffer (1955) found 
that a cuff 4cm wide gave more accurate results than 2.5 or 
8cm cuffs. Robinow et al. (1939) noted some correlation 
between the width of cuff required and arm circumference 
when the latter measured less than 14cm. These authors 
suggested that the tissue s in the arm of a young infant 
were more compressible and were displaced laterally by 
inflation of the cuff such that the diameter of the tissue 
actually compressed was decreased. A similar mechanism 
may explain the need for a relatively narrower cuff
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in dogs but further work is required to examine the 
compressibility of the tissues of the forelimb in this species 
Results obtained in the present work indicate that the 
length of the occluding cuff is of less importance than the 
cuff width. All three cuffs examined were sufficiently 
long to completely encircle the forelimb. Although it has 
been recommended for use in man that the inflatable 
portion of the cuff should be long enough to half encircle 
the limb (Kirkendall et al., 1967) it has been noted that 
a cuff which completely encircles the limb can reduce the 
scatter of the indirect readings obtained (Karvonen, 1962) .
In addition to cuff size the accuracy of the indirect 
technique may be affected by a number of other factors.
In this work and in the studies of Wilson and Clark (1960) 
and Valtonen and Eriksson (1970) indirect pressure was 
estimated in a brachial artery while direct pressure was 
measured in a femoral artery. The latter authors have 
shown that in dogs the femoral pressure may be up to 
lOramHg greater than the brachial pressure. Although 
smaller differences between femoral and brachial pressures 
have been noted in man (Pascarelli and Bertrand, 1964;
Bell, Nielsen, Lassen and Wolfson, 1973) a difference 
between pressure at the site of cuff placement and the 
reference pressure may be of more importance in studies 
where a tail cuff has been used (Klemm and Hemborough,
1966; Baum and Rowles, 1969; Prioli and Winbury, 1960).
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It has also been suggested that indirect methods measure the 
lateral pressure against the wall of an artery, whereas the 
direct method determines the end-on thrust of pressure 
against the diaphragm of a transducer (Van Bergen, 
Weatherhead, Treolar, Dobkin and Buckley, 1954).
However, these authors were unable to detect significant 
differences in brachial artery pressure when a needle 
was directed peripherally or centrally.
The frequency response of the catheter-recorder 
system is important for the accurate measurement of 
the direct pressure. Although this was not examined 
in the present work the diameter and composition of 
the catheters used were similar to those which were 
shown to be satisfactory by Stegall, Kardon and Kemmerer 
(1968). It is possible that the silicone rubber catheter 
used by Baum and Rowles (1969) may have caused the 
directly measured pressure to be damped excessively.
It has been shown that if a given size of cuff 
is applied more tightly the indirect pressure measured 
is reduced (Schaffer, 1955). Difficulty in applying 
cuffs in a uniform manner in dogs with widely differing 
conformation was a possible source of error in some 
of the dogs examined in the present study. However, 
in a given animal, and in the study as a whole, a good 
correlation was obtained between direct and indirect
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values. This indicates that the method should be sufficiently 
accurate to detect changes occurring during anaesthesia in an 
individual animal.
Although indirect techniques have been used to measure 
arterial pressure in conscious dogs (Wilson and Clark, 1954; 
Prioli and Winbury, I960; Romagnoli, 1953; O'Connor, 1955) 
the marked sinus arrhythmia seen in conscious animals, and 
the apprehension shown by untrained animals makes the 
procedure more difficult and less reliable than is the 
case in the anaesthetised dog.
Chapter 2
EVALUATION OF THE ACCURACY OF END-TIDAL CARBON DIOXIDE TENSION 
MEASUREMENT FOR THE ESTIMATION OF ARTERIAL CARBON DIOXIDE 
TENSION IN ANAESTHETISED DOGS
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1. INTRODUCTION
It is generally accepted that measurement of the partial pressure 
of carbon dixoide in arterial blood (PaCO^) provides a better 
indication of the effectiveness of respiration and the balance 
between carbon dioxide production and elimination than measurement 
of respiratory rate and tidal volume (Jennett, 1968). The velocity 
of diffusion of carbon dioxide is sufficiently rapid for pressure 
equilibrium to be established in the lung between alveolar gas 
and pulmonary capillary blood (Comroe, 1965 ). As pulmonary 
capillary blood has the same PCO^ as arterial blood and as 
end-tidal expired gas can be expected to be representative of 
alveolar gas, measurement of end-tidal PCOg should provide 
an accurate estimation of PaC02. It has been found, however, 
in normal unanaesthetised dogs, that PaCO^ is generally 3 mmHg 
greater than the alveolar value (Severinghaus and Stupfel, 1957).
This difference was attributed to the presence of alveolar dead 
space resulting from the ventilation of some nonperfused 
alveoli.
In man, a significant increase in alveolar dead space has 
been found to follow induction of anaesthesia (Severinghaus,
Stupfel and Bradley, 1957; Campbell, Nunn and Peckett, 1958) while 
in a study in dogs anaesthetised with pentobarbitone, Suskind 
and Rahn (1954) found that the alveolar-arterial carbon dioxide 
gradient did not change in any predictable manner.
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In the present study the difference between alveolar (end-tidal) 
and arterial blood PCO^ has been measured to assess the accuracy of 
the end-tidal values in the estimation of PaCO^ during anaesthesia 
produced in dogs of various sizes with a range of anaesthetic drugs 
and techniques. The results should also provide information on 
the size of the alveolar dead space in these animals but no 
attempt has been made to standardize the techniques used to allow 





The 22 dogs (5-40 kg) used in this investigation were clinical 
cases requiring anaesthesia for routine surgical interventions in 
the Department of Veterinary Surgery of the University. All 
animals were free from any detectable abnormality in their 
respiratory and cardiovascular systems.
2.2 Apparatus
The carbon dioxide concentration in the expired air was measured 
with an infra-red analyser (Godart Capnograph, Cardiopulmonary 
Instruments, Rochester, Kent) and recorded continuously with a 
Polygraph pen recorder (AEI Scientific Apparatus Ltd., Urmston, 
Manchester). Arterial PCOg (PaCO^) was measured with a 
Severinghaus electrode (Radiometer Type E5036, V.A. Howe and Co. Ltd., 
London) .
In most cases anaesthesia was maintained with inhalation agents 
delivered with oxygen from a Boyle’s anaesthetic apparatus.
A 'to and fro’ and a circle absorber were both used and in 
one instance gases were delivered with a Magill circuit.
2.3 Drugs
Thiopentone (’Intraval’, May and Baker Ltd., Dagenham, Essex) 
was the agent most frequently used to induce anaesthesia and 
both halothane (’Fluothane' ICI, Macclesfield, Cheshire) and 
cyclopropane (BOC Medical, Harlow, Essex) were used as 
maintenance agents. In three dogs a mixture of etorphine 
and methotrimeprazine (’Immobilon', Reckitt and Coleman,
Hull) was used. Eight dogs were premedicated with aceproraazine
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('Acetylpromazine', Boots Ltd., Nottingham) and in two cases 
atropine sulphate B.P. (Macarthy's Ltd., Romford, Essex) was 
given prior to induction of anaesthesia.
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3. METHODS
3.1 Technique of end-tidal carbon dioxide measurement
In all animals the trachea was intubated with a cuffed 
endotracheal tube and end-tidal carbon dioxide partial 
pressure 'calculated from the plateau obtained
in the record produced by the infra-red analyser. End-tidal 
PCO^ was calculated from the percentage figure obtained from 
the tracing using the formula:
PCOg (mmHg) = (B-50) mmHg x C02%
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(B-50) = Barometric pressure - saturated water vapour pressure 
at 38°C.
The analyser sampled gas continuously from the endotracheal 
tube through a 4mm bore nylon catheter. Mixtures of 4% and 8% 
carbon dioxide in oxygen were used to calibrate the analyser 
and the zero adjustment was made with the carbon dioxide free 
anaesthetic gas mixture used in a given animal.
Preliminary experiments were undertaken to investigate the 
influence of different expired gas sampling techniques on the 
value obtained for under steady state conditions in a
given animal prior to the start of surgery.
3.1.1 Length of sampling catheter
Two lengths of catheter, one being 90cm and the other 
180cm, were used to collect samples from the endotracheal 
tube. Although the longer catheter increased the delay in 
the analysis of the CO^ content of a given expiration.
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identical values of obtained with both catheters.
In all subsequent studies a 90cm catheter was used.
3.1.2 Site of withdrawal of gas sample
The effect of sampling gas from the proximal (oral) and 
distal ends of the endotracheal tube was investigated. It 
was found to be important to sample gas from the distal end 
of the endotracheal tube in animals breathing air to prevent 
the entrainment of room air. When the endotracheal tube was 
connected to an anaesthetic circuit no consistent difference 
was noted when the position of the sampling catheter was 
altered.
3.1.3 Gas sampling flow rate
A gas sampling flow rate of 0.8 I min  ^was found to be
satisfactory in most instances. Variation of the sampling
-1
flow rate between 0.5 and 1.5 I min had little effect on 
P^T^^2 although the appearance of the trace was altered, with 
the faster flow rates producing a narrower expiratory 
plateau. In large dogs little difference in ^g^CO^ was 
noted when different anaesthetic circuits were used or 
when fresh gas inflow into a semi-closed circuit was 
stopped (e.g. Table 7 and Figure 7).
C IR C U IT  CIRCLE ABSORBER  
Greyhound 29 kg Lateral position




L 1 Min. 1
Circle absorber 2 L/Min. Circuit closed No inflow 
Fig. 7 Alteration in capnograph trace produced by stopping the 
inflow into a circle system
C IR C U IT  TO AN D FRO ABSORBER
6 kg. Dog 0-8 L/Min. Sample
1 Min.
Inflow 2 L/Min.
End exp. C02% 6 3
Nil
6-3
Fig. 8 Alteration in capnograph trace produced by stopping 
the inflow into a 'to and fro' system
105
Table  ^ Effects of different circuits and gas inflow rates on 
values of obtained in a 28kg dog
Anaesthetic circuit Fresh gas flow P CO (mmHg)
I mln-l
Circle absorber 4 32
'To and fro' absorber 4 32
'To and fro' absorber 0 33
Magill 4 33.5
In smaller dogs (5-11kg) , when the fresh gas flow was 
stopped the appearance of the trace was altered in such a 
way that a longer expiratory plateau was obtained but 
E^T*“^ 2 not increased (e.g. Figure 8 ) . with small 
dogs on a T-piece system or in animals not connected to an 
anaesthetic circuit, sample flow rates in excess of 0.5 I min 
entrained room air and reduced slightly.
3.2 COMPARISON OF END-TIDAL AND ARTERIAL VALUES OF PCO  ^
Comparisons of PaCO^ were made with dogs
breathing spontaneously and lying in a lateral position. 
Samples of arterial blood were collected from a femoral 
artery by needle puncture and blood was allowed to flow 
into a heparinised syringe under its own pressure.
Each sample was collected over three or four respiratory 
cycles. Syringes were capped and PaCOg was measured 
within 10 min of sample collection. The time of 
collection of an arterial sample was noted on the
. -1
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continuous trace produced by the infra-red analyser, which
sampled gas from the endotracheal tube, in order that
simultaneous values of PaCO^ could be compared.
Where a single comparison was obtained in a given animal,
the arterial sample was collected 20-30 min after induction
of anaesthesia. In some animals a number of comparisons
were made before surgery was begun.
3.3 EVALUATION OF RESULTS
Where more than one comparison was made in a given animal
the mean values of P^^C02 and PaCO^ obtained in that animal
were used in calculating the overall correlation between the
two values in the whole group of dogs. Scatter diagrams
were plotted to examine the relationship between
PaC02 in an individual animal and in all 22 dogs. Correlation
coefficients, equations of linear regression, and group mean
values obtained with simultaneous measurements of P^^CO^ET 2
and PaCO^ were calculated.
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4. RESULTS
4.1 COMPARISON OF END-TIDAL AND ARTERIAL VALUES OF PCO^
Simultaneous measurements of ^^^^02 and PaC02 were made on 
52 occasions in the 22 dogs studied, over a range of PaCO^ 
values of 30-70 mmHg. No more than 6 comparisons were made 
in any one dog. As an example of the results obtained in an 
individual animal the values measured in a 2 3kg Greyhound 
are given in Table 8 .
Table 8 Simultaneously measured values of PaC02 and 2^^002 











Mean 59.7 + 13.0 54.7 + 13.0 5.0 + 1.54
+ SD
In this animal Pg^C02 consistently underestimated PaC02,
the mean difference between the two values being 5mmHg.
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When the equation of linear regression obtained with these results 
was calculated (Figure 9) the regression line was found to lie 
parallel to the 45° line of equal values and the two measurements 
demonstrated a high degree of correlation (r=0.99) which was 
significant at 0 .1% level.
The breeds and weights of the 22 dogs studied and the 
anaesthetic techniques and circuits used are given in Table 9.
The values of PaCO^ and P^^CO^ obtained from these animals 
are given in Table 10 . The difference between the mean 
values obtained with the two techniques of measurement was 
2.ImmHg with the value of PaC02 generally being greater 
than p2T^^2' ^ET^°2 greater than PaCO^ in
7 dogs. The results from these
7 animals can be seen to lie below the 45° line of equal 
values in the scatter diagram shown in Figure 10 while
the majority of values and the calculated regression 
line demonstrate that in most instances the value of 
PaC02 is equal to or greater than The correlation
obtained between simultaneously measured PaC02 and P^^C02 
was statistically highly significant (r=0.85, significant 
at 0.1% level) . In only two dogs was ^ lOmmHg.
These two dogs were amongst the smallest studied but in another
small dog (no. 19) the two values were identical. The weight 
range of the dogs studied and the diversity of anaesthetic drugs 
and circuits used was such that no detailed analysis of the 
influence of these factors on the magnitude of the arterial- 
end tidal PCO2 gradient was attempted.
E  40—
o  30—
45°  line of equal values 
Calculated regression Une 
PaC02 = 0.995 P^ lC02 + 525 
r = 0.99
. — 1~  .
20 30 40 50 60 70
P 2 1 CO2  (mm Hg)
Fig 9 The relationship between simultaneous measurements of end tidal 
carbon dioxide tension (P CO^) and arterial tension (PaCO„) 
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Fig. 10 The relationship between simultaneous measurements of 
end tidal carbon dioxide tension (P CO ) and arterial 
tension (PaCO^) in 22 dogs
techniques used in the comparison of PaCO^ and P S°2
AnaesttDog Breed Wt. Premedication Anaesthetic
No. (kg) drugs* circuit
1 Alsation 37 - Et/Me/Air -
2 Greyhound 29 - Et/Me/Air
3 Poodle 15.5 - Et/Me/O^ ScC
4 Greyhound 23 - Thio/Cyclo/Og cC
5 Greyhound 23 - Thio/Halo/O^ ScC
6 Alsation 5 - 1 ScT
7 Greyhound 29 - 1
8 Retriever 18 - II ScC
9 Beagle 9.5 - 11 ScT
10 Sheltie 7.5 — II cT
11 Sheltie 5.5 - If
12 Bull Mastiff 34 - II ScC
13 - - Atropine 11 cT
14 K.Charles Spaniel 9 II ScT
15 Pointer 40 Acepromazine 11 Magill
16 Cairn Terrier - 11 II ScT
17 Doberman 23 M 1
18 Collie 11 *1 11
19 Poodle 8,5 11 11
20 Alsatian 28 11 Halo/Og cC
21 Collie - Thio/Halo/N^O/O^ ScT
22 Retriever 28 Thio/Cyclo/0 cC
*Et/me = Etorphine methotrimeprazine 
Thio = Thiopentone 
Cyclo = Cyclopropane 
Halo = Halothane
**C = circle absorber
T = 'to and fro' absorber
c = closed
Sc = semi-closed
Table lO Simultaneously measured values of PaCO, and P^^C








1 1 45 48 -3
2 3 55 58 -3
3 1 52 57 -5
4 6 56 53 3
5 6 60 55 5
6 2 64 54 10
7 6 56 53 3
8 1 56 56 0
9 1 49 48 1
10 ' 4 47 43 4
11 5 57 48 9
12 5 40 37 3
13 1 45 39 6
14 1 47 35 12
15 1 40 33 7
16 1 39 45 -6
17 1 44 36 8
18 1 30 33 -3
19 1 36 36 0
20 2 30 34 -4
21 1 34 35 -1
22 1 50 50 O









In an animal with a constant metabolic rate any change in 
alveolar ventilation is reflected by a change in the tension of 
carbon dioxide in arterial blood (PaCO^). An increase in 
alveolar ventilation leads to a decrease in PaCO^ while 
underventilation causes to increase. The measurement
of PaCO^ therefore provides a suitable method for the 
assessment of the effects of anaesthetic drugs on 
respiration.
As the collection of samples of arterial blood for the 
direct determination of PaCO^ with a carbon dioxide electrode 
(Severinghaus and Bradley, 1958) is seldom possible during 
routine veterinary anaesthesia, an indirect method of measurement 
would have considerable advantages. One indirect technique 
which has been used in man involves the calculation of 
PaCO^ from a measurement of mixed venous PCO2 derived using a 
rebreathing technique (Campbell and Howell, 1960).
This method would be difficult to apply to dogs of different 
sizes as a number of different rebreathing times and re­
breathing bags of varying capacity would have to be 
employed. The method investigated in the present study 
involved the estimation of PaCO^ from measurement of the 
concentration of carbon dioxide in end expired gas with a 
rapid infrared analyser (Collier, Affeldt and Farr, 1955;
Burton, 1966 and 1969). The correlation between 
simultaneous measurements of end-tidal carbon dioxide 
tension (P^^COg) and PaCOg was examined to assess the
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accuracy of the end-tidal measurements.
In an individual animal a very good degree of correlation 
(r=0.99) between the two values was found and in all 
of the , dogs studied, with body weights ranging from 5-40kg 
the correlation coefficient obtained with simultaneous 
measurements of and PaCO^ was 0.85. These results
indicate that measurement of should give a reasonably
accurate estimation of PaCOg in dogs of different sizes and 
that changes in PaCO^ in an individual animal are reflected 
in changes of similar magnitude in the value of
These results can be compared with those obtained in a 
recent study where the accuracy of measurements was
assessed in 5 dogs weighing 22-28kg and anaesthetised with 
halothane (Hightower, Kiorpes, Butler and Fedde, 1980).
When dogs were allowed to breath spontaneously or were 
ventilated with a constant pressure ventilator the overall 
correlation coefficient between end tidal and arterial values 
was 0.80. A lower correlation coefficient of 0.46 was 
obtained when dogs were ventilated by intermittent manual 
compression of a reservoir bag. The correlation obtained 
by these workers in spontaneously breathing dogs was 
slightly lower than that found in the present study in 
which animals with a much greater weight range were 
investigated.
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In anaesthetised rabbits, with a mean weight of 2.96kg, Evans 
Hogg and Rosen (1977) found a good correlation between 
and PaCO^ over a wide range of ventilatory rates. In other 
studies in anaesthetised animals, rather than examine the 
correlation between P^^CO^ and PaCO^, the difference between 
the two values has been measured. These investigations were 
primarily designed to examine the influence of a number of 
factors on alveolar dead space.
The presence of alveolar dead space results from the dilution 
of alveolar gas with gas from poorly perfused alveoli with a 
low carbon dioxide content. This causes the PCOg of mixed 
alveolar gas to be reduced below that of arterial blood 
(Severinghaus and Stupfel, 1957). The presence of alveolar 
dead space is thus one of the main reasons for differences 
in the absolute values of Pg^^02 and PaC02.
In a small number of experimental studies the difference 
between PaC02 and PgT^^2 been examined in both conscious
and anaesthetised dogs. Suskind and Rahn (1954) measured 
^ET^^2 ^ thermo-conductivity analyser in three
conscious dogs trained to lie in the supine position 
wearing individually fitted masks and found a mean 
difference between PaC02 and  ^mmHg. During
anaesthesia with pentobarbitone the arterial-end-tidal 
gradient did not change in any predictable manner, the 
values obtained ranging from 4mmHg to -ImmHg. Severinghaus
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and Stupfel (1957) reported a mean difference of 3mmHg with a 
range of l-12mmHg in normal dogs with little change in alveolar 
dead space being produced by pentobarbitone or chloralose 
anaesthesia. In a further study, Severinghaus, Stupfel and 
Bradley (1957) claimed that anaesthesia produced no change 
in the PaCO^-Pg^CO^ gradient. A criticism of this study is 
that control values were obtained in conscious animals 
paralysed with succinylcholine. While this type of study 
should be condemned on humanitarian grounds it is also 
possible that the stress involved in paralysing conscious 
animals may have caused endogenous catecholamine release 
which would have produced an increase in arterial and 
pulmonary perfusion pressures and a decrease in alveolar 
dead space.
In some other investigations in anaesthetised dogs 
significant differences between PaCO^ and been
recorded. Bergman (1963) found gradients ranging from 
3.5-8.4mmHg in dogs anaesthetised with pentobarbitone 
and paralysed with succinylcholine. In fourteen dogs 
(13-29kg) anaesthetised with thiopentone, Suwa, Hedley- 
Whyte and Bendixen(1966) found that physiological dead 
space (anatomical plus alveolar) increased when ventilation 
was controlled in comparison with results obtained in 
spontaneously breathing animals. The increase in dead 
space was correlated with a reduction in cardiac index 
and these authors concluded that differences in 
physiological dead space in dogs were probably due to
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concomitant changes in the pulmonary circulation.
In the present investigation the mean difference between 
PaCO^ and was 2.ImmHg with a range of 12mmHg to
-5mmHg. The mean figure obtained is in close agreement 
with the values reported in dogs by Suskind and Rahn (1954), 
Severinghaus and Stupfel (1957) and Bergman (1963). The 
range of values is however greater than has been previously 
reported and indicates that a variable amount of alveolar 
dead space was present in the dogs examined. In dogs with a 
positive PaCO^-Pg^COg gradient alveolar dead space may 
have been increased if the anaesthetic drugs used or the 
posture of the animals led to a reduction in the perfusion 
of ventilated alveoli (Bergman, 1963; Suwa et al., 1966).
The relationship between PaCOg also depends on
the pattern, rate and depth of respiration (Severinghaus, 
Stupfel and Bradley, 1957) and no attempt was made to 
control these variables.
The range of carbon dioxide gradients noted included 
a number where P^^CO^ was greater than PaCOg. While it is 
probable that measurement inaccuracies may have contributed 
to the larger gradients it is also possible that genuine 
negative PaCO^-P^^CO^ gradients may be obtained in some animals
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Uneven ventilation is likely to elevate Pgy,CC>2 poorly 
ventilated alveoli having a high PCOg usually empty last 
(Severinghaus, Stupfel and Bradley, 1957). It must also 
be noted that alveolar CO^ concentration varies with the 
respiratory cycle. The concentration is reduced during 
inspiration and decreased during expiration as the 
relatively constant output of CO^ is released into a 
lung volume which changes with the different phases of 
respiration (Collier et al., 1955) . With large tidal 
volumes and slow respiratory rates may more closely
approximate (Burton, 1966). Fletcher, Jonson,
Gumming and Brew (1981) have noted negative PaCOg-Pg^CO^ 
gradients in some human patients and postulate that such a 
gradient implies compensation by perfusion for early 
emptying, overventilated alveoli. While mean alveolar 
PCOg is in equilibrium with PaCO^, this mean value is a 
temporal and spatial mean and negative gradients need 
not imply carbon dioxide diffusion against a concentration 
gradient.
In the anaesthetised dogs investigated by Suskind and 
Rahn (1954) small negative gradients were noted and in dogs 
anaesthetised with halothane (Hightower et al., 1980 ) 
superimposition of a 45° line of equal values on the scatter 
diagram shown demonstrates that a number of negative 
gradients were obtained.
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In human patients anaesthetised with nitrous oxide, halothane 
or cyclopropane, PaCO^ has generally been found to be slightly 
greater than and Hill, I960;- Askrog, Pender and
Eckenhoff, 1964; Askrog, Pender, Smith and Eckenhoff, 1964; 
Burton, 1969). On the other hand, Frumin, Bergman and Holaday 
(1959) found that the arterial value was on average 2mmHg less 
than the end-tidal value.
Some of the discrepancies found in these studies and the wide 
range of gradients found in the present study may be attributed 
to minor inaccuracies in the measurement of PaCOg or PgT^^2' 
Correction of the value of PaCOg for a 1°C reduction in an 
animals body temperature relative to the temperature of the CO^ 
electrode would cause the true PaCO^ to be reduced by a factor 
of 0.96 (Severinghaus, 1965). In animals breathing air while 
the infrared analyser was calibrated with CO^:oxygen mixtures 
the value of may have been overestimated by 0.4 per cent
(Ramwell, 1957). Although nitrous oxide and cyclopropane 
were only used in a total of 3 dogs it is unlikely that the 
pressure broadening effect which can be produced by these 
gases (Powell, 1965; Severinghaus, Larsen and Eger, 1951) 
had a significant effect on the results as no consistent 
trend was noted in animals in which these gases were used.
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The total measurement error is unlikely to have been greater 
than 4mmHg and as such would not invalidate the conclusion 
that measurement of produces a reasonably accurate
assessment of PaCO^ in dogs of different sizes and anaesthetised 
with various anaesthetic agents and techniques. It is obvious 
however that particular attention must be paid to the 
accuracy of the measurements made to allow small changes in 
alveolar dead space to be detected. It has also been 
pointed out by Askrog, Pender, Smith and Eckenhoff (1964) 
that a comparison of the effects of different anaesthetic 
agents on alveolar dead space can only be made in normal 
unoperated patients with depth of anaesthesia and tidal volume 
being controlled precisely.
Chapter 3
STUDIES WITH NEUROLEPTANALGESIC MIXTURES IN DOGS
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1. INTRODUCTION
In this section studies to examine the clinical efficacy of 
three different neuroleptanalgesia combinations are described. 
Although Marsboom et al, 1964, reported a study where the 
analgesic component of a fentanyl:fluanisone mixture had been 
given by intravenous injection following the intramuscular 
administration of fluanisone, none of the published studies 
has described the effects produced by the simultaneous 
intravenous administration of both components of a neurolept­
analgesia mixture. In the present work a comparison is made 
of the neuroleptanalgesia effects and side effects produced 
when two neuroleptanalgesia combinations are given by either 
the intravenous or intramuscular routes.
In the reports on the clinical use of neuroleptanalgesia 
mixtures in dogs few quantitative details have been provided 
on the respiratory and haemodynamic effects produced by the 
technique. Marsboom et al. (1964) gave some information on 
the different effects of neuroleptanalgesia drugs on heart 
rate; but effects on blood pressure and end-tidal carbon 
dioxide concentration have not been described. In 
some of the dogs examined in the present study systolic 
blood pressure has been estimated with an indirect method 
of measurement and end-tidal carbon dioxide concentration 
has been measured to provide more information on the 
respiratory effects of the mixtures examined.
118
Pharmacological studies with mixtures of fentanyl and 
droperidol have produced conflicting findings about the effects 
of this combination of drugs on respiration. Yelnosky and 
Gardocki (1964) found that in dogs the respiratory depressant 
effect of the mixture of droperidol and fentanyl was similar 
to that of fentanyl alone, whereas Greene (1972) concluded 
that droperidol potentiated the respiratory depressant effect 
of fentanyl in a study in mice. In a study in man, Poldes, 
Kepes, Torda, Bailey and Wulfsohn (1964) found that 
droperidol had no significant effect on the respiratory 
depression produced by fentanyl when anaesthesia was induced 
with thiopentone, but had a marked antagonistic effect on 
the action of fentanyl when the barbiturate was omitted 
from the anaesthetic technique. An experimental study 
in dogs was therefore planned to investigate further this 




The dogs in which the neuroleptanalgesia techniques were 
investigated were clinical cases presented to the Department of 
Veterinary Surgery of the University for minor surgical 
procedures, examination of painful conditions or for radiography. 
At the outset of the investigation it was envisaged that the 
technique would be extended for use in animals presented for 
major surgery if preliminary results were encouraging.
The investigation of the pharmacological properties of 
fentanyl and droperidol was performed in dogs maintained 
for experimental purposes in the Department.
2-2 Drugs ^
Supplies of droperidol:fentanyl ('Thalamonal Vet') and 
methotrimeprazineietorphine ('Immobilon*) mixtures were 
donated by Janssen Pharmaceutical Ltd. (Marlow, Bucks) and 
Reckitt and Colman (Hull) respectively. The third mixture 
examined contained fluanisone and fentanyl ('Hypnorn') 
and was purchased from Crookes Laboratories (Basingstoke,
Hants).
The composition of the mixtures used was as follows :
-1'Thalamonal Vet' droperidol 20 mg ml
-1fentanyl 0.4 mg ml
'Hypnorn' fluanisone 10 mg ml ^
fentanyl 0.2 mg ml ^
'Immobilon' methotriraeprazine 18 mg ml ^
-1
etorphine 58 y g ml
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3. METHODS
3.1 COMPARISON OF THE EFFICACY OF THREE NEUROLEPTANALGESIC 
COMBINATIONS
3.1.1 Dosage and routes of administration
The combination of droperidol and fentanyl was examined in 
113 dogs, that containing fluanisone and fentanyl in 25 animals, 
and the mixture containing methotrimeprazine and etorphine in 
35 dogs. The manufacturers recommended that the drugs should 
be given by intramuscular injection but on a number of occasions 
the intravenous route was also used with the former two 
combinations. The mixtures, having a fixed ratio of neuroleptic 
and analgesic components were given in doses of 0.05 - 0.25 ml kg 
The doses and routes of administration used and the dose of each 
constituent contained in the volume of the mixture administered 
are given in Table 11.
Atropine premedication 0.1 mg kg~^ was given subcutaneously 
5-15 minutes prior to the intramuscular administration of the 
neuroleptanalgesia mixture in 16 dogs given the droperidol and 
fentanyl combination and in 6 dogs which received fluanisone 
and fentanyl.


























































3.1.2 Evaluation of sedation, analgesia and side effects
The time interval between an injection and the production of 
a maximum degree of sedation and analgesia was noted. Sedative 
effects were assessed subjectively as 'good', 'fair* or 'poor based 
on the degree of immobility and unresponsiveness produced. Analgesia 
was also assessed as 'good', 'fair' or 'poor* in relation to the 
response of an animal to the manipulation being performed.
Analgesia was classed as 'good' when an animal failed to respond 
to any surgical stimulus, 'fair'when a mild response was seen 
and 'poor' when a marked response to a painful stimulus was 
seen. In some cases analgesia was not required as the 
neuroleptanalgesia technique was used in these instances to 
provide sedation and immobilization. In some of these cases 
analgesia was assessed by noting the response of an animal 
to compression of a toe nail.
Animals were observed prior to and throughout the period 
of immobilization and side effects such as spontaneous movement, 
sensitivity to noise, 'nystagmus', defaecation and 
salivation were noted when they occurred.
The duration of useful effect of the combinations 
examined was noted and in a number of animals the effects 
of the analgesic component in a mixture were antagonised with 
a narcotic antagonist. Nalorphine 1 mg kg  ^i.v. ('Lethidrone', 
Wellcome Medical, Crewe, Cheshire) was the antagonist used 
in dogs given the droperidol:fentanyl or fluanisone:fentanyl
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mixtures. In those animals which received methotrimeprazine: 
etorphine,the antagonist used was diprenorphine 0.03 mg kg  ^i.v. 
('Revivon', Reckitt and Colman, Hull).
3.1.3 Evaluation of effects on respiration
Respiratory rate was counted at intervals during the period 
of immobilization produced by the neuroleptanalgesia mixtures 
and the presence or absence of cyanosis in the tongue and oral 
mucous membranes was recorded. In eight dogs given the 
droperidol:fentanyl mixture expired minute volume was measured 
with a Wright's Respirometer attached to a cuffed endotracheal 
tube. Using the technique described in Chapter 2 end-tidal 
carbon dioxide tension was measured in 11 dogs given the 
methotrimeprazine:etorphine mixture and in 4 animals given 
fluanisone and fentanyl.
3.1.4 Evaluation of effects on circulation
Heart rate was counted from the femoral pulse and systolic 
blood pressure was measured in 15 dogs given droperidol:fentanyl, 
in 6 dogs given fluanisone:fentanyl and in 19 animals which received 
methotrimeprazine:etorphine. Blood pressure was measured with 
an indirect method as described in Chapter 1.
3.1.5 Assessment of adequacy of the neuroleptanalgesia technique 
The overall assessment of the adequacy of the neuroleptanalgesia
technique in a given animal was based on the degrees of sedation 
and analgesia obtained in relation to the particular requirements 
of the procedure performed. The presence or absence of significant 
side effects, including undesirable effects on the circulatory or 
respiratory systems were also taken into account in making this
assessment.
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3.2 COMPARISON OF CIRCULATORY AND RESPIRATORY EFFECTS OF FENTANYL 
GIVEN ALONE AND IN COMBINATION WITH DROPERIDOL
Nine experiments were performed in three dogs to examine 
some of the respiratory and circulatory effects of fentanyl alone, 
and in combination with droperidol, in dogs anaesthetised with 
25 mg kg“  ^pentobarbitone- With an interval of at least one week 
between experiments each of three dogs received either 
pentobarbitone alone, pentobarbitone followed after 15 min by 
0.02 mg kg  ^fentanyl, or fentanyl plus 1.0 mg kg  ^droperidol.
Heart rate was counted from the femoral pulse and respiratory rate 
was noted. Systolic blood pressure was measured with an indirect 
method as described in Chapter 1. The trachea was intubated with 
a cuffed endotracheal tube following the topical application 
of lignocaine to the larynx and end-tidal carbon dioxide tension 
in gas withdrawn from the endotracheal tube was measured as 
described in Chapter 2. The effects produced by the neuroleptic 
and analgesic drugs were compared with values obtained in all nine 
experiments 15 min after the administration of pentobarbitone.
3.3 EVALUATION OF RESULTS
The frequency of a particular finding in any two treatment
groups was compared by the construction of 2 x 2 contingency
2
tables and calculation of the % statistic. Students 't' test 
was used to compare quantified variables in different groups and 
in some cases with pre-dose values.
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4. RESULTS
4.1 COMPARISON OF THE EFFICACY OF THREE NEURQLEPTANALGESIC COMBINATIONS
4.1.1 Body weight and age of dogs in which neuroleptanalgesic techniques 
were used
The mean body weight, age, and the ranges of these characteristics 
in each group investigated are given in Table 12. The overall age 
range was 0.2 - 16 years and body weights ranged from 2.0 to 68kg,
The heaviest animals were found in the group given 0.05 ml kg of 
the droperidol;fentanyl mixture while the oldest and some of the 
smallest dogs were present in the group given this mixture with 
atropine premedication. In other respects the groups were broadly 
similar.
4.1.2 Procedures performed with neuroleptanalgesia
The numbers of the various procedures performed with the three 
neuroleptanalgesic combinations are shown in Table 13. The 
technique was used most frequently for minor surgical procedures 
such as the suturing of superficial wounds or the removal of 
small skin tumours. Analgesia was not required when 
neuroleptanalgesia was used to provide immobilization for 
radiography but many of the diagnostic examinations involved 
the examination of painful joints or ears.
4.1.3 Onset and duration of sedation and analgesia
The times of onset of maximum effect and the useful duration 
of action following the intravenous or intramuscular injection 
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Table 14 Onset and duration of sedation andanalgesia
Drugs and doses 
(ml kg" )
Interval between injection 
and maximum effect (min) 









0.5 i.m. 7.2+ 2.8
Methotrimeprazine:etorphine
0.05 i.m. 5.6+ 2.34








A maximum degree of sedation and analgesia was seen within 1-3 min 
following the intravenous administration of the drug mixtures 
whereas in some animals given the dmigs by the intramuscular 
route peak effects were not noted until 10-15 min after an 
injection. No significant differences were found in the mean 
onset times obtained with the three different combinations 
when the intramuscular route was used.
126
The duration of action of the droperidol:fentanyl and the
fluanisone:fentanyl mixtures was similar whereas a longer period
of useful sedation and analgesia was obtained with the
methotrimeprazine:etorphine combination.
4.1.4 Quality of sedation and analgesia obtained
The subjective assessment of the degrees of sedation and
analgesia obtained with the various mixtures examined is given
in Table 15. Sedation was classed as 'good' or 'fair' in the
majority of animals. The only statistically significant
differences between groups were those found between animals
given the droperidol:fentanyl mixture at all doses and those
given methotrimeprazine:etorphine at 0.1 ml kg
“1(Droperidol:fentanyl 0.1 ml kg v. methotrimeprazine:etorphine 
“1 20.1 ml kg i.m. x = 4.22 P < 0.05), with a greater number of
animals given droperidol:fentanyl showing 'good' sedation.
The most profound degree of analgesia was obtained
following the intravenous injection of the droperidol:fentanyl
-1
mixture at 0,1 ml kg or the intramuscular administration 
of the methotrimeprazine:etorphine combination. Both of these 
combinations produced 'good' .analgesia in a significantly
greater number of animals than was found in groups receiving
“1 “1droperidol:fentanyl 0.05 ml kg intravenously or 0.1 ml kg
2
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4.1,5' Incidence of side-effects
The percentage incidence of side effects noted prior to and 
following immobilization is summarized in Tables 15 and 17 
respectively- In a few animals a degree of excitement was noted 
before a maximum degree of sedation was obtained. This effect 
which was shown as repeated attempts to rise, whining, or 
marked spontaneous movements, was seen most frequently in the 
dogs given the higher dose of methotrimeprazine:etorphine. 
Defaecation prior to immobilization was seen most frequently 
in the animals given the fluanisone:fentanyl mixture and 
was not completely eliminated by atropine premedication.
A low frequency of defaecation was seen in dogs given 
methotrimeprazine and etorphine and in animals which received 
the droperidol:fentanyl combination by the intravenous route. 
Salivation and urination were side-effects which were only 
occasionally seen prior to immobilization.
During the period of recumbency spontaneous movement 
was the side-effect most frequently noted in all groups.
This side effect was seen most frequently in dogs given 
methotrimeprazine:etorphine 0.1 ml kg  ^and least frequently
in animals given droperidol;fentanyl 0.1 ml kg  ^i.m.
2
(X = 7.66, P < 0.01). On a number of occasions 
spontaneous movements occurred in response to a sudden 
noise but at other times muscle twitching unrelated to any 
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Oscillatory eye movements differed from normal nystagmus in 
that the direction and timing of the rotational movements did not 
follow any regular pattern. These eye movements were seen most 
frequently in the dogs given methotrimeprazine:etorphine.
During the period of immobilization defaecation occurred 
in a few animals with a similar frequency being seen in all 
groups except those dogs given 0.5 ml kg  ^fluanisone:fentanyl
i.m, where a greater frequency of defaecation had been noted 
prior to immobilization.
4.1.6 Effects on respiration
The minimum respiratory rates, the frequency with which 
cyanosis was noted, and measured values of end-tidal carbon 
dioxide tension are given in Table 18. Both the droperidol: 
fentanyl and fluanisone:fentanyl mixtures produced variable 
effects on respiratory rate with tachypnoea and respiratory 
rates in excess of 60 min~^ being frequently seen. In these 
groups mean respiratory rate was calculated only from results 
obtained in animals where regular respiration was present. 
Respiratory rate varied widely in these groups but no 
statistically significant differences were produced by 
the different dose rates used. The methotrimeprazine:etorphine 
mixture produced a more consistent slowing of respiratory rate 
with the larger dose producing a significantly slower rate 
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Cyanosis was noted most frequently in the dogs given 0.1 ml kg~^
methotrimeprazine:etorphine, the number of animals showing cyanosis
in this group being significantly greater than the number in the
2
groups given droperidol:fentanyl intravenously (% = 17.6, P < 0.001)
The number of animals showing cyanosis in the two groups given the 
higher dose of fluanisone:fentanyl and the lower dose of 
methotriraeprazine:etorphine was not significantly different 
from the number showing this side effect following the higher 
dose of this latter mixture.
End-tidal carbon dioxide tension was increased above normal 
values in all the animals in which measurements were made. The 
greatest values were found in the group given the higher dose 
of methotrimeprazine:etorphine but no statistically significant 
differences were found between the mean values obtained from 
different groups.
Respiratory rates and tidal volumes measured in 8 dogs 
given the droperidol:fentanyl mixture are shown in Table 19.
These results illustrate the wide variation in respiratory 
effects seen with this combination. In dogs which showed 
tachypnoea minute volume was greatly increased and tidal 
volume (ml kg )^ was somewhat decreased.
4.1.7 Effects on heart rate and blood pressure
The mean heart rates obtained prior to the injection 
of drugs and at the time of their maximum effect are given 
in Table 20 . Mean results obtained from the animals in 
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A marked degree of bradycardia was produced in all groups in which 
no atropine premedication was given, the greatest reductions in 
heart rate being found in the groups given the droperidol:fentanyl 
and methotrimeprazine:etorphine mixtures. Atropine premedication 
produced a marked increase in heart rate in both groups in which 
it was given. All changes in heart rate from the pre-injection 
values were statistically significant.
Mean values for systolic pressure ranged from 138 to 152 mmHg 
and no statistically significant difference was found in the 
different groups examined.
4.1.8 Recovery times
Recovery times to head lift and until animals were able to walk 
again, following the intravenous injection of an antagonist, are 
given in Table 21. Head lift occurred most rapidly in animals 
given the mixtures containing fentanyl and was delayed slightly 
in those which received the methotrimeprazine:etorphine mixture. 
Animals which had been given droperidol:fentanyl were able to 
walk within a shorter interval than those which had received 
one of the other two neuroleptanalgesic combinations. Dogs 
remained sedated by the neuroleptic component in the mixture 
for 1-2 hours but any residual analgesia or respiratory 
depression was reversed by the narcotic antagonist drug.
When an antagonist was not used full recovery was not 
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4.1.9 Overall assessment of adequacy of the neuroleptanalgesic techniques
The overall assessment of the adequacy of the techniques 
investigated is summarized in Table 22. The group given 0.1 ml kg  ^
droperidol:fentanyl intravenously achieved the greatest number of 
'good' assessments. Animals in this group were generally well 
sedated, a good degree of analgesia was frequently present and 
the incidence of excitatory side effects and defaecation was 
relatively low. Analgesia was present less consistently in the 
sub-groups given this mixture intramuscularly or at a lower dose 
intravenously, and in two of the sub-groups more spontaneous 
movements were seen.
Animals given the fluanisone:fentanyl mixture showed the 
highest frequency of defaecation prior to immobilization and 
during the period of recumbency spontaneous movements were often 
noted.
The degree of analgesia produced by the methotrimeprazine: 
etorphine mixture was similar to that achieved with the 
intravenous administration of 0.1 ml kg  ^droperidol:fentanyl 
but unacceptable respiratory depression was present in a 
large number of the animals which received the former mixture 
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Supplementary anaesthesia with thiopentone or an inhalational 
agent was required to allow completion of the procedure being 
undertaken in 5 dogs (4.4%) given droperidol:fentanyl mixtures, 
in 2 (8%) given fluanisone:fentanyl and in 6 animals (17%) 
which received the methotrimeprazine:etorphine mixture.
4.2 COMPARISON OF SOME CARDIOVASCULAR AMD RESPIRATORY EFFECTS 
OF FENTANYL GIVEN ALONE AND IN COMBINATION WITH DROPERIDOL
4.22 End-tidal carbon dioxide tension
In Figure 11 it can be seen that fentanyl 0.02 mg kg ^
given alone produced a greater increase in did the
-1combination of an equal dose of fentanyl with 1.0 mg kg 
droperidol. The increase in ^^^COg produced by fentanyl, 
over that which was obtained 15 min after induction of 
anaesthesia with pentobarbitone, was statistically significant 
for 40 min after injection whereas the combination of droperidol 
and fentanyl produced an increase in PgipCO^  which was 
significantly elevated for only 10 min.
4.2.2 Respiratory rate
Both fentanyl and the fentanyl:droperidol combination 
produced some reduction in respiratory rate (Figure 12).
The decrease, particularly at the earlier time points,
appeared to be greater following droperidol:fentanyl but
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in pentobarbitone anaesthetised dogs. Significant differences 
from 15 min. value: *P < 0.05; **P < O.Ol; ***P < 0.001.
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5-15 min, n=9; 15 min+, n=3.
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Fig. 12 Effects of fentanyi and fentanyi;droperidol on
respiratory rate in pentobarbitone anaesthetised dogs 
Mean SD
5-15 min, n=9; 15 mint, n=3.
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Fig. 13 Effects of fentanyi and fentanyi:droperidol on systolic blood 
pressure in pentobarbitone anaesthetised dogs. Significant 
differences from 15 min value: *P<0.05.
Mean t, SD
5-15 min, n=9; 15 mint, n=3.
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Fig. 14 Effects of fentanyi and fentanyi:droperidol on heart rate 
in pentobarbitone anaesthetised dogs. Significant 
differences from 15 min, value: *P < 0.05; **P < 0.01.
Mean +. SD
5-15 min, n=9; 15 mint, n=3.
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alone did not allow any statistically significant reduction in 
respiratory rate to be demonstrated.
4.2.3 Systolic blood pressure
The droperidol:fentanyi mixture produced a reduction in 
systolic blood pressure which was statistically significant 
5 and 10 minutes after injection (Figure 1.3) . A significant 
reduction in blood pressure following fentanyi alone did not 
occur until 15 min after injection and thereafter a" 
similar degree of hypotension was seen in both test groups.
4.2.4 Heart rate
Both fentanyi and the fentanyi:droperidol combination 
produced similar reductions in heart rate for the first
20 minutes after their injection (Figure 14 ). After this
time little further decrease was seen in dogs given 
droperidol with fentanyi but a further reduction to a 
mean rate of 77 min  ^was noted in animals given fentanyi
0.02 mg kg"^ alone.
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5. DISCUSSION
Previous clinical studies with neuroleptanalgesia drugs in 
dogs have generally been restricted to an examination of the 
effects produced by a single mixture, given intramuscularly at 
the manufacturers recommended dose. The clinical use of the 
droperidol:fentanyi combination has been described by 
Yelnosky and Field (1964), Soma and Shields (1964) and 
Franklin and Reid (1965). The combination of fluanisone 
and fentanyi has been evaluated in dogs by Marsboom et al.
(1964) and the raethotrimeprazine:etorphine combination 
has been examined by Alford and Wozniak (1970) and 
Crooks et al. (1970).
The studies described in this chapter were performed 
sequentially as the various neuroleptanalgesia mixtures 
became available for veterinary use in this country.
By examining each mixture in a standard manner it has 
been possible to compare the clinical efficacy of three 
different neuroleptanalgesia combinations in animals 
in which analgesia and sedation were required for minor 
surgical interventions or diagnostic procedures.
Each combination contained a different neuroleptic 
agent. In two mixtures, in which droperidol or fluanisone 
were present, the neuroleptic belonged to the butyrophenone 
class, while methotrimeprazine, a phenothiazine derivative 
was included in the third. The analgesic drug, fentanyi, 
was present in two mixtures and the third contained the 
potent oripavine derivative, etorphine. This study
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thus provided an opportunity to compare the effects produced 
by different, but related, neuroleptic and analgesic components, 
In the two mixtures containing fentanyi the recommended dose 
provided 0.04 mg kg~^ of this agent in one instance (droperidol: 
fentanyi) while 0.1 mg kg~^ fentanyi was included in the 
recommended dose of the fluanisone:fentanyi mixture. The 
effects produced by doses outside the recommended dose range 
were also examined and in addition the mixtures containing 
fentanyi were given by both intravenous and intramuscular 
injection.
In assessing the clinical efficacy of the neurolept­
analgesia techniques investigated it is important to 
consider the effects produced in relation to the sedation 
and analgesia required for the surgical and diagnostic 
procedures which were performed. It is also necessary 
to compare the results with those which can be obtained 
with alternative anaesthetic techniques.
The incidence of excitatory side effects, such as 
spontaneous movement and sensitivity to noise, with all 
three combinations was such that none could be considered 
as a reliable alternative to conventional general 
anaesthesia for major surgical interventions as advocated 
by Yelnosky and Field (1964) and Marsboom et al. (1964),
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Where a brief period of analgesia and sedation was required for 
minor surgical interventions, satisfactory operating conditions 
were obtained on a number of occasions but troublesome side 
effects were frequently seen. For procedures such as 
radiography where sedation only was required, neuroleptanalgesia 
facilitated positioning but a number of animals, being 
sensitive to sudden noises, moved at the critical time when 
a radiograph was being taken.
The main advantage of the technique was the ability to 
antagonise the narcotic component of the mixture such that 
immobilization was reversed and dogs were able to walk 
again within 2-3 minutes. While early ambulation may be 
considered a convenient feature of the technique, particularly 
for out-patients, where this is not required neuroleptanalgesia 
appears to offer few advantages over conventional techniques.
Alternative methods which can be employed for minor 
surgical procedures include the intravenous use of a short 
acting barbiturate, either alone or in combination with 
inhalation anaesthesia, and local anaesthesia in conjunction 
with sedation provided by a neuroleptic drug. The degree 
of sedation produced by a neuroleptic drug alone is less 
profound than that obtained with neuroleptanalgesia 
mixtures (Yelnoski and Gardocki, 1964) and full recovery 
may be prolonged if large doses of neuroleptic agents 
are employed. Recovery from thiopentone anaesthesia 
is more gradual and prolonged than that achieved by 
antagonizing the narcotic component of a neuroleptanalgesia
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mixture, and while recovery from methohexitone anaesthesia is 
generally rapid, marked excitement may accompany recovery 
from this agent in dogs (Fowler and Stevenson, 1961). It 
would appear, therefore, that where early ambulation is 
required, neuroleptanalgesia techniques offer an advantage 
over alternative techniques.
Significant differences were noted in the degree of 
sedation and analgesia obtained, and in the incidence of 
side effects, with the different neuroleptanalgesia 
mixtures examined and with the various doses and routes 
of administration used. When the drugs were given by 
intramuscular administration at their recommended doses, 
the raethotrimeprazine:etorphine mixture provided more 
reliable analgesia than the other two combinations.
The greater narcotic potency of etorphine, relative to 
fentanyi, was also reflected in the greater number of 
animals in the raethotrimeprazine:etorphine group in 
which significant respiratory depression was noted.
While the analgesic potency of narcotic drugs is 
generally paralleled by respiratory depressant effects 
(Blane et al., 1967) it is also possible that in 
animals given the fentanyi containing mixtures the 
neuroleptic component more effectively antagonised 
the respiratory depressant effect of the analgesic 
component (Alford and Wozniak, 1970).
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Good sedation was obtained less consistently with the 
methotrimeprazine:etorphine mixture than with the other two 
combinations. This could indicate either that etorphine 
possesses a greater central excitatory effect than fentanyi 
or that methotrimeprazine was less effective than the 
butyrophenone neuroleptics in suppressing central excitatory 
effects. It has been proposed by Lees and Hillidge (1976) 
that the increased muscle tone produced by etorphine in 
the horse may be produced by a central excitatory effect; 
and in cats excitement is the predominant behavioural 
effect produced by etorphine (Blane et al., 1967).
Many of the dogs given methotrimeprazine:etorphine 
showed oscillatory eye movements. These movements have 
not been recorded in previous studies with this 
combination (Alford and Wozniak, 1970; Crooks et al., 1970) 
but rhythmic oscillation of the eyeballs was observed by 
Soma and Sheilds (1964) in 10 per cent of animals given 
the droperidol:fentanyi mixture. As this side effect was 
also noted in some dogs given fentnayl-containing 
mixtures in the present investigation it seems probable 
that this phenomenon is another manifestation of narcotic 
induced central excitement. Occasional nystagmus was 
also recorded by Marsboom et al. (1964) in dogs given 
fluanisone:fentanyi.
Defaecation was a troublesome side effect which was 
noted most frequently prior to immobilization in dogs 
given fluanisone:fentanyi. This side effect can be
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attributed to a cholinergic effect of the analgesic component 
in the mixtures (Gardocki and Yelnosky, 1964; Blane et al., 1967), 
The lower frequency of defaecation in dogs given methotrimeprazine; 
etorphine may be related to the anticholinergic properties of 
methotrimeprazine (Blane, Boura and Dobbs, 1968) while the 
lower dose of fentanyi in the droperidol:fentanyi mixture 
may explain the reduced incidence of defaecation in this 
group. Atropine given subcutaneously 5 rain before the 
neuroleptanalgesic drugs, as used by Soma and Shields
(1964), Yelnosky and Field (1964) and Franklin and Reid
(1965), failed to abolish defaecation in all instances.
It is possible that atropine premedication would be more 
effective in preventing defaecation if given about 30 min 
prior to the neuroleptanalgesic drugs.
Intravenous administration of the fentanyl-containing 
mixtures had the advantage that sedation and analgesia 
were obtained more rapidly. In the whole series the 
best results were achieved when the droperidol;fentanyi 
mixture was given intravenously at a dose of 0.1 ml kg ^.
The analgesia obtained with intravenous administration was 
more profound but was accompanied by a greater frequency 
of excitatory side effects. As the maximum effect of 
fentanyi is produced more rapidly than that of droperidol 
(Yelnoski and Gardocki, 1964; Yelnosky, Katz and
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Dietrich, 1964) it is possible that excitatory effects could 
be minimised by giving fentanyi at the time of maximum effect 
of the neuroleptic. Studies on neuroleptanalgesia in horses 
have shown that fewer excitatory effects are seen when the 
analgesic component is given some time after the 
neurleptic agent (Mackenzie, 1977), Defaecation was rarely 
seen following the intravenous administration of 
droperidol:fentanyi and the reduced incidence in dogs 
which received fluanisone:fentanyi by this route may be 
related to the lower dose used.
The more frequent occurrence of respiratory depression 
in dogs which received the methotrimeprazine:etorphine 
combination has already been referred to. Cyanosis was 
noted in 57 per cent of the dogs given this mixture 
intramuscularly at the recommended dose rate. Using the 
same dose, Crooks et al. (1970) recorded cyanosis in only 
8 per cent of treated dogs. This difference must be 
attributed to differences in the subjective criteria 
used to assess the presence or absence of cyanosis.
This side effect was noted in a large number of dogs 
given a similar dose of this mixture by Alford and 
Wozniak (1970), but when these workers increased the 
proportion of raethotrimeprazine in the combination 
cyanosis was not observed. As reported previously 
by others (Soma and Shields, 1964; Yelnosky and Field,
1964) the effects of the fentanyl-containing mixtures 
on respiration were more variable with a number of
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animals showing marked tachypnoea. Cyanosis was noted least 
frequently in animals given the droperidol:fentanyi mixture 
and was not observed when lower doses of the fentanyi 
combinations were given intravenously.
The presence of significant respiratory depression in 
animals given fluanisone:fentanyi or methotrimeprazine: 
etorphine, intramuscularly, was confirmed by the demonstration 
of elevated end-tidal carbon dioxide tensions. In an 
experimental study, Short,Greenwald and Bendick (1970) 
found that arterial increased from a control value
of 30 mmHg in unanaesthetised dogs to 45 mmHg in animals 
given methotrimeprazine;etorphine and to 36mmHg in dogs 
given droperidol:fentanyi. The greater respiratory 
depressant effect of the methotrimeprazine:etorphine 
mixture is in agreement with the clinical findings in the 
present study.
Although it has been claimed by Blane, Boura and 
Dobbs (1968) that the anticholinergic effect of metho­
trimeprazine should reduce the bradycardia produced by 
the vagal action of etorphine, a similar degree of 
bradycardia was noted with all three neuroleptanalgesic 
combinations. Atropine premedication produced marked 
tachycardia and it would seem reasonable to withold 
atropine unless a marked bradycardia develops. In 
resting dogs, heart rate is influenced by a marked 
vagal inhibitory action (Dodds, Dolamore and Twissell,
1981) and normal heart rates of 80 min  ^and 66 min"”^
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have been reported (Shepard and Whitly, 1964; Long, Truex and 
Friedman, 1955).
It was not possible to measure blood pressure in conscious 
animals but systolic pressure was similar in all three groups 
during the period of immobilization.
The cardiovascular effects produced by neuroleptanalgesic 
drugs in the dog are similar to those found in the pig 
(Becker and Beglinger, 1980) but contrast markedly with 
results obtained in the horse where hypertension and 
tachycardia are consistently found (Hillidge and Lees,
1971; Daniel and Ling, 1972; MacKenzie, 1977).
In the study in dogs anaesthetised with pentobarbitone, 
it was found that the combination of droperidol and fentanyi 
produced less respiratory depression than fentanyi alone.
This difference was established by measuring end-tidal 
carbon dioxide tension and no significant difference was 
noted in the respiratory rates produced by the two 
treatments. Janssen et al. (1963) found that, in 
anaesthetised dogs, droperidol stimulated respiration 
by increasing the sensitivity of the respiratory centre 
to carbon dioxide and, in man, a beneficial effect of 
droperidol on fentanyi induced respiratory depression 
has been noted (Foldes et al., 1964; Corssen and De Kornfeld, 
1966). The possibility that neuroleptic drugs can 
antagonise, to some extent, the respiratory depressant 
effect of narcotic analgesics is also supported by
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the findings of Alford and Wozniak (1970) with etorphine and 
methotrimeprazine. Conflicting results have however been 
obtained by Yelnoski and Gardocki (1964) in anaesthetised 
dogs and by Greene (1972) in mice. These authors monitored 
respiratory minute volume and respiratory rate respectively.
As neuroleptanalgesic drugs can produce a significant 
reduction in metabolic rate in the dog (Gemperle, 1965) 
it is possible that the measurement of end-tidal carbon 
dioxide tension in the present investigation provided 
a more sensitive evaluation of the respiratory effects of 
these compounds.
In this study it was also found that the combination of 
droperidol and fentanyi produced a greater hypotensive effect 
than fentanyi alone for the first 15 min, after administration, 
This difference may be attributed to a reduction in peripheral 
resistance due to the a-adrenoceptor blocking activity of 
droperidol (Janssen et al., 1963; Schaper, Jageneau and 
Bogaard, 1963; Yelnosky, Katz and Dietrich, 1964). The 
hypotensive effect of fentanyi alone in pentobarbitone 
anaesthetised dogs has been noted previously by Gardocki 
and Yelnoski (1964). These authors found a significantly 
smaller reduction in heart rate in vagotomised dogs but 
the hypotensive effect persisted.
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The changes in heart rate produced by fentanyi alone and 
fentanyi;droperidol, in the present investigation, were similar 
for the first 20 rain after administration. The smaller 
reduction in rate seen at later time points in animals given 
droperidol:fentanyi may possibly be attributed to baroreceptor 
reflex activity in response to the vasodilatation induced by 
droperidol (Schaper et al., 1963).
Chapter 4
A L K Y L P H E N O L S  A S  IN T R A V E N O U S  A N A E S T H E T IC  
A G E N T S
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1. INTRODUCTION
While there is general agreement that, with the inhalational 
anaesthetic agents, anaesthetic potency can be predicted from 
lipid solubility (Meyer, 1937; Miller et al, 1972; Kaufman, 1977) 
the search for new agents still depends largely on an empirical 
approach. This is particularly the case with injectable agents 
where compounds must have the right structure as well as being 
lipid soluble (Davis, 197 5). Although structure-activity 
relationships have been investigated within the barbiturate 
series (Sharpless, 1970; Dundee and Wyant, 1974) no comprehensive 
information relating the potencies of barbiturates to their 
partition coefficients is available. The steroid anaesthetics 
also have definite structure activity relationships 
(Gyermek and Soyka, 19 75; Phillips, 1975) and it has been 
shown that, within this class of compounds, minor changes in 
molecular configuration, which would not be expected to 
alter lipid solubility, can have marked effects on 
anaesthetic activity. It can be seen that structural changes 
which affect anaesthetic potency, duration of action and 
toxicity in one class of compounds, are generally only 
relevant to that particular series of related compounds.
Many of the lipophilic compounds which have been 
synthesised in the past have never been examined in tests 
for anaesthetic activity because of their low solubility 
in aqueous solutions. The recent availability of the 
surface active agent Cremophor EL as a solubilizing agent
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has removed this obstacle and has allowed the investigation of 
previously untested lipophilic compounds.
During the testing of compounds selected on a random 
basis it was found by the author that 2,6-diethylphenol 
produced anaesthesia when injected intravenously in mice. 
Induction of anaesthesia was not immediate but the activity 
shown by this compound was sufficiently interesting to 
justify an evaluation of the anaesthetic activity of a 
series of related alkylphenols.
Compounds were provided by Mr. R. James of the 
Chemistry Department of ICI Pharmaceuticals Division. Some 
were obtained from commercial sources and purified and others 
were synthesised by the introduction of alkyl groups into 
the ortho position of an appropriate phenol.
The synthesis and preliminary structure-activity 
considerations of this group of alkylphenols have been 
reported by James and Glen (1980). In the present study 
more detailed experiments, designed to examine the 
anaesthetic potency and speed of onset of anaesthesia of a 
selected group of 2,6 dialkyIphenols are described. On 
the basis of the results obtained in these studies,
2,6-diisopropylphenol (disoprofol) was selected for further 






Specific pathogen free Albino mice were housed in wire mesh 
cages and allowed free access to a standard pelleted mouse diet (P.M.D.) 
and tap water.
Rats
Specific pathogen free Albino rats were housed in wire mesh 
cages and allowed free access to a standard pelleted rat diet (P.R.D.) 
and tap water.
Rabbits
Dutch rabbits were purchased from an accredited breeder and 
housed individually in metal cages. Rabbits were allowed free 
access to a standard pelleted diet (R.G.P.) and tap water.
Cats
Domestic cats were purchased from an accredited breeder 
and housed in pairs in metal and wire mesh cages. Cats were fed 
once daily with kennel meat (Spillers) and fresh milk.
Pigs
Young domestic pigs (Large White X Landrace) were purchased 
locally and housed individually in concrete and tubular metal 
pens. They were allowed free access to tap water and fed 
twice daily with Sow Breeder Meal.
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2.2 Drugs
Cremophor EL (BASF, Germany) a polyoxyethylated castor oil 
with surfactant properties, in a 10% (v/v) concentration in water 
was used to prepare solutions containing lOmg ml~^ of an 
alkylphenol test compound for intravenous injection. Test 
compounds were provided by Mr. R. James of ICI Pharmaceuticals 
Division, Macclesfield, Cheshire . In some instances ethyl 
alcohol (6% v/v) and dimethyl sulphoxide (6% v/v; Hopkin and 
Williams, Chadwell, Essex) were required as additional 
solubilizing agents. Disoprofol ('Diprivan', ICI, PLC, 
Macclesfield, Cheshire) was prepared in a standard formulation 
containing lOmg ml"^ in 15% (v/v) Cremophor EL and 8.66% (v/v) 
ethyl alcohol. In rats, cats and pigs this formulation was 
used undiluted but for some experiments in mice the formulation 
was diluted with isotonic saline to obtain a preparation 
containing 5mg ml~^ disoprofol.
A research sample of etomidate was donated by Janssen 
Pharmaceutical Ltd., Marlow, Bucks, and the following drugs 
were obtained commercially:
Thiopentone sodium ('Intraval', May and Baker Ltd., 
Dagenham, Essex); alphaxalone/alphadolone acetate* ('Althesin', 
Glaxo Laboratories, Greenford, Middlesex); methohexitone
“1 -1 *'Althesin' contains 9mg ml alphaxalone and 3mg ml alphadolone
acetate. For the sake of brevity the trade name 'Althesin' is
used throughout this thesis and doses are based on the total
steroid content of 12mg ral~^ .
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sodium (’Brietal', Lilly Eli & Co. Ltd., Basingstoke, Hants); 
propanidid ('Epontol', Bayer ÜK Ltd., Haywards Heath, West Sussex); 
ketamine hydrochloride ('Ketalar*, Parke Davis & Co., Pontypool, 
Gwent); pentobarbitone sodium ('Nembutal', Abbott Laboratories Ltd., 
Queenborough, Kent); droperidol ('Droleptan'. Janssen Pharmaceutical 
Ltd., Marlow, Bucks); chlorpromazine hydrochloride ('Largactil',
May and Baker Ltd., Dagenham, Essex); diazepam ('Vallium',
Roche Products Ltd., Welwyn Garden City, Herts); atropine 
sulphate injection B.P. and hyoscine hydrobromide injection BP 
(Macarthy's Ltd., Romford, Essex); pethidine injection BP 
(Roche Products Ltd.); pentazocine hydrochloride ('Fortral',
Winthrop Laboratories, Surbiton, Surrey); halothane ('Fluothane') 
and trichloroethylene ('Trilene', ICI PLC); cyclopropane (British 
Oxygen Co., Harlow, Essex); enflurane ('Ethrane', Ohio Medical 
Products, Madison, Wisconsin); methoxyflurane ('Penthrane',
Abbott Laboratories Ltd., Queenborough, Kent); di-ethyl ether 
(MacFarlane Smith Ltd., Edinburgh); chloroform (Hopkin and 
Williams Ltd., Chadwell Heath, Essex); lignocaine hydrochloride 
('Xylocaine spray', Astra Chemicals Ltd., Watford, Herts); 
suxamethonium chloride injection BP ('Anectine', Wellcome 
Medical Division, Crewe, Cheshire); gallamine triethiodide 
('Flaxedil', May and Baker Ltd.); pancuronium bromide 
('Pavulon', Organon Laboratories Ltd., Morden, Surrey);
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tilbocurarine chloride injection BP ('Tubarine' (miscible) injection, 
Wellcome Medical Division); neostigmine injection BP ('Prostigmin', 
Roche Products Ltd.).
Drug doses are all expressed as mg kg  ^body weight and where 
drugs were administered in the form of a salt the doses refer 
to the amount of the relevant salt.
151
3. METHODS
3.1 ASSESSMENT OF ANAESTHETIC POTENCY AND THERAPEUTIC RATIO
Test compounds were administered intravenously to groups 
of male mice weighing l8-22g. All injections were given over 
a standard injection period of lO seconds. A range of 6-8 doses 
was given, including a dose producing 100% lethality and one which 
failed to produce loss of righting reflexes for a minimum period 
of 30 seconds. Mice which lost their righting reflexes following 
the injection of a test compound were placed in a heated box 
in which the ambient temperature was maintained at 35^C during 
the period of sleep.
3.1.1 Preliminary screening tests
In preliminary tests, designed to select the best compound 
from the alkylphenol series, groups of 5 mice were used at 
each dose tested. The median hypnotic dose (HD^ )^ was 
estimated by interpolation from the dose-response curve as 
that dose which would be expected to cause loss of righting 
reflexes for a minimum period of 30s in 50% of mice. This 
technique is based on the method of probit analysis of 
Miller and Tainter (1944). To achieve an accurate estimate 
with this method it is necessary to examine doses producing 
effects in the range of 40% to 60%. In some instances, 
because of the steep slope of the dose-response lines 
obtained, these estimates were expressed as a dose range 
giving O and 100% effects with closely spaced doses.
152
The median lethal dose (LD^ )^ was estimated in the same way,
as that dose which would be expected to produce a lethal effect
in 50% of mice, and therapeutic ratio was calculated as the ratio
LD__/HD^^. The definition of HD^_ and values within a
5 0  5 0  5 0  5 0
- 1
5-10 mg kg dose range was deemed to be sufficiently accurate 
for a preliminary assessment of the activity and toxicity of a 
range of compounds to be made.
In addition to the assessment of potency and therapeutic 
ratio, a number of additional observations were made in these 
preliminary screening tests. Note was taken of the speed 
of onset of anaesthesia and the duration of the period of loss of
righting reflexes. Since these features were noted at doses
equal to 2 x HD^^, the being taken in some instances as
the median dose within a defined dose range, it was not always 
possible to be certain that these observations were made at 
exactly equipotent doses. For this reason, limits were defined 
within which speed of induction was classed as immediate
(<lOs; i.e. mice lost righting reflexes by the end of an
injection), slow (10-15s), or very slow (>15s) and duration 
of action was classed as brief (<5 min), moderate (5-10 min), 
or long (>10 min). A non-linear increase in the duration 
of anaesthesia with increasing doses indicated that a 
particular compound was accumulating in body tissues to a 
significant extent.
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Analgesia was assessed by noting the response to tail pinching. 
Muscle tremors and myoclonia were noted as excitatory side effects 
and compounds deemed to produce poor muscle relaxation were those 
which failed to abolish muscle tone during anaesthesia. Mice were 
observed for 10 days following the test to allow any delayed deaths 
to be noted.
3.1.2 Comparative studies with disoprofol and standard agents 
When disoprofol had been selected for further evaluation
a more accurate assessment of anaesthetic potency and therapeutic ratio
was required. In these experiments groups of 10 mice were used at
each dose examined. The and as defined above were50 50
estimated by fitting parallel logit lines derived from the dose 
response results (Ashton, 1972). With this 
method it was also possible to derive 95% confidence limits 
for the estimates of HD^^, and therapeutic ratio.
Experiments were done with disoprofol, thiopentone,
'Althesin', methohexitone and propanidid to allow the results 
obtained with disoprofol to be compared with those produced 
by some currently used injectable anaesthetic agents.
3.2 ASSESSMENT OF SPEED OF ONSET OF ANAESTHESIA
3.2.1 Method development
In order to develop a standardized technique for the 
evaluation of the speed of onset of anaesthesia, the 
relative importance of the effects of a number of factors 
which could influence the speed of induction of anaesthesia 
were evaluated in mice.
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Groups of male mice (18-22g) were studied and drugs were
injected into a tail vein while the mice were restrained in a
conical perspex holder. It was possible to observe mice
through the transparent restraining apparatus and induction time
was measured with a stop watch as the interval between the
beginning of an injection and the occurrence of head drop.
Preliminary experiments were performed with thiopentone to
investigate the effect of variations in speed of injection,
environmental temperature, drug dosage and concentration, on
the speed of onset of anaesthesia with this agent.
a) Speed of injection
A standard dose of 40mg kg  ^of thiopentone, prepared at a
—
concentration of 5 rag ml was given to groups of 5 mice over
injection times ranging from 5 to 40 seconds.
The speed of injection was found to have a marked effect
on anaesthesia onset time as mean induction time was found
to increase in a linear fashion from 5s to 26.2s as the
duration of injection was increased from 5 to 40s (Table 23).
Table 23 The effect of variations in the speed of injection on
- 1
the speed of induction obtained with 40 mg kg thiopentone in mice. 
Drug concentration 5 mg ml~^
Duration of injection (s) 5 10 15 20 25 30 35 40
Induction time (s) 5,0 8.0 11. 0 14.4 16.2 17.8 22.4 26.2




A standard dose of 40 mg kg of thiopentone, prepared in
-1
concentrations ranging from 2 to 10 mg ml , was given to 
groups of 10 mice over a constant injection time of 10 seconds.
Although there was a slight reduction in induction time 
with the highest concentrations used (Table 24), the influence 
of variation in drug concentration on induction time was 
very much less than the influence of speed of injection noted 
in the previous experiment.
Table 24. The effect of variations in drug concentration on
-1the speed of induction obtained with 40 mg kg thiopentone in mice, 
All doses given over s.
Drug concentration (mg ml 2 4 6 8 10
Induction time (s) 7.9 7.6 7.5 7.0 6.6




*P < 0.05 Induction time significantly different from that
-1
**P < 0.001 obtained with 2 mg ml . Student's unpaired t test,
c) Environmental temperature
A range of doses of thiopentone, prepared at a concentration of 
5 mg ml , was given to groups of 10 mice over injection times of 
Is or 10s. One set of experiments was performed at room 
temperature (23°C), whereas in a second series mice were held in 











21-24^0 room temperature 
■°36°C warming box
8040ID 20
Log dose mg kg-1
Fig. 15 Effect of environmental temperature on induction 
time with thiopentone.
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Induction time was found to decrease as the dose of thiopentone
given was increased (Figure 15). Alteration of the environmental
temperature produced no apparent effect on induction time when a
1-s injection was used. Following the lO-s injection, mice in
which the body temperature was maintained at 36°C showed
significantly faster induction times (P<0.002) at doses
—
greater than 40 mg kg in comparison with mice held at room 
temperature before induction of anaesthesia (Figure 15). In all 
subsequent studies mice were kept in a warming box at 36°C prior 
to induction of anaesthesia,
d) Drug dosage
The results obtained in the above experiments indicated that 
drug dosage and speed of injection were the most important factors 
influencing the speed of induction of anaesthesia. To investigate 
the importance of drug dosage further experiments were performed 
with thiopentone and methohexitone using standard injection times 
of Is or 10s.
The median hypnotic dose (HD^^ as defined in Section 3.1) of
each agent was calculated using the graphical method of Miller
and Tainter (1944). Ten mice were used at each dose given for
the estimation of the HD^_. The HD_^ values obtained in this part50 50
of the study are given in Table 25.
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Table 25 values obtained with thiopentone and methohexitone
using two injection times
-1 -1 mg kg +_ SEM mg kg SEM
1-s injection lO-s injection
Thiopentone 19.5 -f 0.56 21 0.90
Methohexitone 7.0+0.60 8+0.43
With both drugs the figures obtained with the 10-s injection
were slightly greater than those found with the 1-s injection time. 
This indicates that with the slower injection a certain amount of 
drug dilution and redistribution occurs during the course of the 
injection such that the dose given has to be increased slightly 
to produce the same degree of depression of the central nervous 
system. As the apparent potency of a drug can be influenced by 
the rate of injection, injection times the same as those used 
in the calculation of were used in subsequent estimations
of induction times.
Having established an HD^^ for each agent, increasing doses 
up to 2 X were then given to further groups of 10 mice and
mean induction times were plotted against the dose given 
(Figure 16) . From the dose response lines thus obtained and 
the previously calculated HD^^, it was then possible to 
compare induction times at any given multiple of the 
(Figure 17) .
The results shown in this figure indicated that the use of 
a rapid injection minimised the influence of dose on induction
A  Methohexitone 
•  Thiopentone
-  Injection lime 10s








Dose mg kg"^ ( log scale 1
2




— Injection time 1 sec
 injection time 10 secs
10-
E
-  4 -
2 -
0 1.0 1.25 1.5 1.75 2.0
Dose/HDjQ
Fig. 17 Anaesthesia induction times with equipotent doses 
of thiopentone and methohexitone in mice.
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time and virtually parallel dose response lines were obtained. A 
technique involving the use of a 1-s injection time was therefore 
preferred for studies where the prime objective was the 
comparison of the rate at which different compounds were 
able to penetrate the blood-brain barrier.
3.2.2 Comparison of disoprofol induction time with that 
of standard agents
The above technique, utilizing standardized injection times 
of Is or 10s for the estimation of and induction times,
was used to compare the induction time obtained with disoprofol 
with that of standard agents. On referring to the dose-response 
curves used in the potency estimations, the minimal dose which 
anaesthetized 100% of mice was found to be close to
1.25 X HDgQ. This point was therefore selected as the 
equianaesthetic dose at which induction times were noted. The 
speed of induction obtained with disoprofol was compared with 
that achieved with pentobarbitone, thiopentone, propanidid, 
ketamine, methohexitone, ’Althesin' and etomidate.
3.2.3 Detailed comparison of structure-activity 
relationships within a group of 2,6-dialkyIphenols
Having established a satisfactory technique for the 
measurement of the speed of induction of anaesthesia, a number 
of alkyIphenols were examined in more detail. Compounds were 
selected partly on the basis of results obtained in primary 
screening tests and partly to provide groups of related
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compounds with which to further define structure-activity 
relationships within a series of 2,6-dialkyIphenols.
In addition to the estimation of speed of induction, 
duration of action and respiratory effects were also examined 
in the same animals. Groups of 10 male mice (18-24g) were 
given a range of doses of each test compound. A 1-s injection 
time was used for all doses and the was calculated by
probit analysis as described in Section 3.1. Duration of 
action was noted following the administration of a dose 
equal to 2 x HD^^ and respiratory rates were counted with the 
aid of a low pressure transducer (Devices UPl) connected 
to a 2ml syringe barrel, one minute after the administration 
of this dose. The use of this technique for the evaluation 
of the respiratory effects of drugs in mice has been 
described by Bradshaw, Biswas and Pleuvry (1973). Induction 
times were calculated as described in the previous section 
at 1.25 X HDgQ.
3.3 EVALUATION OF ANAESTHETIC PROPERTIES IN RABBITS
Results obtained in primary screening tests with
alkylphenols were used to select compounds for further
evaluation in rabbits. Compounds without serious side
-1effects, with an HD^^ ^  20 mg kg and a therapeutic 
ratio ^ 4 in mice were selected for further testing
in rabbits. Test agents were prepared as aqueous 
solutions containing 25 mg ml  ^in Cremophor EL 10% (v/v), 
and injected into a marginal ear vein over a period 
of 20s. A range of doses was examined to give some
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indication of minimum hypnotic and lethal doses, and to assess the 
quality of anaesthesia obtained. Each dose was generally given 
to only a single rabbit and four to six rabbits were used 
to study each compound. Speed of onset, duration of anaesthesia, 
muscle relaxation, and any excitatory effects were noted. In 
addition, compounds which produced a period of respiratory arrest 
lasting more than 20s at anaesthetic doses were classed as potent 
respiratory depressants. Thiopentone sodium was used as a 
standard drug in this test.
3.4 DURATION OF ACTION, RECOVERY TIMES AND RESPIRATORY EFFECTS 
OF DISOPROFOL AND STANDARD COMPOUNDS
Doses approximately equivalent to 2 x HD^^ were given to 
groups of 10 male mice (18-24g) over an injection period of 
10s. Respiratory rates were counted as described in 
Section 3.2.3 one minute after induction of anaesthesia.
The duration of loss of righting reflex was noted in each 
mouse as was the time required after righting before mice 
were willing and able to walk from the centre to the 
periphery of a 30cm diameter disc. Co-ordination was tested 
with a metal rod walking test, mice being classed as 
co-ordinated when after a maximum of four attempts they 
either remained on the rod for 20s or walked to the end 
of the rod within a shorter period.
Experiments were performed with disoprofol, thiopentone, 
'Althesin' and methohexitone.
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3.5 EVALUATION OF CUMULATIVE EFFECTS
3.5.1 Cumulation in mice
The cumulative effect of repeated, doses of disoprofol
was evaluated using the technique described by Child et al
(1971) . Five mice were each given an initial dose of
disoprofol which produced a period of sleep of about 5 minutes 
-1A dose of 25 rag kg given over 10s was found to be suitable. 
When righting reflexes returned 30s were allowed to elapse 
before a further injection of the same dose was given. The 
sleeping time between repeated injections was noted and the 
experiment was continued until a total of 10 doses of 
disoprofol had been given. During the experiment mice 
were kept at an ambient temperature of 36°C.
For comparative purposes similar experiments were
done with thiopentone and 'Althesin', the doses used being
-1 “1 40 mg kg and 12 mg kg respectively.
3.5.2 Cumulation in rats
Cumulative properties were examined in rats by 
investigating the effects produced by the continuous 
infusion of disoprofol, given at a constant rate of 
0.9 ml hr  ^ (10 rag ml  ^concentration) for periods of 
one and two hours. Two groups of five female rats 
(200-225g) were used.
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A 25 B.W.G. 'Butterfly* cannula (Abbott Laboratories, 
Queenborough, Kent) was filled with saline containing 100 i.u. 
heparin ml” ,^ and attached to a 3-way tap. The cannula was 
introduced into a tail vein and held in position with adhesive 
tape. Heparinised saline was then injected through the 
cannula to confirm its correct placement. An induction dose 
of disoprofol was then given over 20s, through the 3-way 
tap, followed by a flushing injection of saline. The dead 
space of the cannula was filled with disoprofol and the tap 
was connected to a primed nylon infusion catheter (Manometer 
line,200/3495/060, Portex Limited, Hythe, Kent) attached to 
a syringe infusion pump ('Unita' Braun, Melsungen, Germany). 
Rats were placed on a heated pad and body temperature was 
maintained at 38°C + l^C during the period of anaesthesia 
and recovery.
At 10 minute intervals during the maintenance period 
respiratory rate was counted visually and heart rate was 
derived from a Lead II electrocardiograph signal with an 
electronic ratemeter. The degree of muscle relaxation 
produced by the anaesthetic and the presence or absence 
of palpebral and pedal withdrawal reflexes were also recorded. 
After the end of an infusion, the time intervals until the 
animal could lift its head, and later regain the ability 
to walk, were noted.
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3.6 EVALUATION OF CARDIOVASCULAR AND RESPIRATORY EFFECTS
The objective of the study was to examine some of the 
cardiovascular and respiratory effects of disoprofol in 
conscious, unrestrained, and unpremedicated animals.
Comparative studies were performed with thiopentone and 
'Althesin'.
A group of 7 pigs (four females and three castrated 
males) weighing 17-40kg was used. One week prior to the 
start of the experiment, polythene cannulae were surgically 
implanted in a carotid artery and a jugular vein under 
halothane anaesthesia. The cannulae were passed subcutaneously 
to emerge on the dorsal aspect of the neck. Heparinised saline 
was injected to ensure their patency and they were closed with 
the crimped shaft of a hypodermic needle.
Preliminary experiments had previously been performed 
to determine equivalent anaesthetic doses of the three agents 
in the pig. A minimal anaesthetic dose was established 
as that dose which was just sufficient to produce a 
brief period (3-5min) of anaesthesia. This dose and a 
dose equal to twice the minimum anaesthetic dose were 
chosen for the subsequent study. The doses selected 
were as follows:
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“1 -1Disoprofol 2.5 mg kg 5.0 mg kg
Thiopentone 10 mg kg 20 mg kg
'Althesin* 1.8 mg kg ^  3.6 mg kg ^
The experiment had a cross-over design in that each 
pig received both doses of the three anaesthetic agents.
At least two clear days were allowed between successive 
experiments in the same animal.
The pigs were found to settle easily in a wooden 
box with a wire mesh lid. Saline filled polythene 
cannulae were passed through this mesh and connected to 
the cannulae which had been surgically implanted. Anaesthetic 
drugs were injected from outside the box, through the catheter 
connected to the venous cannula, over a standard injection 
time of 30 seconds. The arterial catheter provided samples 
for blood-gas analysis and was otherwise connected to a 
Bell and Howell L221 strain gauge transducer for the 
continuous measurement of arterial pressure. Mean arterial 
pressure was calculated as diastolic pressure plus 1/3 pulse 
pressure. Samples of arterial blood were collected anaerobically 
into heparinised syringes prior to anaesthesia and three and 
20 minutes after induction. Standard Radiometer electrodes 
were used to measure PO^ PCOg and pH in these samples.
Base excess was calculated from the pH and PCOg values 
using the Henderson-Hasselbaich equation. Heart rate 
was derived electronically from the blood pressure signal 
and respiratory rate was counted visually. Arterial blood 
pressure and heart rate were recorded continuously with
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Devices M19 heated stylus recorder. Recording was continued until 
the animals regained consciousness.
3.7 EVALUATION OF INTERACTIONS BETWEEN DISOPROFOL AND ANCILLARY 
DRUGS USED IN ANAESTHESIA
3.7.1 Interactions with drugs used in preanaesthetic medication 
Studies were carried out in male mice weighing 18-20g. The 
drugs used were chosen as representative examples of the 
ataractic, sedative, analgesic and anticholinergic classes of 
drug, frequently administered prior to anaesthesia (Riding, 1965; 
Foster, 1966). The doses originally chosen were expected to 
allow each class of drug to exhibit its pharmacological 
effect in mice and were much greater than the doses normally 
used for preanaesthetic medication in man. In a preliminary 
experiment the drugs were administered subcutaneously, and 
30 minutes later the gross behavioural effects produced were 
noted. The drugs and doses used and the effects produced 
were as follows ;
Chlorpromazine hydrochloride 3 -1mg kg deep sedation
Diazepam 3
-1
mg kg deep sedation
Pentobarbitone sodium 10 mg kg 1 very slight ataxia
Droperidol 1 mg kg-1 deep sedation
Pethidine hydrochloride 10 rag kg"^ no apparent effect
Pentazocine hydrochloride 10 mg kg-l no apparent effect
Atropine sulphate 1 mg kg ^ no apparent effect
Hyoscine hydrobromide 1 mg kg-i no apparent effect
16 6
In order to quantify the degree of sedation produced by 
the ataractic drugs, and to allow equipotent doses to be 
chosen for interaction studies further experiments were done 
in mice with chlorpromazine, diazepam and droperidol. These 
drugs were examined in an open field test (Turner, 1965) 
in which spontaneous or exploratory activity is measured, and 
in a test in which evidence of muscle relaxation is shown by 
the inability of a mouse to draw up its hind legs onto a 
wire supporting its forelegs. Five groups of 10 mice were 
used in each test, four groups receiving increasing doses of 
one of the test agents, given 30 minutes prior to testing, 
and a control group injected with saline.
The results obtained in these two tests are shown in 
Figures 18 and 19. All the doses of chlorpromazine and 
droperidol produced marked reductions in spontaneous activity. 
Diazepam at 1.5 mg kg  ^increased activity slightly but 
at 3.0 mg kg  ^produced a very large reduction in activity.
All the drugs produced dose-related muscle relaxation, the 
most marked effects being produced by the highest doses of 
chlorpromazine and diazepam. The doses chosen for interaction 
studies were those which produced approximately 50% reduction 
in spontaneous activity and/or muscle relaxation. These 
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Fig. 18 Inhibition of spontaneous motor activity by premedicant 
drugs in mice
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Chlorpromazine hydrochloride 1.0 mg kg
Diazepam 2.0 mg kg ^
“1Droperidol 0.25mg kg
As no significant behavioural effects had been produced 
by the other premedicant drugs examined in the preliminary 
experiment, the doses originally selected were used in the 
interaction studies.
To examine the interaction of the premedicant drugs with 
disoprofol, each drug was given subcutaneously to a group of 
10 mice, 30 minutes prior to induction of anaesthesia with 
an intravenous injection of 25 rag kg  ^disoprofol, given 
over lO seconds. Mice were kept in a warming box at an 
ambient temperature of 35-37°C. A control group of 10 
mice was given disoprofol alone.
Duration of loss of righting reflex and the intervals 
between recovery of righting reflexes and the ability to 
walk and co-ordinate were observed. Co-ordination was 
deemed to have returned when a mouse was able to maintain 
balance on a 1cm diameter metal rod fixed horizontally 
10cm above bench level. The duration of any period of 
apnoea at induction, and respiratory rate one minute 
following the injection of disoprofol were also measured 
in control and premedicated mice using the methods 
described in Section 3.2.3,
As the results obtained in this experiment indicated 
that chlorpromazine, diazepam, droperidol and atropine 
produced significant changes in the sleeping time
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produced by disoprofol, and in the recovery indices examined, a 
further experiment was designed to compare the potentiation 
seen with disoprofol with that produced by the combination of 
these premedicant drugs with thiopentone and 'Althesin'. 
a) Comparative studies with thiopentone and 'Althesin'
Chlorpromazine (0.25 - 2.0 mg kg~^), diazepam (0.5 - 
4.0 rag kg"l), droperidol (0.125 - 0.5 mg kg“ )^ or 
atropine (1.0 mg kg"^) were given subcutaneously to mice 
30 minutes prior to induction of anaesthesia with disoprofol 
thiopentone or 'Althesin'. A group of 10 male mice (18-20g) 
received each dose of premedicant drug. The anaesthetic 
drugs were given at a single dose rate equivalent to twice 
their as previously determined (Section 3.1).
Sleeping times, recovery times and respiratory rates 
were measured as described in the previous section.
3.7.2 Interactions with inhalation anaesthetics 
The combination of disoprofol with a range of inhalation 
anaesthetic agents was examined in a group of 6 adult cats 
(three male and three female) weighing between 1.8-2.3kg.
All the cats were anaesthetised on more than one occasion 
but an interval of at least one week was allowed between 
successive experiments.
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Each cat was given an induction dose of 7.5mg kg  ^
disoprofol and the trachea was intubated with an uncuffed 
tube following the aerosol application of 10 rag lignocaine 
hydrochloride to the laryngeal mucosa. Anaesthesia was 
then maintained for one hour with one of a variety of 
inhalation agents. The inhalation agents examined were 
halothane, nitrous oxide, trichloroethylene, cyclopropane, 
enflurane, methoxyflurane, diethyl ether and chloroform. 
Halothane was vapourized in a 50:50 mixture of nitrous 
oxide and oxygen while the other agents were mixed solely 
with oxygen. Three cats were used for each agent 
investigated. The inspired concentration of each agent 
was adjusted to maintain a light level of anaesthesia, 
the lower concentrations used being those required for 
maintenance of anaesthesia in this species.
Cats were unpremedicated with the exception of the 
group given diethyl ether. In this case 0.2mg atropine 
sulphate was administered intramuscularly 30 minutes 
prior to induction of anaesthesia with disoprofol.
Halothane was vaporized in a Mark III 'Fluotec' 
vapouriser. All the other volatile agents were 
vapourized in a universal vapourizer (Raventos, 1956), 
the concentration of vapour delivered being calculated 
from the density and molecular weight of the compound.
The delivered concentration could be readily altered 
by changing the flow rate of oxygen passing through 
the saturated vapour in the vapourizer. Cyclopropane
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mixtures in oxygen were prepared by passing the two gases through 
calibrated rotameters at a flow rate calculated to provide final 
cyclopropane concentrations in the range 2o% ~ 30%,
All agents, with the exception of cyclopropane, were
in the first instance delivered to the cats with an Ayre‘s T-
piece circuit, with a fresh gas flow rate ranging from 
-1
1.5 - 4 t min depending on the concentration of agent 
being produced. When inspired concentrations, suitable to 
maintain light surgical anaesthesia, had been determined 
in this manner, one or two experiments in each group were 
carried out with the anaesthetic mixtures prepared in large 
nylon reservoir bags. With these bags it was possible to 
administer the agents with a non-rebreathing circuit 
utilizing unidirectional valves. A pneumotachograph was 
incorporated on the inspiratory side of these valves to 
allow measurement of tidal volume with an electronic 
integrator. In all cats given cyclopropane reservoir 
bags were used instead of a continuous flow T-piece 
circuit.
Following induction of anaesthesia with disoprofol, 
respiratory rate was counted at 10 min intervals and leads 
were attached to monitor the electrocardiogram and to 
measure heart rate with a cardiotachometer. The P-R 
interval in the Lead II electrocardiogram was measured 
prior to and following inhalation of each vapour or 
gas mixture. Any abnormalities in the electrocardiogram 
were noted as they occurred. At the end of the maintenance
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period the duration of the recovery phases was noted.
3.7.3 Interactions with neuromuscular blocking drugs
a) Experiments in cats
Male and female cats were used to investigate any possible
interactions between disoprofol and the neuromuscular blocking
drugs suxamethonium, gallamine and pancuronium. All drugs were
given in a manner which simulated their use in clinical practice,
The cats, weighing 1.8 - 2.4kg were given 0.2mg atropine
sulphate intramuscularly 30 minutes prior to induction of
anaesthesia with 7.5 mg kg  ^disoprofol.
Throughout the period of relaxant induced muscle paralysis,
anaesthesia was maintained with 0.5 - 2.0% halothane in oxygen,
delivered with an Ayre's T-piece circuit. A fresh gas flow of 
-13 % min was used and in all cases the trachea was intubated 
with an uncuffed endotracheal tube. When muscle paralysis 
proved to be short lasting, anaesthesia was maintained for 
a minimum period of 30 minutes. In other instances 
anaesthesia was maintained beyond this point if spontaneous 
respiration was not present. During the maintenance 
period Lead II electrocardiograms were monitored and 
heart rates counted. During the period of respiratory 
paralysis, positive pressure ventilation was provided by 
intermittent occlusion of the expiratory limb of the 
T-piece circuit.
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On a number of occasions the neuromuscular blocking drugs 
were antagonized with O.lmg neostigmine methyl sulphate given 
with 0.2mg atropine sulphate. In some animals the non­
depolarizing drugs were given when spontaneous respiration 
had returned following the administration of suxamethonium,
b) Experiments in pigs
Because of the histamine releasing properties of 
tubocurarine in the cat (Hall, 1971) the effects produced 
by the combination of this relaxant with disoprofol were 
investigated in pigs. Male and female pigs weighing 
between 12 and 22 kg were given 0.3mg atropine sulphate 
and 2.5mg droperidol, intramuscularly, 30 minutes prior 
to induction of anaesthesia with 5 mg kg“  ^disoprofol.
A Magill semi-closed circuit was used during maintenance
of anaesthesia with 0.5 - 2.0% halothane given in a total
“1fresh gas flow of 6 & min of a 50:50 mixture of nitrous 
oxide and oxygen. Cuffed endotracheal tubes were used 
in pigs, with 2 mg kg  ^suxamethonium being given in 
each case to facilitate endotracheal intubation.
Tubocurarine (0.15 - 3.0 mg kg )^ was given when 
spontaneous respiration had returned and a stable level 
of anaesthesia had been achieved. The duration of the 
period of respiratory paralysis produced by tubocurarine, 
and recovery times following the discontinuation of halothane 
anaesthesia were noted.
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c) Experiments in mice
It is known that, in man, the intravenous anaesthetic, 
propanidid, potentiates the period of apnoea and respiratory 
depression produced by the neuromuscular blocking drug, 
suxamethonium (Clarke, Dundee and Daw, 1964). Experiments 
were performed in mice in an attempt to develop an animal 
model in which it would be possible to demonstrate this 
interaction. The combination of disoprofol and other 
standard intravenous anaesthetics, with suxamethonium, could 
then be examined in this model to see if any similar 
interaction might be encountered, 
i) Method development
Preliminary experiments were performed with thiopentone
and suxamethonium to select doses of these agents which would
produce anaesthesia for about 5 minutes and a period of relaxant
induced apnoea of less than 1 minute. It was hoped that if a
suitable dose could be found, an equivalent dose of propanidid
could then be combined with suxamethonium to see if a longer
period of apnoea and respiratory depression could be demonstrated,
-1
An intravenous dose of 50 mg kg thiopentone alone 
produced no apnoea and a 6 minute period of sleep. When this 
dose of thiopentone was followed immediately by an 
intravenous dose of 0.5 mg kg~^ or 1.0 mg kg~^ suxamethonium, 
sleeping times were extended but apnoea was not consistently 
produced. Increasing the dose of suxamethonium to 1.5 mg kg"^ 
produced persistent apnoea and death. A similar result was
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obtained when the dose of thiopentone was reduced to 40 mg kg” .^ 
The results of these preliminary experiments are summarized in 
Table 26 .






■ .... ............- —
Result
50 - 6 min sleep
50 0.5 - 1,0 no apnoea
50 1,5 apnoea/death
40 1.5 apnoea/death
In a further experiment 100% oxygen was administered to
_ 1
mice following induction of anaesthesia with 40 mg kg 
thiopentone. Suxamethonium 1,5 mg kg  ^was then given and 
oxygen supplementation was continued until regular 
respiration returned. In this experiment the mean apnoea 
time induced by suxamethonium was 22.5 5.4 s. All mice
survived but sleeping time was extended to 14.2 _+ 3.1 min.
When the same doses of thiopentone and suxamethonium 
were mixed together and given in a single injection, and 
oxygen supplementation given as in the previous experiment, 
the mice failed to survive.
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The next modification of the technique involved reducing
the dose of suxamethonium to 1.0 mg kg  ^and giving this dose
_ 1
in a single injection mixed with 40 mg kg thiopentone.
When oxygen administration was stopped on the return of 
regular respiration, apnoea time was 22.5 8.2 s, but
sleeping time varied from 8 min to more than 1 hour. When 
oxygen was given for 2.5 min after the injection of the 
mixture of thiopentone and suxamethonium mean apnoea 
time was 29.5 _+ 2.3 s and sleeping time was still prolonged 
but more consistent (8.8 ;+ 2.2 min). The administration of 
oxygen throughout the period of sleep produced the desired 
result with mean apnoea time being 40 _+ 19.3 s and mean sleep 
time 5.5 1.6 min. The effects produced by these different
periods of oxygen supplementation are summarized in Fig-20 ,
As this technique appeared to give satisfactory 
results with thiopentone and suxamethonium, further experiments 
were performed with a range of equivalent doses of thiopentone 
and propanidid. The doses used were multiples of the 
previously determined (Section 3.1),
The anaesthetic drugs were mixed with a fixed dose of 
1 mg kg  ^suxamethonium and injected into a tail vein over 
20s. Groups of 10 male mice (18-20g) received the 
anaesthetic/suxamethonium combinations while others were 
given the anaesthetic agents alone. The dose volume was 
0.1ml in mice which received the anaesthetic alone and 
0.2 ml when one of the mixtures was given. Sleeping 
time (loss of righting reflex) and the duration of apnoea.
T = Thiopentone 40 mg/kg 
S ' Suxamethonium 1.0 mg/kg 
A c Apnoea
7-/7// / //T-r/r/ y//
%S I eep Time 8 min - 1 hour
f i i € f t ^  if / f t f t / / / / / r /L
A
02
Sleep Time 5.6 min
02
Time in min
Fig. 20 The effect of supplementary oxygen on thiopentone/ 
suxamethonium interactions in mice.
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ending with the return of regular respiration, were noted.
Respiratory rate was measured 2 min after an injection by
the method described in Section 3.2.3. Mice were kept in
a warm box at an ambient temperature of 35 + . and
~1100% oxygen was delivered at a flow rate of 1 & min 
with a face mask throughout the period of sleep.
The results obtained in this experiment are given 
in Table 27 and Fig. 21. At the doses examined neither 
of the anaesthetics, when given on their own, produced 
any apnoea. At equivalent doses (2 x HD^^) both drugs, 
when combined with 1 mg kg suxamethonium produced a 
similar period of apnoea. In this respect the model 
failed to demonstrate any significant difference between 
the thiopentone and propanidid combinations. On the other 
hand, marked differences were noted in the respiratory 
rates measured 2 min after induction of anaesthesia. 
Respiratory rates were reduced slightly in mice given 
thiopentone and suxamethonium whereas much greater 
reductions were noted in those given propanidid and 
suxamethonium.
This difference between the two agents indicated 
that the model would be suitable for the examination of
any possible interaction between new anaesthetic agents 
and suxamethonium. The above method was therefore 
used to investigate the effects produced by the 
combination of disoprofol and suxamethonium. Comparative 
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methohexitone and 'Althesin’, with all the anaesthetic drugs
being given at a dose equal to twice their and the dose
“1of suxamethonium being standardized at 1 mg kg 
3.8 STATISTICj^ ANALYSIS
Student's unpaired *t‘ test was used to compare the 
means of results obtained from different groups of animals.
A paired 't' test was used when more than one measurement 
was obtained from the same animal in the cardiovascular 




4.1 THE SELECTION OF DISOPROFOL
4.1.1 Primary screening tests
Following the discovery by the author of anaesthetic 
activity in the compound 2,6-diethylphenol , a further 188 
alkylphenols were examined in the primary screening test in mice. 
The most interesting compounds were found in the 2,6-dialkyl 
series whereas monosubstituted phenols as a class showed only 
moderate activity and therapeutic ratios were low. Corresponding 
para-isomers proved toxic as did the parent compound, phenol.
The results obtained with 28 compounds from the 2,6-dialkyl 
series are summarized in Table 28.
The 2,6-di-n-alkylphenols from 2,6-diraethylphenol (1) to 
2-n^butyl-6-n-prppylphenol (5) exhibited similar activity with 
moderate potencies and therapeutic ratios. Induction of 
anaesthesia with compounds (3), (4) and (6) was slow and 
with doses greater than 2 x HD^^ recovery was prolonged.
In the 2-n-alky1-6-sec alkyl subgroup,compounds (7) - (18), 
potency was found to increase as the total number of carbon 
units (SC) in the side chains increased, reaching a maximum 
at SC=7-8, e.g. (8), (13)., (15), (17) and (18). The
introduction of a cycloalkyl moiety, e.g. (9) resulted in 
decreased activity in comparison with the sec-alkyl derivative (8)


















1 CH3 OH3 20-30 80 I B
2 CH3. O2H5 30 loo I B
3 ^2«5 15-20 100 S B
4 C2H5 - € 38^ 20-40 100 VS B
5 n-OsH^ 20-30 100 I B
6 n-C4Hg 20-40 100-200 vs B
’7 CH3 . 0 8 (083)2 20-30 80 I B
8 CH3 0 8 (0831-0-03833 15-20 100 vs L
9 CH3
0
30-40 140-160 vs B
lO CH3 0 (083) 3 40-60 120-140 I B
11
^2^5 0 8 (083)2
15-20 60—80 I B
12
^2«5
OH(083)0283 10-15 80 I B
13
^2«5 0 8 (0831-0-038 .^ 10-20
100-120 I B
14 n-CsH^ 0 8 (083)3 20-30 80 I B
15 n-CsHv 0 8 (083)0383 10-20 120 s B
16 n-^sHv 0 8 (0831-0-0 ^Hg 50 140 vs M
17 n-C4H9 0 8 (083)3 20 100 I B
18 - C 4H9 0 8 (083) (=2^ 5 20-30 120 vs M












20 0 8 (083)3 08 (08 3) 3 5-10 50-60 I B
21 0 8 (083)3 0 8 (083)0383 5-10 50 I B
22 0 8 (083)3 08 (C83)-n-03H.^ 10-15 80 S L
23 0 8 (083) 3 CH(083)-n-0^Hg 10-15 100-120 S L
24 0 8 (083)2 0
30-40 100-120 s L
25 0 8 (083)0383 -C-O385 20-40 120-140 s B
26 0 8 (083)0383 08 (083)038^ 5-10 60 s M
27 0 8 (C83)-n-0 3H3 0 8 (083)-n-038 .^ 15-20 160-180 vs L
- 28 0 (083) 3 0 (083) 3 80-100 120
(a) Speed of onset of anaesthesia I= immediate , <10S; S = slow. 10-15s ;
VS = very slow, > 15s
(b) Duration of anaesthesia B = brief, < 5 min; M = moderate, 5-10 min ;
L = long, > lO min.
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When EC ^ 8 e.g. (8), (16) and (18) induction of anaesthesia 
was slow, and at higher doses prolonged recovery was seen. In 
the rest of this group, with the exception of compound (15), 
therapeutic ratios were good, and induction and recovery were 
smooth and rapid.
The most interesting compounds were found in the group of
2,6-di-sec-alkyIphenols - compounds (19) - (27), Activity was 
generally high, though cyclic analogues were again less active 
than their sec-alkyl equivalents, e.g. (19) of. (20), (25) cf.
(21) and (24) cf. (23). Potency increased with increasing 
chain length of the substituents, reaching a maximum at 
EC = 6-8 e.g. (20) - (22) and (26), Therapeutic ratios were 
good and induction of anaesthesia was rapid when EC ^ 7 but 
became slower when the side chains were further increased in 
length. Analgesia was noted during the period when the 
righting reflex was lost with a large proportion of the 
compounds in this series and the overall quality of anaesthesia 
with compounds (20) - (23), (26) and (27) was good. The 
compound 2,6-di-tert-butylphenol, included here for comparison 
was essentially inactive as an anaesthetic,
4.1.2 Detailed comparison of structure-activity
relationships within the group of 2,6-dialkyIphenols 
The results obtained in the more detailed study of selected 
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results confirmed those obtained in the primary screening test.
a) Di-ri-alky Iphenols
In the group of di-rv-alkyl substituted compounds the most 
active compound was again found to be 2,5-diethylphenol (3) and 
induction of anaesthesia with this compound was more rapid than 
had been expected on .the basis of the primary test result.
The slow onset of anaesthesia seen with 2-npbutyl-6-n-propylphenol 
(6) was confirmed and extended induction times were also found 
with 2,6-dimethylphenol (1) and 2,6-di-rv-propylphenol (5). The 
duration of anaesthesia was similar with all the compounds in 
this group and the death of 50% of the animals given
2.6-dimethylphenol (1) at 2 x confirmed the lower 
therapeutic ratio of this compound. With the exception of
2.6-di-rv-propylphenol (6) respiratory depression appeared 
to increase as %C increased, and apnoea was seen most 
consistently with the two compounds - compounds (3) and (4) - 
which showed the most rapid onset of anaesthesia.
b) 2-n-alkyl-6-sec-alkyIphenols
Of the four compounds from this subgroup examined in the 
detailed test, 2-ethy1-6-isopropyIphenol (11) was found to be 
the most active and to produce the most rapid induction of 
anaesthesia, and the greatest degree of respiratory depression. 
Sleeping times were found to increase as ZC increased.
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c) 2,6-di-sec-alkyIphenols
The compounds in this subgroup were again found to be more 
active than those in the other two groups, Although compounds 
(21) and (26) were more active than 2,6-diisopropyIphenol (20), 
a slow induction of anaesthesia was seen with the former two 
compounds. The duration of anaesthesia with compounds (22) and 
(26) was slightly longer than that seen with compounds (20) and 
(21). No significant differences in the respiratory effects 
of these compounds could be demonstrated although 2,6-diisopropyIphenol 
(20) appeared to be among the group of compounds from all three 
subgroups which showed least respiratory depression. The 
compounds from other subgroups, which showed minimal respiratory 
depression - compounds (1), (2) and (7) - were much less 
active than 2,6-diisopropyIphenol (20).
d) Correlation of anaesthetic effects with lipophilicity 
Partition coefficients between octanol and water (log P) for
selected analogues were determined by Mr. P.J. Taylor using a 
high pressure liquid chromatographic technique (Mirrlees Moulton,
Murphy and Taylor, 1976). As the results obtained indicated that, 
to a first approximation, log P g EC, the compounds in Table 29 
have been rearranged in Table 30 . Compounds with equal numbers 
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have a similar degree of lipophilicity, are grouped together.
It can be seen in Table 30 that there does not appear to be a 
direct relationship between lipophilicity, based on the total 
number of carbon atoms in the substituents and anaesthetic 
potency. Within the groups containing 5-8 carbon atoms quite 
marked differences in anaesthetic potency were found despite 
the fact that, within any particular group, the compounds would 
be expected to have a similar degree of lipophilicity. Significant 
differences in induction time were also found in some groups of 
compounds with similar lipophilicity and no significant 
correlation between sleeping times, respiratory effects and 
lipophilicity could be demonstrated.
4.1,3 Evaluation of anaesthetic properties in rabbits
The most active compound in the 2,6-di-r^-alkyIphenol 
subgroup, 2,6-diethyIphenol (3) had a low therapeutic ratio 
in the rabbit and induction of anaesthesia with a dose of 
20 mg kg  ^was slow in this species.
Four compounds -(18), (11), (12) and (15) - from the 
2-n-alky1-6-sec-alkyl subgroup were selected for evaluation 
in rabbits but were subsequently eliminated from further 
testing because of slow induction of anaesthesia, sometimes 
accompanied by excitement and poor muscle relaxation. The 
compound, 2-ethy1-6-(1-methyIbutyl)phenol (13) was also 
examined in this species and found to produce good anaesthesia, 
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The results obtained in rabbits with the best compounds 
in the 2,6-di-sec alkyl series, as identified in the primary 
screening test, are summarized in Table 31. As with all 
phenols tested in this species, therapeutic ratios were generally 
lower than those obtained in mice. Excitement was frequently 
seen on induction and muscle relaxation was sometimes poor. 
However, 2,6-diisopropyIphenol (20) was exceptional in that it 
produced smooth, rapid induction, and recovery with good 
muscle relaxation and a short but useful period of anaesthesia.
On the basis of this result in rabbits, and the confirmation 
in mice that this compound produced a more rapid induction of 
anaesthesia than two other more potent compounds - (21) and 
(26) - 2,6-diisopropyIphenol (disoprofol) was selected for 
further evaluation in comparative studies with standard 
anaesthetic compounds.
4.2 STUDIES TO COMPARE THE PHARMACOLOGICAL PROPERTIES OF 
DISOPROFOL WITH THOSE OF STANDARD ANAESTHETIC AGENTS
4,2.1 Anaesthetic potency and therapeutic ratio 
The results obtained with disoprofol and the standard 
agents, thiopentone, ’Althesin', methohexitone and propanidid 
are given in Table 32. The activity of disoprofol in mice 
was found to lie between that of thiopentone and methohexitone 
being closer to the latter. In the mouse, disoprofol was 
found to be 1.8 times more potent than thiopentone and
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propanidid while 'Althesin' was 3.6 times more active than 
disoprofol. The therapeutic ratio obtained with disoprofol
was similar to that found with thiopentone and much lower than 
that of 'Althesin*.
Table 32 Activity and lethality of disoprofol and standard 




































95% confidence limits in parenthesis
4.2.2 Speed of onset of anaesthesia
The HDgQ values obtained with disoprofol and the standard agents 
examined in this study, using two injection times, are given in Table 33.
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-1 ±Table 33 Median hypnotic doses (HD^^ mg kg — SEM) of i.v.





1 0 “ S injection
HDgo (lOs)
“ so ( is)
Pentobarbitone 21.5 + 0.63 20.6 + 0.60 0.96
Thiopentone 19.5 + 0.56 21.0 + 0.90 1.08
Propanidid 15.4 + 0.52 21.5 + 0.63 1.40
Ketamine 9.6 + 0.36 12.2 + 0.49 1.27
Disoprofol 7.5 + 0.44 12.0 + 0.57 1.6
Methohexitone 7.0 + 0.60 8.0 + 0,43 1.14
’Althesin’ 2.5 + 0.14 3.3 + 0.11 1.32
Etoraidate 1.1 + 0.09 1.25 + 0.05 1.14
With the exception of pentobarbitone, values were
greater when a slower rate of injection was used. The greatest 
differences between the figures obtained with the different 
injection times were found with disoprofol and propanidid.
When a range of doses up to 2 x of each agent was
given using a Is-injection, the induction times shown in 
Figure 22 were obtained. Induction times with pentobarbitone 
were too slow to be included in this figure.
Similar experiments were done using a 10s injection time. 
When induction times were plotted against equal multiples 
of the for each agent the values for induction times
at 1.25 X shown in Table 34 were derived.
Etomidate 
■— ■ 'A lthesin'
* — *  Methohexitone 









Log dose mg kg'
1.0
Fig. 22 The relationship between anaesthesia induction time 












Fig. 2 3 Anaesthesia induction- times in mice with equipotent doses
of intravenous anaesthetics. All doses given over one second.
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Examples of the induction time-dose response relationships 
obtained using a 1-s injection time with disoprofol, thiopentone, 
methohexitone and ketamine are shown in Figure 23.
Table 34 Comparison of induction times with i.v. anaesthetics 













With the 1-s injection time the shortest induction times 
were found with thiopentone and 'Althesin'. Induction time with 
disoprofol was similar to that obtained with propanidid. With 
ketamine, and particularly with pentobarbitone, induction times 
were much longer than those of the other standard agents.
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Following the 10-s injection, similar induction times were 
found with disoprofol and the standard agents, with the exception 
of ketamine and pentobarbitone where induction was again found to 
be prolonged.
4.2.3 Duration of action, recovery times and respiratory 
effects of disoprofol and standard compounds 
The results obtained with doses equivalent to 2 x HD^^ of 
disoprofol and the standard agents examined in this study are 
given in Table 35 . Mean sleeping time with disoprofol was 
similar to that obtained with thiopentone and slightly longer 
than that found with 'Althesin' and methohexitone. Recovery of 
walking ability returned after a similar period with all the 
drugs, but the slight difference between disoprofol and the 
barbiturates was statistically significant. Following 
anaesthesia with disoprofol, methohexitone and 'Althesin', 
mice regained co-ordination rapidly, whereas almost 50 minutes 
elapsed before those mice given thiopentone had recovered 
completely. Recovery from the effects of disoprofol and 
thiopentone was free from excitatory side effects, whereas 
mice recovering from methohexitone and 'Althesin' showed 
some muscle tremor and twitching, particularly when being 
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Respiratory rates obtained with thiopentone and disoprofol 
were slower than those found with methohexitone and 'Althesin', 
but only in the comparison with 'Althesin' was this difference 
statistically significant.
4.2.4 Evaluation of cumulative effects
a) Cumulation in mice
The sleeping times produced in mice, following the repeated 
injection of equivalent anaesthetic doses of disoprofol, 
thiopentone and 'Althesin' are given in Table 36 , The results 
demonstrate that in comparison with thiopentone, the sleeping 
times produced by disoprofol and 'Althesin' were only extended 
to a slight extent as repeated injections were given. Initial 
sleeping times with all three drugs were similar and while the 
period of sleep produced by disoprofol and 'Althesin' increased 
to 15 min and 18 min respectively, that produced by thiopentone 
increased to more than 3 hours after a fourth dose.
This result indicates that, in the mouse, disoprofol 
resembles 'Althesin' in showing minimal cumulation in this 
species. In contrast, the prolonged sleeping time obtained 
following the repeated injection of thiopentone demonstrates 
that this compound accumulates to a significant extent in 
body tissues.
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Table 36 Sleeping time (min) with repeated doses of disoprofol, 
thiopentone and 'Althesin' in mice (mean _+ S.D.; n=5)
Dose Disoprofol Thiopentone 'Althesin'
25 mg kg“  ^ 40 mg kg~^ 12 mg kg~^
1 4,6 + 0.56 3.86 + 0.79 5.03 + 0.85
2 7.1 + 0.89 30.3 + 9 . 8 1 8.6 + 1.34
3 8.4 + 1,37 148.6 + 57.5 9.5 + 1.77
4 10.0 + 2.13 >180 13,7 + 3.3
5 10.8 + 1.67 10.4 + 1.08
6 10.2 + 1.9 18.2 + 11.76
7 10.8 + 1.2 16.2 + 5.4
8 11.7 + 2.53 17.6 + 7.9*
9 13.5 + 2.9 18.7**
10 15.4 + 4.57 18.3***
* n=4 Remaining mice could not be given further
** n=3 injections because of mechanical damage to
*** n=2 their tail veins.
b) Cumulation in rats
Mean infusion dose rates and recovery times to head lift 
and the return of the ability to walk are given in Table 37. 
Using a standard infusion rate of 0.9 ml hr  ^of disoprofol in 
rats weighing 200-225g the mean doses administered were 
0.69 +_ 0.01 mg kg“  ^min  ^in the rats given a one hour infusion 
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Fig. 24 Heart and respiratory rates in rats during the infusion 
of disoprofol.
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maintained for two hours. Head lift occurred 5.08 _+ 1.8 minutes 
after the end of the shorter administration and 10.66 3,99 minutes
after the two hour infusion.
The drug 'utilization rate' was calculated as the total dose 
of disoprofol given, including the induction dose, divided by the 
total period of sleep until head lift occurred. The slight 
increase in recovery time following the longer infusion was reflected 
in the slightly lower drug 'utilization rate' in this group.
Mean respiratory and heart rates recorded from the two groups 
of rats are shown in Figure 24. Although the rates of both 
variables decreased slightly during the first hour of 
infusion, no significant further decline was encountered 
in those animals where the infusion was continued for a further 
hour. The presence of the palpebral reflex and a weak pedal 
withdrawal reflex indicated that a light level of anaesthesia 
was maintained in both groups of animals.
As clinical signs of deepening anaesthesia and increased 
depression of respiratory and heart rates were not seen, and as 
recovery times were only moderately increased in the animals 
given the two hour infusion, it can be concluded that only 
minimal tissue accumulation of disoprofol had occurred.
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4,2,5 Evaluation of cardiovascular and respiratory effects 
in pigs
The use of animals with chronically implanted arterial- and 
venous cannulae allowed the cardiovascular and respiratory variables 
measured during anaesthesia to be compared with values obtained 
in the resting animal prior to induction of anaesthesia. The 
effects produced by disoprofol, thiopentone and 'Althesin' on 
mean arterial pressure and heart rate are summarized in Tables 38 
and respectively. The percentage changes in these variables, 
with the two doses used, are shown in Figures 25 and 26 and 
the results obtained in individual animals are given in 
Appendices 4 and ^,
Similar mean values of mean arterial pressure, within the 
range 89-92 mmHg were obtained prior to anaesthesia in all 
the groups investigated. All three agents produced an initial 
hypotensive effect which was significant one minute after 
injection. Following the administration of the lower dose of 
each agent there were no significant differences between 
agents in the degree of hypotension produced. With the larger 
dose, both disoprofol and thiopentone produced a more profound 
hypotensive effect than 'Althesin' but only in the comparison 
of disoprofol with 'Althesin' was this difference statistically 
significant (p < 0.05). After this initial hypotensive
effect, both thiopentone and 'Althesin' produced 
increases in blood pressure. In the case of pigs given the 
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Time (minutes) Postdose 
Pig. 25 Percentage changes in heart rate and mean arterial 
pressure in pigs given minimum anaesthetic doses of 
















Predose 1 2 3 4 5 20
level
Time (minutes) Postdose
Fig. 26 Percentage changes in heart rate and mean arterial pressure 
in pigs given 2 X minimum anaesthetic doses of 'Althesin', 
thiopentone and disoprofol.
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pressure 3, 4 and 20 minutes after induction was significantly
greater than the pre-anaesthetic value. The increase at 3
“1minutes after injection in pigs given 3.6 rag kg 'Althesin' 
was also statistically significant. The absence of a pressor 
effect with disoprofol allowed a more rapid return to pre-dose 
values with this agent.
The initial hypotensive effect produced by all three agents 
was accompanied by tachycardia which was most marked in the 
animals given thiopentone and 'Althesin', With the larger 
doses of the latter agents, heart rates were still significantly 
greater than pre-dose values 20 minutes after induction of 
anaesthesia. At this same time point, in the pigs given 
disoprofol, heart rate had returned to the base line value.
When the heart rates produced by the different agents were 
compared in the same animals, the tachycardia produced by the 
low dose of 'Althesin' was significantly greater than that 
produced by 2,5 mg kg""^  disoprofol for the first 5 minutes 
after induction of anaesthesia. The difference between 
disoprofol and thiopentone was only statistically significant 
at 1 minute. Following the administration of the larger 
dose of each agent, all three anaesthetics produced an 
initial degree of tachycardia. At 5 and 20 minutes after 
induction the tachycardia produced by thiopentone was 
significantly greater than that caused by disoprofol but 
the difference between 'Althesin' and disoprofol was not 
statistically significant.
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The mean results obtained from blood gas analyses are given
in Table 40. Three minutes after induction of anaesthesia, 
arterial pH values were significantly reduced in animals given
the lower dose of thiopentone and disoprofol. At the 20 minute
time point the only significant change, in animals receiving
the lower dose, occurred in the pigs given 1.8 mg kg ^
'Althesin' where arterial PO^ values were slightly reduced.
Following the larger dose of all three agents significant
reductions in arterial pH were produced 3 minutes after
injection. Values for arterial PO^ were significantly reduced
at this time point but a significant increase in arterial
PCO^ was seen only in the pigs given 20 mg kg  ^thiopentone.
Slight reductions in PO^ remained at 20 minutes in animals given
thiopentone and 'Althesin' but no statistically significant
change at this time was seen in the pigs given disoprofol.
Although a number of statistically significant changes in
arterial pH and blood gas tensions were found the actual
changes were small. Calculation of base excess values from
the mean values obtained for pH and arterial PCO^ indicated
that, in the animals given thiopentone, the reduction in pH
was almost entirely attributable to an increase in arterial
PCO^ whereas in those given disoprofol a mild metabolic
acidaemia contributed to the reduction in pH. Calculated
values for base excess are given in Table 41,
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Table 41 Calculated values for base excess In pigs anaesthetised 
with disoprofol, thiopentone and 'Althesin'
“1Base excess (mmol.iZ, )




















It can be concluded that the cardiovascular and respiratory 
effects measured indicate that the properties of disoprofol are 
generally similar to those of thiopentone and 'Althesin'. At 
the higher dose examined disoprofol produced a greater degree of 
arterial hypotension than 'Althesin', but the hypotensive 
effect of disoprofol was accompanied by a significantly smaller 
degree of tachycardia. Although none of the agents examined 
produced marked respiratory depression as indicated by the 
blood gas measurements, a reduction in respiratory rate was 
noted 1 minute after injection of the higher dose of all three 
agents. Respiratory rates had returned towards the pre-dose
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values by the time the first arterial sample was collected for 
blood-gas measurements 3 minutes after injection.
In this study in pigs one animal given 2.5 mg kg  ^
disoprofol showed an unexpected response characterized by 
paddling limb movements and the appearance of patchy erythema 
over the abdomen and neck. These patches later became 
cyanotic and the skin rash disappeared after 10 minutes 
and recovery was uneventful. This pig had previously been 
anaesthetised with thiopentone and 'Althesin', the latter 
being given 5 days before disoprofol. The same animal was 
subsequently given the solubilizing agent Cremophor EL alone and 
two further doses of disoprofol. No untoward reactions occurred 
on these occasions and it was presumed that the adverse response 
might have been caused by a pulmonary embolus derived from 
the implanted venous cannula.
4.2.6 Evaluation of interactions between disoprofol and 
ancillary drugs used in anaesthesia
a) Interactions with drugs used in pre-anaesthetic medication 
In Table 42 the sleeping times and recovery times obtained 
with disoprofol given alone and in combination with a range of 
drugs used in pre-anaesthetic medication are given. The 
respiratory effects of these drug combinations are summarized 
in Table 43=
Of the premedicant drugs examined only chlorpromazine and 
diazepam produced highly significant increases in sleeping time 
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also produced a slight prolongation of sleeping time. A number 
of drugs, in particular droperidol and diazepam, produced some 
delay in the rec'overy of walking ability and co-ordination and 
a short but statistically significant delay in the recovery 
of co-ordination was also seen following atropine and hyosine 
premedi cation.
The respiratory effects of disoprofol were altered most 
markedly by the prior administration of atropine orhyoscine. 
These drugs abolished the short period of apnoea normally 
produced by disoprofol and respiratory rates were significantly 
greater than those produced by disoprofol alone. Chlorpromazine 
also produced a slight increase in respiratory rate while 
diazepam premedication increased the respiratory depressant 
effect of disoprofol to a slight extent. The increase in 
respiratory rate produced by chlorpromazine 1 minute after 
induction of anaesthesia followed a slight prolongation of 
the period of apnoea produced by this combination.
i) Comparative studies with thiopentone and 'Althesin'
Dose-response effects on sleeping time, recovery of 
co-ordination and respiratory rate produced by premedication 
with diazepam, droperidol and chlorpromazine prior to 
anaesthesia with equianaesthetic doses of disoprofol, 
thiopentone and 'Althesin' are shown in histogram form 
in Figures 27, 28 and 29. The effects produced by a single
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Premedicant dose mg kg‘ ^
Fig. 27 The influence of premedicant drugs on anaesthesia
sleeping time in mice. Mean values +, SD, n=lO
*P < 0.01 Significant differences from unpremedicated























0.5 1.0 2.0 4.0 0.125025 0.5 025 0.5 1.0 2.0 1.0
Diazepam Droperidol Chlorpromazine Atropine
Premedicant dose mg kg-1
Fig. 28 The influence of premedicant drugs on the recovery of
co-ordination following anaesthesia in mice. Mean values ^  SD, n=10
*P < 0.01 Significant differences from unpremedicated 
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Fig. 29 The influence of premedicant drugs on respiratory rate during 
anaesthesia in mice Mean values + SD, n=10
P < 0,01 Significant differences from unpremedicated mice.
**P < 0.001 Students unpaired t test.
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The prolongation of sleeping and recovery times noted in the 
previous experiment when disoprofol was given following 
premedication with diazepam, droperidol or chlorpromazine was 
seen again. A more marked increase in sleeping time and delay 
in the recovery of co-ordination was found in mice anaesthetised 
with thiopentone following premedication with the same compounds, 
while similar effects were seen in mice anaesthetised with 
disoprofol or 'Althesin'. Of the three premedicant drugs,given 
over a range of doses diazepam potentiated all three anaesthetics 
to the greatest extent. Because of the marked potentiation 
produced by this agent and by chlorpromazine in mice anaesthetised 
with thiopentone the maximum doses of these premedicant drugs 
were reduced in animals receiving thiopentone. Two mice given 
thiopentone after premedication with 1.0 mg kg  ^chlorpromazine 
died as did a similar number in the group given disoprofol 
following chlorpromazine 2.0 mg kg~^.
Premedication with atropine 1.0 rag kg"^ produced a significant 
delay in the recovery of co-ordination in mice anaesthetised with 
thiopentone and disoprofol but not in those given 'Althesin'.
The higher doses of diazepam produced significant 
reductions in respiratory rate with all three anaesthetic 
agents. Premedication with droperidol and chlorpromazine 
had a minimal effect on respiratory rate during anaesthesia 
but the highest dose of chlorpromazine showed a significant 
depressant effect in mice anaesthetised with 'Althesin'.
The lower doses of droperidol produced a slight increase 
in respiratory rate with all three anaesthetic agents but
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this effect was not statistically significant. Atropine 
premedication also tended to increase respiratory rate 
during anaesthesia but only in the case of the group given 
disoprofol was the change consistent.
These results indicated that premedicant drugs which 
produced significant effects in mice anaesthetised with disoprofol 
also induced qualitatively similar effects in mice anaesthetised 
with thiopentone and 'Althesin'. A similar degree of potentiation 
of sleeping and recovery times was seen with disoprofol and 
'Althesin' whereas greater effects were seen when the premedicant 
drugs were given in combination with thiopentone.
b) Interactions with inhalation anaesthetics
A summary of the main findings obtained when anaesthesia 
was maintained in cats with a range of inhalation anaesthetics, 
following induction of anaesthesia with 7,5 mg kg"^ disoprofol 
is given in Table 44.
Anaesthesia was maintained satisfactorily with all of the 
inhalation agents tested and no unexpected interactions 
were observed. The responses of the cats during maintenance 
reflected the pharmacological properties of the inhalation 
agents employed. Ventricular extrasystoles were noted 
during maintenance of anaesthesia with trichloroethylene 
and chloroform. Only minor changes in P-R interval were 
seen and these were consistent with the observed changes 
in heart rate. Respiratory depression was noted with 
halothane, cyclopropane, enflurane and methoxyflurane.
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by an increase in respiratory rate. With the other depressant 
agents both tidal volume and respiratory rate were decreased, 
Trichloroethylene and di-ethyl ether produced characteristic 
tachypnoea.
Recovery times were, as expected, very rapid with 
cyclopropane and enflurane, rapid with halothane and considerably 
slower with the other agents.
c) Interactions with neuromuscular blocking drugs
i) Experiments in cats
Following induction of anaesthesia with 7.5 mg kg"^ 
disoprofol suxamethonium provided excellent muscle relaxation 
for intubation whereas the onset of relaxation with 
pancuronium and gallamine was slower. When gallamine was 
used topical anaesthesia was required to allow reasonably 
rapid intubation. A summary of the results obtained in 
this study is given in Table 45 .
All the animals used in these experiments recovered 
uneventfully and in a number of instances the effects of 
different neuromuscular blocking drugs were compared in 
the same animal. Limb movements were noted in one cat 
at the time of injection of pancuronium. These were 
attributed to the fact that the level of anaesthesia 
was insufficient to prevent spontaneous movement when 
the animal was disturbed during the injection of the 
neuromuscular blocking drug. One cat developed a transient 
period of bradycardia (92 beats rain 15 min after 
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had been given. Two other cats given suxamethonium and 
pancuronium showed periods of nodal rhythm during the 
inhalation of halothane. Recovery times were increased 
slightly in cats given suxamethonium and gallamine, 
when anaesthesia was discontinued after 30 minutes.
No unexpected interactions were observed which could 
be related to the combination of disoprofol with any 
of the neuromuscular blocking drugs investigated,
ii) Experiments in pigs
The results obtained in pigs are summarized in Table 46. 
The dose of 0.3 mg kg  ^of tubocurarine produced a period 
of apnoea longer than would be desirable for clinical 
purposes. In a pig anaesthetised with thiopentone 0.2 mg kg“  ^
tubocurarine also produced an extended period of apnoea.
With either disoprofol or thiopentone, when the dose of 
tubocurarine was reduced to 0.15 mg kg  ^a suitable duration 
of muscle relaxation was obtained and residual relaxation was 
readily reversed with neostigmine in two pigs.
All the animals used in this study recovered 
uneventfully and no unexpected interactions were observed 
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Fig. 30 Respiratory rates in mice two minutes after injection of 
thiopentone or propanidid alone and in combination with 
suxamethonium.
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ill) Experiments in mice
The effects produced by suxamethonium given in combination 
with disoprofol, thiopentone, 'Althesin' and raethohexitone 
are summarized in Table 47, A similar period of apnoea was 
produced by suxamethonium in every case. Some decrease in 
respiratory rate, measured 2 min after induction of anaesthesia, 
was seen in mice given thiopentone but a much more marked effect 
was seen in mice anaesthetised with propanidid. An example 
of a record obtained from mice given thiopentone or propanidid 
is shown in Figure 30,
Some prolongation of sleeping time was seen with all of the 
anaesthetic agents but again the most marked effect was noted 
in mice given propanidid.
The failure of suxamethonium to produce a significant 
reduction in respiratory rate in mice anaesthetised with 
disoprofol suggests that this combination of drugs should 
be unlikely to produce a prolonged period of respiratory 
depression as seen with propanidid and suxamethonium in man*
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5. DISCUSSION
The discovery of anaesthetic activity in the alkylphenol 
series has allowed the structure-activity relationships within 
this series to be examined in more detail in this chapter. 
Preliminary considerations of structure-activity relationships 
(James and Glen, 1980} indicated that, in general, potency and 
kinetics appeared to be a function of both the lipophilic 
character and the degree of steric hindrance exerted by ortho 
substituents. The more detailed examination of selected 
alkylphenols described in this study confirmed the observation 
that anaesthetic potency was not correlated directly with 
lipophilicity. In a group of compounds, all of which 
contained 6 carbon atoms in their side chains, and would be 
expected to be equally lipophilic, values ranged
from 7.5 mg kg  ^ (2,6-diisopropylphenol) to 26.5 mg kg ^
(2,6-di-n-propylphenol). The presence of lipophilic 
groups close to the phenolic-OH group is likely to 
reduce non-specific binding and to increase anaesthetic 
potency (R. James, personal communication). The 
influence of this effect was confirmed but further 
rationalization of structure-activity relationships 
must await accurate measurements of the hydrogen 
bonding properties of selected compounds.
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It was also found that speed of induction was not solely 
dependent on anaesthetic potency. Optimum potency, speed 
of onset, minimal respiratory effects and absence of excitatory 
effects were obtained only with 2,6-diisopropylphenol 
(disoprofol).
Comparative studies with disoprofol and standard 
anaesthetic agents were designed to predict the likely 
behaviour of the new compound in man. Results obtained 
in mice indicate that disoprofol is slightly less potent 
than methohexitone and 1.8 times more active than 
thiopentone. The therapeutic ratios obtained with 
standard agents in this study were lower than those 
reported in a previous investigation in mice (Child et al,
1971). This discrepancy can be explained by the use 
of a standard injection time and the definition of a 
finite minimum sleeping time in the present work. The 
relative potencies of the standard drugs obtained with 
this method reflect more closely results obtained in 
man. As in this study, Clarke et al (1968) and 
Stella, Torri and Castiglioni (1979) found thiopentone 
to be approximately equipotent with propanidid whereas 
Child et al, (1971) noted AD^^ figures of 13.2 mg kg~^ 
and 22.9 mg kg”  ^for thiopentone and propanidid 
respectively.
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The importance of using standardized injection times was 
confirmed in studies designed to compare the speed of onset 
of disoprofol anaesthesia with that of standard agents. In 
this investigation the of disoprofol decreased from
12.0 rag kg  ^to 7.5 mg kg“  ^when injection time was 
decreased from 10 seconds to 1 second, A similar increase 
in potency was seen with propanidid when a faster injection 
rate was used. This indicates that a certain amount of 
dilution, redistribution, and possibly even metabolism, 
occurs during the course of the slower injection. When 
equipotent doses of the anaesthetic drugs were injected 
over 1 second, the speed of onset of disoprofol 
anaesthesia was similar to that obtained with propanidid 
and marginally slower than the onset of thiopentone 
and 'Althesin' anaesthesia. Induction times with ketamine 
and pentobarbitone were much greater than those of 
the other standard agents. The ranking of induction times 
in mice was similar to that reported in man by Dundee 
(1957) and Carson, Dundee and Clarke (1975). The 
absolute induction times obtained with a 1-s injection 
time in mice were shorter than those found in man 
when a similarly rapid injection was given. This 
difference is probably due to a shorter circulation 
time in the mouse. When a 10-s injection was used in 
mice, onset times with the rapidly acting agents were 
similar to those reported in man following a rapid 
injection (1-2 s) during a period of reactive
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hyperaeinia produced by temporary ischaemia of the forearm 
(Clarke et al, 1968). These authors, in estimating the 
relative potency of thiopentone, methohexitone and propanidid 
made the assumption that all three drugs have a similar 
speed of onset. While this assumption may be valid with 
these particular agents, this technique would tend to 
underestimate the potency of a drug which was marginally 
slower in onset as a larger dose would be required to 
reach the desired end-point in the limited time set. This 
criticism emphasises the interrelationship which exists 
between anaesthetic potency and induction time, both of 
which are influenced by rate of injection. As the 
results obtained with standard agents in mice are 
similar to those obtained in man it can be predicted 
that disoprofol should be a rapidly acting agent in 
man.
In assessing the duration of anaesthesia produced 
by disoprofol and standard anaesthetics, doses equal to 
twice were used. As different compounds may not
have parallel dose response curves (Stella, Torri and 
Castiglioni, 1979; Kissin, 1980) it is difficult to 
make an accurate comparison in this way. However, 
the results obtained with standard drugs were in general 
agreement with those found in man (Dundee and Wyant,
1974). The duration of anaesthesia produced by disoprofol 
was longer than that obtained with methohexitone and
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’Althesin' and shorter than that produced by thiopentone. 
While early recovery from a single dose of thiopentone 
occurs reasonably rapidly, EEG analysis (Doenicke,
Kugler and Laub, 1967) and simulated driving tests 
(Korttila et al, 1975) indicate that full recovery 
requires several hours. In mice it was possible to 
demonstrate a significant delay in recovery of 
co-ordination following thiopentone in comparison with 
disoprofol, methohexitone and 'Althesin'.
In the experiment in which the cumulative properties 
of disoprofol were compared in mice with those of thiopentone 
and 'Althesin' the results obtained with the standard agents 
were similar to those of Child et al (1971). Disoprofol 
resembled 'Althesin' in that sleeping times were extended 
to a slight extent with repeated injections whereas marked 
increases in sleeping time were noted with thiopentone.
The continuous infusion of disoprofol in rats provided 
further evidence of a minimal cumulative effect. Heart 
and respiratory rates remained stable when the duration 
of the infusion was increased from 1 to 2 hours and a 
minimal increase in recovery time was noted after the 
longer infusion. These results suggest that the blood 
concentration of disoprofol is kept reasonably constant 
during an infusion due to rapid metabolism of the drug 
in the liver. Additional experiments (Glen and Growcott,
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unpublished observations) have shown that disoprofol sleeping 
time in rats can be decreased by the induction of liver drug 
metabolizing enzymes with phenobarbitone. A similar result 
has been obtained in rats with 'Althesin' (Novelli, Marsili 
and Lorenzi, 1975; Sear and McGivan, 1980). These 
results confirm the significant role that hepatic metabolism 
plays in limiting the duration of anaesthesia following 
disoprofol and 'Althesin'. It can be predicted that 
disoprofol should show minimal cumulative effects in man 
and in this respect should resemble methohexitone, etomidate 
'Althesin' and propanidid (Clarke and Dundee, 1966; Kay, 
1976).
With the exception of the study by Becker and Beglinger 
(1980), in which the cardiovascular effects of neurolept- 
analgesic drugs were examined in pigs, this species has 
not been used previously in investigations of the 
haemodynamic effects of anaesthetic drugs. In the 
present investigation the use of surgically prepared 
animals allowed control values to be obtained in 
conscious, unrestrained animals and avoided problems 
in the interpretation of results as encountered when 
control values have been obtained in anaesthetised 
animals (Chen et al, 1959; Lerman and Baton, I960;
McCarthy et al, 1965).
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In pigs disoprofol, thiopentone and 'Althesin' all produced 
an initial hypotensive effect and an increase in heart rate. The 
magnitude of the reduction in arterial pressure seen immediately 
after the injection of thiopentone depends on the change of 
the balance between cardiac output and total peripheral 
resistance (Conway and Ellis, 1959). Cardiac output may be 
reduced by a reduction in the contractile force of the left 
ventricle (Price and Helrich, 1955; Cotten and Bay, 1956).
The increase in heart rate can be attributed to a baroreceptor 
reflex response to hypotension (Schaper et al, 1963; Cox,
1972) and possibly also to central depression of normal vagal 
tone (Dodds, Dolamore and Twissel, 1981). In man, Fieldman, 
Ridley and Wood (1955) and Flickinger, Fraimow, Cathcart and 
Nealon (1961) found that thiopentone produced an increase 
in total peripheral resistance, while variable effects 
were noted by Elder, Nagano, Eastwood and Harnagel (1955) 
and no significant changes were observed by Dobkin and 
Wyant (1957). Decreases in arterial pressure, stroke 
volume and systemic vascular resistance with a slight 
increase in cardiac output as a result of compensatory 
tachycardia have been recorded in human patients given 
'Althesin' (Campbell et al, 1971; Leary, Coleman, Downing 
and Moyes, 1972; Savege, Blogg, Foley, Ross, Lang and 
Simpson, 1973; Sear and Prys-Roberts, 1979). In surgically 
prepared goats a small dose of 'Althesin' produced a 
greater degree of tachyardia than a larger dose (Foex 
and Prys-Roberts, 1972) and in cats. Child et al (1972a)
209
noted, transient hypotension and tachycardia with ’Althesin' 
and thiopentone.
The results obtained with thiopentone and ’Althesin’ are 
therefore similar to those described in man and other animal 
species. The greater degree of tachycardia seen with 
thiopentone and 'Althesin', in comparison with that noted with 
disoprofol, may indicate a greater degree of baroreceptor 
sensitivity with the former two drugs and may explain the 
later increases in blood pressure seen with these agents. 
Alternatively, these drugs may produce a different effect 
on total peripheral resistance. This possibility is 
supported by results obtained in further experiments 
where cardiac output was measured (Glen, Hunter and 
Lees, unpublished observations). In these experiments, 
thiopentone and 'Althesin' produced an increase in 
peripheral resistance, measured 2 minutes after injection, 
whereas disoprofol produced a slight reduction in this 
variable.
The potentiation of disoprofol sleeping time produced 
by premedication with droperidol, diazepam and chlorpromazine 
was expected as these drugs have previously been shown to 
potentiate barbiturate and steroid anaesthesia in mice 
(Janssen, 1963; Gyermek, 1974). The delay in recovery 
of co-ordination following premedication with atropine 
or hyoscine may be a reflection of the central depressant 
effect which can be produced by high doses of these
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compounds (Stewart, 1955). Comparative studies with 
thiopentone and 'Althesin' confirmed that the potentiating 
effect of the premedicant drugs on disoprofol anaesthesia 
was not unique as similar or greater effects were found 
with the standard agents.
Diazepam also produced some potentiation of the 
respiratory depressant effect of disoprofol. A similar 
potentiation of barbiturate induced respiratory depression 
has been noted with diazepam in animals (Southgate and 
Wilson, 1971) and in man (Prensky, Raff, Moore and Schwab,
1957). The increase in respiratory rate produced by 
chlorpromazine and droperidol premedication may 
have been due to the ability of these compounds to 
increase the sensitivity of the respiratory centre to 
carbon dioxide (Janssen et al, 1963).
An unexpected finding was the ability of atropine 
to reverse the respiratory depression induced by 
disoprofol. This suggests that the respiratory depressant 
effect is cholinergically mediated. Stewart (1965) has observed 
that in man respiratory depression induced by premedicant 
doses of morphine may be counteracted by the concurrent 
administration of atropine. Cholinergic mechanisms also 
appear to be responsible for the respiratory depression 
produced in animals poisoned with organophosphorous 
cholinesterase inhibitors (Harris, Fleisher, Vick and
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Cliff, 1969). In t±iese animals treatment with atropine reversed 
the respiratory depressant effect.
The combination of disoprofol with a range of inhalation 
anaesthetics and neuromuscular blocking drugs produced few 
unexpected interactions, The movement seen in one cat given 
pancuronium was attributed to inadequate anaesthesia but 
may have been due to the initial neuromuscular stimulant 
action of the non-depolarizing agent as sometimes seen in 
cats (Payne, 1961). No interaction with suxamethonium was 
demonstrated and in this respect disoprofol differs from 
propanidid, an agent known to potentiate suxamethonium 
apnoea (Clarke, Dundee and Daw, 1964; Howells et al, 1964).
Chapter 5
T H E  R O L E  O F  C R E M O P H O R  E L  I N  A N A P H Y L A C T O ID  R E A C T IO N S  P R O D U C E D  B Y  
C R E M O P H O R -C O N T A IN IN G  A N A E S T H E T IC S
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1. INTRODUCTION
It has been shown that injection of the intravenous 
anaesthetic agents thiopentone, propanidid and 'Althesin' 
can produce histamine release in man (Lorenz et al, 1972; 
Doenicke et al, 1973). The amount of histamine released 
is normally insufficient to be of any clinical significance 
but a large increase in plasma histamine concentration has 
been found to be a common factor in patients who have 
developed an anaphylactoid reaction following the administration 
of the Cremophor containing anaesthetic, propanidid 
(Lorenz et al, 1972). In human volunteers, these authors were 
unable to demonstrate histamine release following the 
administration of the hypnotic agent etomidate, or the 
solubilizing agent Cremophor EL when given on its own 
(Doenicke et al, 1973).
The original aim in this study was to find an animal 
model in which to evaluate the histamine-releasing 
propensity of Cremophor EL and Cremophor-containing 
anaesthetics. The unsuitability of the dog as a species 
in which to examine the ability of Cremophor-containing 
compounds to produce histamine release has been referred 
to in the introduction (Section 6 ). In the dog the 
intravenous administration of Cremophor almost invariably 
induces a massive release of histamine (Lorenz et al, 1971b). 
The pig resembles man in being insensitive to the histamine
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releasing properties of Cremophor EL (Lorenz et al, 1971b)and 
was selected as a suitable species in which to evaluate the 
effects of Cremophor-containing anaesthetics.
Preliminary studies in pigs failed to demonstrate any 
significant increase in plasma histamine concentration 
following a single injection of the Cremophor-containing 
anaesthetic 'Althesin'. At this time, the finding by 
Watkins et al (1976) of a high frequency of subclinical 
"hypersensitivity" reactions in man, following single and repeated 
injections of 'Althesin', propanidid and methohexitone, 
prompted an examination of the effect of repeated doses 
of 'Althesin' in the pig. The reactions in man were 
characterized by significant changes in white cell counts.
In early studies in pigs it was found that the repeated 
administration of 'Althesin' produced a rapid and marked 
reduction in the number of circulating polymorphonuclear 
leucocytes and that this effect was accompanied by an 
abnormal clinical response. Further experiments were 
therefore designed to examine the effects of repeated 
injections of a range of Cremophor-containing and 
Cremophor-free anaesthetics. In this way it was hoped 
that the role of the surfactant Cremophor EL in producing 




Miniature pigs (Gottingen derived strain) of both sexes 
and weighing 12-20kg were used. They were housed individually 
in concrete and tubular metal pens, fed twice daily with Sow 
Breeder Meal, and allowed free access to tap water.
2.2 Drugs
One water soluble anaesthetic, thiopentone sodium 
('Pentothal, Abbott) and two surfactant-containing anaesthetics, 
'Althesin' (Glaxo) and 'Epontol' (Bayer), were examined. 
Thiopentone was prepared as a 2.5% w/v solution in water for 
injection B.P. 'Althesin' contains a mixture of two steroids, 
Alphaxalone 0.9% w/v and alphadolone acetate 0.3% w/v 
solubilized in 20% w/v polyoxyethylated castor oil 
(Cremophor EL, BASF), whereas 'Epontol' contains propanidid 
5% w/v solubilized in 20% w/v Micellophor, a butanol 
extract of Cremophor EL. The active agents, alphaxalone/ 
alphadolone and propanidid were also obtained from their 
respective manufacturers and formulated in a non-Cremophor 





One week before the first administration of a test agent, 
carotid and jugular cannulae were surgically implanted to allow 
arterial pressure to be measured and to facilitate the 
administration of test agents and the withdrawal of blood 
samples. For this procedure pigs were sedated with 0.2 mg kg  ^
droperidol and anaesthesia was induced and maintained with 
halothane.
When test agents were administered arterial pressure was 
measured, before and during the period of anaesthesia, with 
a Bell and Howell strain gauge transducer. Heart rate was 
derived electronically from the arterial pressure‘input 
and records of both measurements were obtained on a Devices M19 
recorder. Rectal temperature was measured during anaesthesia 
with a mercury thermometer. Abnormal clinical responses and 
sleeping times to head lift were noted.
Samples of arterial blood were collected before the 
administration of a test agent and at 2, 5, 10 and 20 min 
after injection. Arterial pH, PO^ and PCO^ were measured in 
heparinized blood samples using standard Radiometer or 
Corning electrodes. Samples for plasma histamine measurement 
were collected into EDTA and centrifuged at 1500g for 60 min.
An equal volume of trichloracetic acid was added to the 
supernatant, to precipitate protein, and plasma histamine 
concentration was measured using an automated fluorimetric 
assay (Evans, Lewis and Thomson, 1973). Total and
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differential white cell counts were performed by standard 
methods.
The doses of the anaesthetic agents investigated were 
as follows: thiopentone 10 mg kg alphaxalone/alphadolone
0.15 ml kg  ^ (1.8 mg kg”  ^total steroids) and propanidid 
10 mg kg” .^ These were the minimum doses required to 
produce unconsciousness in the miniature pig. The use of 
an alternative solvent system containing 10% ethyl alcohol 
and 25% propylene glycol allowed a comparison to be made 
of the effects of Cremophor-free preparations of 
alphaxalone/alphadolone and propanidid with those of the 
commercially available preparations of 'Althesin' and 'Epontol' 
containing Cremophor EL and Micellophor respectively. 
Solvents, when examined alone, were given in a volume and 
concentration equal to that contained in the anaesthetic 
formulations. All injections were given over 30 seconds.
In most instances an interval of 1 week was allowed 
between the administration of each dose of a test agent. 
Additional experiments were performed with 'Althesin' using 
intervals of 4, 14 and 21 days and Cremophor was also 
readministered after a 14-day interval. Different groups 
of pigs (3-6 per group) were used for each agent or interval 
examined. Thus each pig received only two injections 
of the same agent.
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3.2 Statistical evaluation of results 
The significance of differences occurring within an 
experiment was estimated with Student's paired t-test.
A similar test was also used to compare differences obtained 




The results obtained in the first series of experiments where 
a 1-week interval was allowed between the administration of two 
doses of a test agent are summarized in Table 48 and Appendix 6.
4.1 Abnormal clinical responses
Cremophor EL and the Cremophor and Micellophor-containing 
agents 'Althesin' and 'Epontol' all produced frequent reactions 
when a second administration was given 7 days after the 
first exposure. On only one occasion, when alphaxalone and 
alphadolone were given in alcohol and propylene glycol, was 
an abnormal response seen on the first administration of any 
agent. The second administration of alphaxalone and alphadolone 
in the same solvent produced abnormal clinical responses in 
two of four pigs. No such responses were seen when propanidid 
was administered in alcohol and propylene glycol or when this 
solvent mixture was given alone. No abnormal responses were 
seen following the repeated administration of thiopentone.
Pigs showing an abnormal response developed an initial 
cutaneous hyperaemia and frequently showed convulsive limb 
and head movements. Peripheral cyanosis or a transient 
urticarial rash appeared later (Fig, 31). The responses produced by 
different agents were generally similar. Convulsive kicking 
and peripheral cyanosis were noted most frequently in the 
animals receiving Cremophor EL or 'Epontol', while the 
overt signs of a response were less marked following 
administration of the alphaxalone/alphadolone mixture in 






















§ s s  
tj § I








04 o I—1 1-4 <U
1 04 <0 <Ü 0)
H X S Ü G
S w O 'i4 0
H O G 04
s G -4 01
a n  rH (U










O w • Cn
Eh 0  "H














G rH  D l
O G 0
01 0) r 4 ■K W G  01
G G 0 0 G
O G 0 T3 •H 14 ü 01
4J •H r 4  <n T3 0 rH  rH
G 01 rH q -G •H G <13 >1
01 01 0 X 04 G 04 O i
04 r: +J G  rH <ts 0 G  0
0 +j G G  C 04 a >1 M
■r4 r-4 o 04 0 01 5  ^g a 04 rH H S4















Fig. 31 Urticarial rash produced by a second injection of
Cremophor given seven days after an uneventful first 
exposure
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to Cremophor became unable to stand for a short period, salivated 
excessively and vomited. Rectal temperature did not change 
significantly during any of the reactions. No treatment or 
supportive therapy was given and all animals survived.
4.2 Sleeping times
Mean sleeping time on both exposures to each of the 
anaesthetic agents investigated are given in Table 49 and 
results obtained in individual animals are tabulated in 
Appendix 7,
Pigs receiving a second injection of 'Althesin* 
or alphaxalone/alphadolone in the alternative solvent slept 
for a longer period than that found on the first exposure 
to these agents, but the difference was not statistically 
significant.
4.3 Respiratory effects
In pigs showing an abnormal response a period of apnoea 
of 20-60S was seen frequently following the administration of a 
test agent. On other occasions a brief period of irregular 
respiration or coughing was noted. Respiratory depression 
appeared to be central in origin and not associated with 
bronchospasm. Changes in arterial PO^ and PCO^ in pigs 
showing abnormal responses are shown in Figure 31 , in which 
it can be seen that PO^ decreased slightly in the groups 
receiving the anaesthetic agents but was virtually unchanged 
at 2 min in the group responding to the second injection 
of Cremophor. In no case was the reduction in PO^ values 
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Fig. 31 Changes in arterial PO^ and PCOg in pigs which showed an 
abnormal clinical response.
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was frequently evident, arterial oxygenation had returned to 
normal in the groups which received the anaesthetic agents.
Arterial PCO^ values were not altered significantly and the changes 
in pH did not indicate any effect on metabolic acid-base 
status.
The decrease in PQ^ values in pigs given thiopentone, 
or propanidid in the alternative solvent, was similar to that 
seen in pigs showing an adverse response to one of the other 
anaesthetic formulations. It would appear, therefore, that 
adverse clinical responses are not associated with any 
significant change in blood gas values.
4.4 Plasma histamine concentration
Plasma histamine concentration was not invariably 
increased in pigs which exhibited an abnormal response 
(Table 48 and Appendix 6). Increases were found most 
consistently in pigs given Cremophor or ‘Epontol’.
Despite the finding of large concentrations of 106 ng ml“  ^
and 135 ng ml  ^at 2 min in individual pigs in the groups 
given Cremophor and ’Epontol* respectively, none of the 
groups showed a consistent increase which was statistically 
significant. The mean plasma histamine concentrations found 
in pigs which showed abnormal responses are given in Fig. 32.
In one pig which showed an abnormal response to a second 
injection of alphaxalone and alphadolone in 











Fig. 32 Plasma histamine concentration in pigs which showed 
an abnormal clinical response.
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histamine concentrations increased from 46 ng ml~^ to 84 ng ml”^
2 min after injection. The increase noted in two pigs given a 
second injection of thiopentone was not associated with any 
other sign of an abnormal response.
4.5 Haemodynamic effects
In all animals in which an abnormal clinical response was 
noted, and on two occasions when no clinical signs indicating 
an abnormal response were seen, a marked hypertensive response 
developed a few seconds after the administration of the test 
agents. Maximum mean arterial pressures in the groups which showed 
abnormal reactions are given in Table 50.
Maximum increases in arterial pressure were achieved 
within 1 min and thereafter mean pressure returned to pre-dose 
values over the succeeding 5-10 min. The increase in arterial 
pressure usually preceded any overt sign of an adverse 
response and the maximum values reached were similar in all 
groups showing an anaphylactoid response. A typical record 
illustrating these changes is shown in Figure 33. in this 
animal the first administration of 'Epontol' produced only a 
brief depressor effect, whereas the second injection, given 
7 days later, produced a marked pressor response. On only 
one occasion was a similar pressor response noted on the first 
administration of a test agent. The record obtained from this 
animal, which was given alphaxalone/alphadolone in alcohol 
and propylene glycol is shown in Figure 34.
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Fig, 33 The effect of two injections of.'Epontol' on arterial 









Fig. 34 The effect of two injections of alphaxalone/alphadolone 
on arterial pressure in a pig. Blood sampling artefacts 
are present on lower trace.
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No marked pressor effects were seen on the second administration 
of thiopentone, or propanidid given in a non-Creraophor formulation, 
and it would appear that a hypertensive response is a consistent 
feature of the analphylactoid response seen with the other agents.
Heart rate increased as the pressor effect was initiated but 
in many instances reflex bradycardia occurred when the hypertensive 
response was fully developed. Pulse pressure was frequently 
reduced about 5 min after drug administration and at this time 
a peripheral pulse could not be readily detected.
4,6 Effects on white blood cells
In one pig in which an abnormal clinical response was noted 
following the first injection of alphaxalone/alphadolone in alcohol 
and propylene glycol, the polymorph count decreased from a value 
before injection of 9.03 x 10^ litre " to 4.4 x 10^ litre  ^2 min 
after injection. No significant changes in total or differential 
white cell counts occurred in any other pig following the first 
administration of a test agent.
A typical finding in pigs showing an adverse response to a 
second administration of a test agent was the virtual 
disappearance of polymorphonuclear leucocytes in blood samples 
collected 2 and 5 min after injection. This decrease in 
polymorph count was reflected in the total white cell count. 
Lymphocyte numbers were not significantly altered (Figure 35).
The mean changes in polymorph count 2 min after the second 
administration of each test substance are given in Table 51. 
'Althesin', 'Epontol', alphaxalone/alphadolone in alcohol and 
propylene glycol, and Cremophor all produced marked changes at
1 2 - 1 A - A  Polymorphs Day 1 
A - A  Polymorphs Day 8 
D-D Lymphocytes Day 1 










Fig. 35 Polymorph and lymphocyte counts in pigs which responded 
to a second injection of Cremophor EL given 7 days after 
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Fig. 36. Polymorph counts in pigs which showed an abnormal clinical 
response.
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this time whereas thiopentone, propanidid in alcohol and propylene 
glycol, and this latter solvent mixture on its own, produced only 
minor effects. The time course of these changes in polymorph 
count, in animals in which adverse clinical responses were 
noted, is depicted in Figure 36.
4.7 Effect of varying the interval between injections
The results obtained in experiments in which the interval 
between two injections of Cremophor or 'Althesin' was varied 
between 4 and 21 days are summarized in Table 52. a high 
frequency of adverse responses to 'Althesin' occurred when a 
second injection was given after 1 or 2 weeks, whereas only 
one mild reaction was produced when the interval between 
two injections was 4 days or 3 weeks. Adverse responses to 
the second administration of Cremophor were noted less 
frequently when the interval between two injections was 
extended from 1 to 2 weeks. The changes in polymorph 
count, at the different times of challenge (Figures 37 and 38) 
reflected the changes in clinical responses. This result 
suggests that sensitivity to Cremophor may possibly be lost 
more rapidly than that to 'Althesin'.
In conclusion Cremophor and the Cremophor-containing 
agents 'Althesin' and 'Epontol' all produced similar 
analphylactoid responses when a second administration was 
given after an uneventful first exposure. In addition 
to clinical signs, a marked increase in arterial pressure 
and an immediate but transient decrease in the number of 
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Fig. 37 Polymorph count {as % of pre-dose value) in pigs given 
'Althesin* on Day 1 and after intervals of 4, 7, 14, 
or 21 days. n = number examined.r = number of adverse 
responses.
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Fig. 38 Polymorph count (as % of pre-dose value) in pigs given 
Cremophor on Day 1 and after intervals of 7 or 14 days.
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consistent features of the response in the pig.
No similar responses were induced by the repeated 
injection of thiopentone, or propanidid in a non-Cremophor 
formulation. The replacement of Cremophor by alcohol and 
propylene glycol as the solubilizing agent for alphaxalone 
and alphadolone failed to prevent the production of 
anaphylactoid responses with this mixture of steroids,
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5. DISCUSSION
An examination of the results obtained with experimental 
anaesthetics in chapter 4 and a comparison of published results 
with the lipophilic anaesthetic 'Althesin' with those obtained 
with the related water soluble steroid, minaxolone, (Punchihewa, 
Morgan, Lumley and Whitwam, 1980; Prys-Roberts, Sear and Adam, 
1981; Prys-Roberts and Sear, 1980; McNeill, Clarke, Dundee 
and Briggs, 1981) indicates that desirable pharmacokinetic 
properties and freedom from excitatory effects may be more 
readily achieved with lipophilic agents.
The new agent, disoprofol, examined in chapter 4, is a 
highly lipophilic anaesthetic and is currently solubilized 
in Cremophor EL. The use of this solubilizing agent has two 
main disadvantages. Firstly, the ability of Cremophor to 
produce histamine release and hypotension in the dog (Lorenz 
et al, 1971b)precludes the clinical or experimental 
use of disoprofol in this species. Secondly, the 
advisability of using Cremophor in the formulation of a 
new agent for use in man must be questioned as doubt still 
exists about the involvement of Cremophor in the 
production of anaphylactoid reactions in man following 
the administration of the Cremophor-containing anaesthetics 
'Althesin' and 'Epontol'.
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Lorenz (1975) has speculated that the role of Cremophor 
in producing reactions in man may be related to the combined 
effects of a surfactant with an anaesthetic agent, with 
mast cell membranes being altered by the anaesthetic drug 
to facilitate binding of the wetting agent and the release 
of histamine. This conclusion was reached, and Cremophor 
per se was exonerated, as previous studies had shown that 
the administration of Cremophor alone produced no effect 
in patients who had previously reacted adversely to the 
Cremophor containing agent 'Epontol' (Lorenz et al, 1972; 
Doenicke et al, 1973). An alternative explanation, 
proposed by Watkins et al (1976), was that Cremophor 
could possibly act as an adjuvant such that the 
allergenicity of the anaesthetic agent would be 
increased.
Previous attempts to produce hypersensitivity 
responses in laboratory animals by the repeated 
injection of 'Althesin' or Cremophor proved 
unsuccessful (G.E. Davies and A.V. Thompson, personal 
communication). It has also been shown, in man, that 
the injection of Cremophor alone produces no significant 
change in heart rate or arterial blood pressure (Savege et al, 
(1973b).
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On the other hand, circumstantial evidence which tends 
to incriminate Cremophor, continues to accumulate. The 
introduction of 'Althesin' in a Cremophor formulation was 
followed by a greater number of reports of anaphylactoid 
reactions than had previously been noted with the water 
soluble barbiturates (Clarke et al, 1975). The features 
of the adverse responses described were similar to those 
which had been observed previously with another Cremophor- 
containing agent, 'Epontol' (Bradburn, 1970;
Johns, 1970; Larard, 1970). In addition, reactions to 
'Althesin' have been reported in patients previously 
anaesthetised with 'Epontol' (Notcutt, 1973) and 
adverse reactions to 'Epontol' have also been noted 
after an earlier uneventful exposure to 'Althesin'
(Dye and Watkins, 1980). The presence of Cremophor 
as a common factor in reactions of this type has also 
been noted by Thornton (1978). Further circumstantial 
evidence pointing to the involvement of Cremophor has 
been provided by Huttel, Shou Olesen and Stoffersen (1980), 
These authors found that when the solvent in diazepam 
was changed from propylene glycol to Cremophor the 
frequency of hypersensitivity reactions increased from 
virtually zero to 5 in 5,200.
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The results described in this chapter were obtained in an 
animal model in which it was possible to produce anaphylactoid 
reactions with Cremophor and Cremophor-containing anaesthetics. 
These results indicate that, in the mini pig, Cremophor is 
responsible for the reactions produced by 'Epontol'. No adverse 
responses were encountered when propanidid, the active agent 
in 'Epontol', was given in an alternative non-Cremophor 
solvent. Cremophor on its own produced typical reactions but 
the results obtained with 'Althesin' were less clear. While 
3 out of 4 pigs showed an adverse response when a second 
administration of 'Althesin' was given, the steroid 
constituents of 'Althesin', alphaxalone and alphadolone 
acetate, also produced reactions when given in a non- 
Cremophor formulation. This indicates that, while 
Cremophor may play a part in some of the reactions to 
'Althesin', hypersensitivity to the steroid constituents 
may also be important.
Reactions in man have been classed as 'anaphylactoid' 
as the clinical features of a response are insufficient 
to distinguish between antibody-mediated reactions, 
complement-mediated reactions, and reactions due to the 
release of histamine from mast cells by a direct action 
of the injected substance (Watkins and Clarke, 1978; Watkins,
1979). The time course and appearance of the response in 
the pig suggests that these reactions too should be called
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'anaphylactoid'. Sensitivity was induced within 7 days of a 
previous exposure and disappeared if the interval between two 
injections was extended to three weeks. An additional feature 
of the response in the pig is that, in animals which have 
responded to a second injection of 'Althesin', the subsequent 
injection of Cremophor produces no further response (Glen,
Davies, Thomson, Scarth and Thompson, 1978). Should a 
similar phenomenon occur in man, this mechanism could 
explain the failure of Lorenz et al (1972) to precipitate 
a response with Cremophor in patients who had already 
reacted to 'Epontol'. True analphylactic responses can be 
induced in the pig by the repeated injection of 
ovalbumin (Glen and Hunter, unpublished observations) 
and in this case an interval of 3 weeks between injections 
is required. A challenge dose of ovalbumin produces a 
response similar to that seen in pigs given Cremophor, 
but in contrast to Cremophor-sensitized animals 
subsequent challenges with ovalbumin produce a similar 
or greater response.
In assessing the relevance of results obtained in 
the pig it is necessary to examine the mechanisms thought to be 
responsible for reactions in man: The time course of the response
to Cremophor in the pig indicates that the mechanism involved is 
unlikely to mimic the mechanism responsible for reactions which occur on 
the first exposure to a Cremophor-containing agent in 
man. Alternate pathway activation of complement C3 
or the direct release of histamine from mast cells appear
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to be responsible for most of these reactions (Watkins,
Milford Ward and Appleyard, 1977; Watkins, 1979). The pig 
model is also unlikely to mimic true IgE mediated responses 
where sensitivity may persist for a much longer time (Lilly 
and Hoy, 1980; Fisher, 1980). Although reactions to 
barbiturate anaesthetics occur more rarely, a greater 
proportion of these reactions involve IgE mediated responses 
(Wyatt and Watkins, 1975).
Many of the adverse reactions to 'Althesin' do, however, 
follow a previous exposure to this drug or another Cremophor- 
containing agent. An analysis of the figures of Clark et al, 
(1975) indicates that of 65 patients who reacted to 
'Althesin', 35 had received a Cremophor-containing anaesthetic 
previously. In more than 50 per cent of these patients the 
second administration had been given within 1 month of the 
first. A similar frequency of previous exposure to 
'Althesin' was noted by Beamish and Brown (1981) while 
Radford, Lockyer, Sear and Simpson (1980) found that 
of 22 patients with clinical signs of hypersensitivity 
to 'Althesin', 17 had received the drug on at least 
one previous occasion. Watkins, Allen and Milford Ward 
(1978) have suggested that a short term 'memory' phenomenon, 
involving lymphocyte receptors and IgD, may be responsible 
for these reactions and the time course of the response in 
the pig supports this theory. Results obtained in the pig 
may therefore be of predictive value in detecting compounds 
likely to produce this latter effect in man.
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In two important aspects the clinical response in the pig 
differs from the response in human patients. While hypotension 
and bronchospasm are frequently encountered in man, hypertension 
is produced in the pig and bronchospasm has not been observed. 
These differences are probably due to species differences in 
responsiveness to the biogenic amines or kinins released 
during a reaction. The histamine content of pig plasma 
is about 100 times greater than that of man (Lorenz et al, 1971a) 
and elevation of plasma histamine concentration was a minor 
and inconsistent finding in the present investigation. Bronchial 
and vascular tissue in the pig may therefore be relatively 
insensitive to small increases in plasma histamine
concentration. It has also been shown by Lorenz et al (1971j^ ) that 
a pressor response is produced in the pig by the injection of 
the histamine releaser, compound 48/80.
The possible involvement of complement in reactions 
in man has been mentioned. When complement is activated 
the anaphylatoxins and are released and leucoycte
chemotaxis and aggregation is induced (Gigli, 1979;
Williams, 1979). This results in a reduction in 
circulating polymorphonuclear leucocytes (Craddock,
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Fehr, Daimasso, Brigham and Jacob, 1977). The marked reduction
in circulating leucocytes noted in the present investigation
suggests that complement activation and the release of
may also occur in the pig. As produces arteriolar constriction
in the perfused porcine kidney and on topical application to
rabbit omentum (Hugli, 1979) release of this
anaphylatoxin could have contributed to the hypertensive
response seen in the pig. In this respect species
differences may also be important as, unlike animal sera,
complement activated human serum contains little
spasmogenically active (Hugli, 1979).
Aggregation of polymorphonuclear leucocytes, induced by
release, may also cause pulmonary dysfunction due to 
aggregates becoming lodged in pulmonary capillaries 
(Hammerschmidt, Weaver, Hudson, Craddock and Jacob, 1980).
Although only minor changes in blood gas tensions were found 
in pigs the transient presence of leucoemboli could have 
triggered a sympathoadrenal response. This may be 
considered as a further possible explanation for the 
hypertensive response noted in pigs. Further work would 
be required to examine fully the role of complement 
in the pig reaction.
At present no explanation can be given for the marked 
susceptibility shown by the pig to Cremophor containing 
agents. The complement system contains a number of 
interacting activating, inhibiting and inactivating
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systems (Gigli, 1979). It is possible that a relative deficiency 
of an inactivator or inhibitor in the pig could cause the 
complement system to be more readily activated in this 
species. Whatever mechanism is involved it is apparent 
that a reaction is triggered only when an animal has been 
sensitized with an earlier injection of Cremophor.
Apart from the known direct histamine releasing properties 
of Cremophor on first exposure in dogs (Lorenz et al, 1971b), 
reactions to 'Althesin' have been reported in cats (Stogdale, 
1978; Dodman, 1980). As most of these reactions were 
histaminoid in type and occurred on the first exposure to 
the drug direct histamine release by Cremophor was probably 
responsible. However, the possible involvement of 
complement activation in some of these reactions cannot 
be excluded.
G E N E R A L  D IS C U S S IO N  A N D  C O N C L U S IO N S
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The experiments described in chapters 1 and 2 were designed 
to investigate the accuracy of indirect methods for the measurement 
of systolic blood pressure and the estimation of arterial PCO^ in 
dogs. This work was initiated as non-invasive techniques for 
the measurement of these parameters have not been widely used 
in routine veterinary anaesthesia or in the clinical evaluation 
of new anaesthetic agents in dogs. In earlier studies these 
indirect methods have been evaluated in relatively small numbers 
of animals and the accuracy of the indirect methods has not been 
systematically investigated in animals of widely differing 
size. In this study the indirect methods were examined in dogs, 
with body weights ranging from 5-47kg and anaesthetised with 
a range of different anaesthetic agents and techniques.
The accuracy of the indirect method of blood pressure 
measurement was found to depend on the selection of the correct 
width of occluding cuff for a given size of animal. On the 
basis of the results obtained it can be recommended that a 
cuff 2.5cm wide should be used in animals weighing less than 
19kg and a 3.75cm cuff in animals of greater weight. The 
accuracy of the technique was also dependent on foreleg 
circumference; but the correlation obtained with the 
simpler measurement of body weight was equally good. The 
results obtained with the correct size of cuff for a given 
animal were deemed sufficiently accurate for the 
applications envisaged. The technique was readily applied
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to anaesthetised dogs and problems with movement artefacts 
were rarely encountered.
Values of end-tidal PCOg were found to correlate closely 
with simultaneous direct measurements of arterial PCOg, with 
the arterial value being on average 2.ImmHg greater than the 
end-tidal tension. While this mean value agrees well with 
results obtained in previous studies in dogs (Suskind and 
Rahn, 1954; Severinghaus and Stupfel, 1957) the range of 
differences between arterial and end-tidal tension was 
greater in this study. The accuracy of the method in 
estimating arterial PCO^ was adequate for clinical studies 
as arterial and end-tidal values correlated closely in 
individual animals. Further work would be required to 
investigate possible differences in arterial-end-tidal 
PCO^ gradients caused by different anaesthetic agents.
These indirect methods were used in the investigation 
of neuroleptanalgesia drugs described in chapter 3. Little 
difference could be detected in the hypotensive effects 
produced by the combinations examined; but measurement 
of end-tidal PCO^ confirmed the presence of significant 
respiratory depression in dogs given fluanisone:fentanyl 
or methotrimeprazine:etorphine. In the examination of 
the respiratory effects of the fentanyl:droperidol mixture 
in anaesthetised dogs, end-tidal PCO2 measurement proved 
to be a sensitive technique. With this method it was 
possible to show that droperidoi anatagonised the respiratory
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depressant effect of fentanyl to a significant extent. A similar 
effect could not be established by noting effects on respiratory 
rate due to the marked variation observed in the control values. 
Further evidence of the ability of neuroleptic drugs to 
antagonise respiratory depression was obtained in mice 
anaesthetised with disoprofol. This effect appears to be 
manifested only in the presence of respiratory depression as 
droperidol has been shown to produce little effect on 
ventilation in normal mice and rabbits (Greene, 1972;
Khanna and Pleuvry, 1978). Although Janssen et al (1953) 
have postulated that droperidol may increase the sensitivity 
of the respiratory centre to carbon dioxide, the mechanism 
involved in this interaction requires further study.
Of the neuroleptanalgesia techniques investigated, 
the intravenous administration of the droperidol:fentanyl 
mixture produced the best overall results. However, a 
significant frequency of troublesome side effects was noted 
with all the drugs examined and the technique was not considered 
suitable for major surgery as advocated by Yelnosky and Field 
(1964) and Marsboom et al (1964). The neuroleptanalgesia 
technique could probably be improved by administering the 
neuroleptic component before the analgesic, but the delay 
involved would reduce the convenience of the technique in 
out-patients. While the ability to reverse immobilization 
with a narcotic-antagonist drug is an advantage it must be 
remembered that analgesic effects will also be terminated.
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The experiments in laboratory animals, described in chapter 
4 were done to identify a potential new intravenous anaesthetic 
and to compare the properties of disoprofol with those of 
currently used injectable anaesthetics. The search for new 
agents has continued because none of the available drugs can be 
considered to be completely satisfactory. Thiopentone, although 
widely used as an induction agent, has a long elimination 
half life (Ghoneim and Van Hamme, 1978; Christensen et al,
1980) and cannot be considered as a suitable agent for use in 
continuous infusion techniques. This agent may also cause 
extensive tissue damage if injected perivenously or intra- 
arterially (Kinmonth and Shepherd, 1959). Involuntary muscle 
movements and hiccough have been noted in a number of patients 
receiving methohexitone; and pain on injection, excitatory 
effects and emetic sequelae have been observed with etomidate 
{Holdcroft et al, 1976; Hendry, Miller and Lees, 1977; Zacharias 
et al, 1979). Propanidid is associated with a high incidence 
of post-anaesthetic nausea, vomiting (Clarke, Montgomery,
Dundee and Bovill, 1971) and venous sequelae such as thrombosis 
or thrombophlebitis (Carson et al, 1972); and techniques of 
neuroleptanalgesia and dissociative anaesthesia have limited 
applications (Dundee and Wyant, 1974). 'Althesin' remains as 
a drug which produces relatively few excitatory effects 
(Clarke, Dundee and Carson, 1972), little venous damage 
(Carson et al, 1972) and has a short elimination half life 
(Simpson, 1978). The use of 'Althesin' has however decreased
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due to the relatively high frequency of anaphylactoid reactions 
encountered with this agent (Clarke et al, 1975).
In the investigation of the anaesthetic properties of 
disoprofol in animals, new techniques were developed to examine 
the interrelationship between speed of injection, anaesthetic 
potency and speed of induction of anaesthesia. Anaesthetic 
potency and speed of induction increased when a faster rate 
of injection was used and it was concluded that disoprofol 
was a rapidly acting agent with a short duration of action 
and an anaesthetic potency 1.8 times greater than that of 
thiopentone.
An examination of recent trends in anaesthesia reveals 
renewed interest in techniques of total intravenous anaesthesia 
(Savege et al, 1975; Dundee, 1978). This trend coincides 
with current concern about theatre contamination by 
anaesthetic gases and vapours (Spence and Knill-Jones, 1978; 
Smith and Shirley, 1978). A major requirement in any agent 
used to maintain anaesthesia by intravenous infusion is that 
the injected compound should be rapidly metabolised, such 
that minimal tissue accumulation occurs and rapid recovery 
can be obtained. In experiments in which disoprofol was 
given by repeated injection to mice, and by infusion to rats, 
little evidence of cumulation was seen. Disoprofol may 
therefore have pharmacokinetic properties which would make 
it a suitable agent for maintenance of anaesthesia with 
an infusion technique.
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In other studies with disoprofol cardiovascular and 
respiratory effects were found to be generally similar to those 
of thiopentone and 'Althesin'. No unexpected interactions were 
encountered when disoprofol was given in combination with drugs 
used in preanaesthetic medication, inhalation anaesthetics 
and neuromuscular blocking drugs. The combination of disoprofol 
and suxamethonium was examined in a new model, using mice, in 
which it was possible to demonstrate the known potentiating 
effect of propanidid on suxamethonium induced respiratory 
depression (Clarke, Dundee and Daw, 1964). No similar 
interaction of disoprofol with suxamethonium was found.
This suggests that plasma cholinesterase is not involved in 
the metabolism of disoprofol and that potentiation of 
suxamethonium apnoea is unlikely to be produced in man with 
this agent.
Results obtained in preliminary clinical studies in 
human patients (Rogers, Dewar, McCubbin and Spence, 1980; Kay 
and Stevenson, 198 0; Briggs, Clarke, Dundee, Moore, Baker 
and Wright, 1981) have confirmed that disoprofol produces 
anaesthetic effects in man similar to those predicted 
from these animal studies. Reports of pain on injection 
in a proportion of patients were however unexpected as 
this side-effect had not been predicted from the animal 
studies. Further work will be required to investigate 
the species differences responsible for this discrepancy.
240
Disoprofol is a lipophilic compound and, being poorly 
soluble in water, is currently formulated with the solubilizing 
agent Cremophor EL. As this agent is also present in 'Althesin', 
and 'Epontol* and as conflicting views have been expressed about 
the contribution of Cremophor to the relatively high frequency 
of anaphylactoid reactions encountered with these agents 
(Clarke et al, 1975; Lorenz, 1975; Watkins et al, 1976) 
it was necessary to examine further the role of Cremophor 
in these reactions.
The experiments described in chapter 5 were done in a 
new animal model in which it was possible to produce characteristic 
anaphylactoid reactions when a second administration of 
Cremophor or a Cremophor-containing agent was given 1-2 weeks 
after an uneventful first exposure to the same agent. Although 
it is unlikely that the mini-pig model reflects all of the 
mechanisms responsible for anaphylactoid reactions to 
injectable anaesthetics, the features of the model suggest 
that it may simulate those reactions in which a short term 
'memory' phenomenon has been implicated in man (Watkins,
Allen and Milford-Ward, 1978). The results obtained in 
pigs indicate that Cremophor alone can produce a 
response and any new agent formulated in Cremophor would be 
expected to induce the same response. The pig is apparently 
a very sensitive species in which to demonstrate this 
response and the model should prove useful in the search 
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APPENDICES
Appendix 1
Simultaneously measured values of indirect (Id) and direct (D)
systolic pressure in a dog (32 kg) obtained with occluding cuffs
of three different widths








225 180 +45 170 180 -10
195 188 +7 175 180 -5
195 180 +15 175 180 -5
170 160 +10 120 120 0
190 176 +14 145 150 -5
145 140 +5 154 160 -6
130 130 0 140 148 -8
145 142 +3 115 122 -7
170 160 +10 120 130 -10
145 139 +6 135 140 -5
160 150 +10 135 140 -5
160 150 +10 132 148 -16
150 138 + 12 180 210 -30
155 160 -5 140 146 -6





Mean 156 157 10,7 147 156 9-3
































+ 17.8 + 18.6 + 8.8
Appendix 2
Simultaneously measured values of indirect (Id) and direct (D) 
systolic blood pressure (mmHg) in dogs
Dog No. 2.5 cm cuff 3.75 cm cuff
Id D Id D
1 151 160
2 103 107 lOO 114
3 103 111
4 152 163 135 153
5 152 199
6 108 103 104 103
7 151 160 159 162
8 163 167 160 172
9 114 105 95 100
10 106 91
11 138 150 125 160
12- 81 95 76 95
13 110 148
14 118 120
15 133 125 128 126
16 168 164 150 163
17 96 93 86 97
18 128 106 113 107
19 120 132 96 120
20 183 166 155 171
21 160 175
22 111 132
23 127 112 109 112
24 148 160
25 83 96
26 161 150 143 150
Appendix 2 (Cont’d.)
Dog No. 2.5 cm cuff 3.75 cm cuff 5.0 cm cuff
Id D Id D Id D
27 112 105
28 210 220 190 225 179 220
29 210 210 179 198 168 168
30 100 102
31 198 193
32 170 160 165 170
33 188 164 156 141 150 160
34 210 210 190 215
35 90 109
36 75 78 71 82
37 160 138 152 158 130 143
38 140 129 128 141
39 155 155 153 159
40 161 122 148 137
41 167 158
42 145 114 117 115
43 160 164




48 127 114 105 103




Breed, weight, foreleg circumference and the difference between indirect
and direct measurements (Id-D) of systolic pressure in dogs









1 Terrier X 6.5 10.5 -9
2 Collie X 8.0 14.5 -4 -14
3 Poodle 8.5 13.5 -8
4 Spaniel 9.5 14.4 -11 -18
5 West Highland 9.75 15 -47
6 Labrador 10 15.5 +5 +1
7 Terrier X 10.5 16 -9 -3
8 Whippet 11.25 16 -4 -12
■ 9 Collie X 11.5 17.5 "f*9 -5
10 Spaniel 12.5 16 +15
11 Collie X 13.0 15.5 -12 -35
12 Corgi 13.5 18.5 -14 -19
13 West Highland 13.5 18.5 -38
14 Beagle 13.5 17 -2
15 Collie X 14 16 +8 +2
16 Terrier X 14 17.25 +4 -13
17 Terrier X 15.5 16.5 + 3 -11
18 Wire Haired Terrier 15.5 16.5 +22 +6
19 Collie 16 18.5 -12 -24
20 Collie 17.25 17 +17 -16
21 Terrier X 18 18.5 -15
22 Bull Terrier 18 21 -21
23 Spaniel 18.5 19 +15 -3
24 Labrador 18.5 17 -12
25 Terrier X 19 18 -13
26 Dalmation 19 18 +11 -7
»endix 3 (Cont’d.)






2.5cm cuff 3.75ora cuff 5.0cm (
27 Boxer 23 19.2 +7
28 Greyhound 23 17.2 -10 -35 -41
29 Greyhound 24 19 0 -19 0
30 Setter 24 21 -2
31 Collie X 24.5 20.5 +5
32 Greyhound 27 19.5 +10 -5
33 Greyhound 27- 20.4 +24 +15 -lo
34 Labrador 27 19.5 0 -25
35 Labrador 27 20.5 -19
36 Alsatian 27 23 -3 “11
37 Greyhound 28 19.6 +22 —6 -13
38 Alsatian 28 22.8 +11 -13
39 Labrador 28 19 0 -6
40 Greyhound 28 20 +39 +11
41 Alsatian 29 22.4 +9
42 Alsatian 29 22 +31 +2
43 Alsatian 30 22 -4
44 Retriever 32.5 25 -17 -28
45 Doberman 33 22.5 + 7
46 Boxer 33 24 -3
47 Labrador 34 22 +17
48 Alsatian 34 23 +13 +2




51 Labrador 47 22 +5
Appendix 4
Effects of .Intravenous anaesthetics on mean arterial pressure in pigs
Thiopentone 
Pig No.
lOmg kg“  ^
Pre-dose 1
Mean arterial pressure 
Minutes after injection 
2 3 4 5 20
74 83 65 93 128 121 115 80
12 84 62 89 85 84 83
55 86 70 92 88 92 95
43 119 87 126 125 123 120 129
3 84 70 87 87 . 87 87 82
4 94 80 118 108 91 91 91
5 87 64 88 89 90 86 90
6 95 74 93 94 93 95 93
Mean 92 72 98 101 98 97 94
± S.D. +12 +8.6 +15 +17.6 +15. 3 +13.7 +17.8
Thiopentone 20mg kg“^
74 87 62 113 130 108 108 97
12 95 57 103 98 98 93 100
43 89 86 107 103 98 97 107
3 90 72 97 114 112 112 95
4 90 50 85 93 93 93 91
5 92 53 98 118 118 118 99
Mean 91 63 101 109 105 104 98
+ S. D. +2.7 +13.5 +9.6 +13,9 +9.7 +10.6 +5.4
Appendix 4 (cont’d)
’Althesin’ l.Smg kg-1 Mean arterial pressure (mmHg)
Pig. No. Pre-dose Minutes after injection
1 2 3 4 5 20
43 88 83 97 93 97 103
12 86 76 89 89 91 97
74 95 70 94 96 95 95
55 97 84 113 103 105 102
3 86 93 103 102 102 109 98
4 91 67 79 77 76 82 98
5 93 73 90 90 85 80 89
Mean 91 78 95 93 93 95 95
± S.D. +4.4 +9.1 +10,.9 +8.9 +10.0 +10.8 +5-2
'Althesin' 3.6rag kg
1 78 65 95 104 104 102 91
55 93 77 109 115 105 97 88
43 92 82 150 125 120 101 89
74 87 78 85 96 91 88 97
12 92 57 79 100 108 105 91
3 88 67 81 92 91 91 86
4 102 81 98 92 85 87 87
5 82 81 96 95 93 91 84
Mean 89 74 99 102 lOO 95 89
+ S.D. +7.3 +9.3 +22 .8 +11.9 +11.6 +6.9 +4.0
Appendix 4 (cont'd)
Disoprofol 2.5 mg kg Mean arterial pressure (mmHg) 
Minutes after injection
Pig No. Pre-dose 1 2 3 4 5 20
55 91 87 86 82 81 83 85
43 102 77 97 90 91 96 99
12 86 61 145 142 98 87 70
74 89 68 83 83 83 83 94
3 93 77 86 87 88 89 88
4 88 55 77 80 81 80
5 84 75 71 73 70 70 80
Mean 90 71 92 91 85 84 86
+ S.D. +5.9 +10.9 +24.7 j^ 23.1 +8.9 +8.1 +10.3
Disoprofol 5.0 rag kg
55 85 75 96 99 93 90 92
74 87 53 67 85 87 87 86
12 87 58 67 93 97 96 80
43 97 80 81 89 92 93 107
3 89 53 85 90 91 91 85
4 101 66 71 82 91 94 86
5 89 65 73 75 80 82 83
Mean 91 64 77 88 90 90 88
+ S.D. +5.9 +10.5 +10. 8 + 7.8 +5.4 +4. 7 +9.0
Appendix 5
Effects of intravenous anaesthetics on heart rate in pigs
-1Thiopentone lOmg kg -1Heart rate min
Minutes after injection
Pig No. Pre-dose 1 2 3 4 5 20
74 96 164 120 136 132 130 104
12 116 172 146 136 136 136
55 124 196 180 196 200 184
43 88 180 116 112 106 106 88
3 110 200 160 164 160 160 132
4 160 180 192 188 188 188 172
5 124 186 140 144 144 144 126
6 120 200 140 140 132 128 124
Mean 117 185 149 152 150 147 124
+ S.D. ±21-. 7 +d3.3 +26.8 +28.5 + 31, 3 +28,5 +28.5
Thiopentone 20mg kg ^
74 104 160 180 138 138 140 132
12 98 162 184 172 164 150 114
43 116 180 148 144 140 138 116
3 148 200 216 212 208 208 172
4 140 188 184 184 180 180 164
5 136 186 170 198 196 196 168
Mean 124 179 180 175 171 169 144
+ S.D. +20.6 +15.6 +22.1 +29.4 +28.9 +30.1 +26.8
Appendix 5 (cont'd)
'Althesin' 1.8mg kg ^ Heart rate — 1min
Minutes after injection
Pig No. Pre-dose 1 2 3 4 5 20
43 130 224 224 220 232 224
12 144 200 220 220 220 200
74 160 180 212 220 224 224
55 148 224 212 208 212 220
3 104 170 160 160 160 160 150
4 140 208 196 200 200 188 176
5 132 148 200 138
Mean 136 193 203 205 208 202 155
+ S.D. +17.7 +2 8.6 +21.6 4^3.4 +25.9 +25.5 +19.4
'Althesin' “13.6mg kg
1 104 180 148 148 136 112
55 84 188 212 212 198 168 124
43 92 156 176 160 156 152 114
74 90 160 120 130 160 160 136
12 82 126 124 136 138 138 100
3 110 200 200 192 172 164 156
4 124 160 180 170 170 166 140
5 156 200 200 208 200 188 164
Mean 105 171 170 170 171 159 131
+ S.D. +24.9 +25.5 +35.5 +31.7 +22.4 +17.0 +2 2.3
Appendix 5 (cont'd)
Disoprofol 2.5mg kg-1 Heart rate min 
Minutes after injection
Pig No. Pre-dose 1 2 3 4 5 20
82 120 168 130 120
55 116 156 148 146 144 136 124
43 108 156 140 136 132 128 112
12 124 148 200 190 180 144 128
74 84 120 116 116 108 104 84
3 90 172 152 136 124 116 100
4 128 156 164 164 162 160
5 134 164 154 156 152 144 132
Mean 112 153 153 151 143 133 114




82 loo 188 170 160 140 138 110
2 112 186 168 144 120 136 118
1 84 100 100 100 92 80
55 108 200 200 184 176 172 128
74 84 310 124 112 108 104 86
12 114 180 180 190 170 152 116
43 132 112
3 116 192 184 172 168 160 126
4 136 172 168 180 172 164 138
5 136 188 170 174 170 166 130
Mean 113 180 163 157 147 143 115
+ S.D. +17.3 +21.6 +29.4 +32.2 +30.6 +28.2 +19.8
Appendix 6
Responses obtained in mini-pigs given a second administration of















372 - - -
351 - - - +
400 - - - -
408 - - — -
301 - - - -
162 'Althesin'(b) — - _ -
167 A,C,R + + +
383 F,C,R + + -
426 F,C,R + + +
364 'Epontol'(c) A,F,E,C + + +
386 F,E,C +
352 F,E,C + + +
375 A,F,E,C + + -
474 E,C + -
45 3 +
(a) Adverse clinical responses: A=Apnoea >30s; C=Cyanosis; 
R=Erythematous rash; F=Flush; E=Excitatory effects
(b) 'Althesin' contains alphaxalone/alphadolone in 20% 
Cremophor EL
(c) 'Epontol' contains propanidid in 20% Micellophor, a 
butanol extract of Cremophor EL
Appendix 6 (cont'd)
Pig No. Agent Adverse Hypertensive Decrease in Increase in
clinical response polymorphs plasma
response BOiranHg 50% histamine
(a) 50%
394 A l p h a x a l o n e /  P , R  + -  -
a l p h a d o l o n e ( c )
379 " F + -
362 " — _ — _
349 " — + + +
452 P r o p a n i d i d ( c )  -
482 " - -
522 -
543 " - -
250 C r e m o p h o r  E L  -  +  +  -
254 " V , E , C  + +  +
318 " V , E , C  + + +
329 " V , E , C  + +  +
366 "  E  +  + +
397 E t h y l  a l c o h o l /  - -
p r o p y l e n e  g l c y o l  
365 -
545 " - -
(a) Adverse clinical responses: F=Flush; R=Erythematous rash;
V=Vomiting; E=Excitatory effects; C=Cyanosis
(c) Solubilized in ethyl alcohol and propylene glycol
Appendix 7
Sleeping times in pigs produced by two doses of anaesthetic agents 
given at an interval of 7 days
Thiopentone lOmg kg Sleeping time (min)







Mean + S.D. 10.0 + 3.4 10.3 + 3.7
'Althesin' -11.8mg kg
162 5 10
‘ 167 8 18
383 6 7
426 7 19
Mean + S.D, 6.5 + 1.2 13.5 + 5.9







Mean + S.D. 2.9 + 1.1 3.5+3.3
Appendix 7 (cont'd)
Sleeping time (min)














Mean + S.D. 4.0 + 0.81 4.5 + 0.57
